General References


Ma B, Lei X, Guan Y et al. Maintenance of retinal cancer stem cell-like properties through long-term serum-free culture from human retinoblastoma. Oncol Rep 2011; 26:135-43.

Ma B, Polsky-Fisher SL, Vickers S, Cui D, Rodrigues AD. Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics. Drug Metab Dispos 2007; 35:1301-7.

Ma B, Prueksaritanont T, Lin JH. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos 2000; 28:125-30.

Ma CX, Adjei AA, Salavaggione OE et al. Human aromatase: gene resequencing and functional genomics. Cancer Res 2005; 65:11071-82.

Ma EY, Rubel EW, Raible DW. Notch signaling regulates the extent of hair cell regeneration in the zebrafish lateral line. J Neurosci 2008; 28:2261-73.

Ma F, Sun T, Shi Y et al. Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib. Lung Cancer 2009; 66:114-9.

Ma H, Hu Z, Wang H et al. ERCC6/CSB gene polymorphisms and lung cancer risk. Cancer Lett 2009; 273:172-6.

Ma J, Bradbury JA, King L et al. Molecular cloning and characterization of mouse CYP2J6, an unstable cytochrome P450 isoform. Biochem Pharmacol 2002; 64:1447-60.

Ma J, Lin JY, Alloo A et al. Isolation of tumorigenic circulating melanoma cells. Biochem Biophys Res Commun 2010; 402:711-7.

Ma J, Lindquist S. Conversion of PrP-Sc-like conformation in the cytosol. Science 2002; 298:1785-8.

Ma J, Möllsten A, Falhammar H et al. Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy. J Diabetes Complications 2007; 21:28-33.

Ma J, Ramachandran S, Fiedorek FT Jr, Zeldin DC. Mapping of the CYP2J cytochrome P450 genes to human chromosome 1 and mouse chromosome 4. Genomics 1998; 49:152-5.

Ma J, Wang D, Ward DC et al. Structure and chromosomal localization of the gene (BDKRB2) encoding human bradykinin B2 receptor. Genomics 1994; 23:362-9.

Ma J, Wollmann R, Linquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2002; 298:1781-5.

Ma JD, Nafziger AN, Villano SA, Gaedigk A, Bertino JS Jr. Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults. Antimicrob Agents Chemother 2006; 50:1130-5.

Ma JX, Zhang KL, Liu X et al. Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China. Cancer Lett 2006; 240:253-60.

Ma JZ, Beuten J, Payne TJ, Dupont RT, Elston RC, Li MD. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum Mol Genet 2005; 14:1691-8.

Ma K, Xiao R, Tseng HT, Shan L, Fu L, Moore DD. Circadian dysregulation disrupts bile acid homeostasis. PLoS One 2009. doi:10. 1371/journal. pone. 0006843.

Ma KY, Yang N, Jiao R et al. Dietary calcium decreases plasma cholesterol by down-regulation of intestinal Niemann-Pick C1 like 1 and microsomal triacylglycerol transport protein and up-regulation of CYP7A1 and ABCG 5/8 in hamsters. Mol Nutr Food Res 2011; 55:247-58.

Ma KY, Zhang ZS, Zhao SX et al. Red yeast rice increases excretion of bile acids in hamsters. Biomed Environ Sci 2009; 22:269-77.

Ma L, Cheng GH, Wang H, Li L, Gong YQ, Liu QJ. Association of the ABCG1 gene polymorphism with the susceptibility and severity of coronary atherosclerotic disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2010; 27:506-11.

Ma L, Dong F, Denis M, Feng Y, Wang MD, Zha X. Ht31, a protein kinase A anchoring inhibitor, induces robust cholesterol efflux and reverses macrophage foam cell formation through ATP-binding cassette transporter A1. J Biol Chem 2011; 286:3370-8.

Ma MK, McLeod HL. Lessons learned from the irinotecan metabolic pathway. Curr Med Chem 2003; 10:41-9.

Ma Q, Brazeau D, Zingman BS et al. Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV. Pharmacogenomics 2007; 8:227-35.

Ma Q, Forrest A, Rosenkranz SL et al. Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos 2008; 29:91-101.

Ma S, Yang D, Li D, Tang B, Yang Y. Oleic acid induces smooth muscle foam cell formation and enhances atherosclerotic lesion development via CD36. Lipids Health Dis 2011; 10:53.

Ma T, Huang C, Zong G et al. Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. J Pharm Pharmacol 2011; 63:587-93.

Ma W, Xu J, Wang Q et al. Interaction of functional NPC1 gene polymorphism with smoking on coronary heart disease. BMC Med Genet 2010; 11:149.

Ma WJ, Lv GD, Zheng ST et al. DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China. World J Gastroenterol 2010; 16:641-7.

Ma X, Cheung C, Krausz KW et al. A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4. Drug Metab Dispos 2008; 36:2506-12.

Ma X, Qi X, Chen C et al. Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls. Breast Cancer Res Treat 2010; 122:495-501.

Ma X, Shah YM, Guo GL et al. Rifaximin is a gut-specific human pregnane X receptor activator. J Pharmacol Exp Ther 2007; 322:391-8.

Ma XJ, Hilsenbeck SG, Wang W et al. The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol 2006; 24:4611-9.

Ma XJ, Wang Z, Ryan PD et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004; 5:607-16.

Ma XY, Liu JP, Song ZY. Associations of the ATP-binding cassette transporter A1 R219K polymorphism with HDL-C level and coronary artery disease risk: A meta-analysis. Atherosclerosis 2011; 215:428-34.

Ma Y, Fan S, Hu C et al. BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha. Mol Endocrinol 2010; 24:76-90.

Ma Y, Ni W, Zhu W, Xiong Y, Deng X. Association of genetic polymorphisms of CYP 2C19 with hypertension in a Chinese Han population. Blood Press 2011; 20:166-70.

Ma Y, Sachdeva K, Liu J et al. Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23. Drug Metab Dispos 2004; 32:1317-24.

Mabry CC, Digeorge AM, Auerbach VH. Leucine-induced hypoglycemia. I. Clinical observations and diagnostic considerations. J Pediatr 1960; 57:526-38.

MacDonald CJ, Cheng RY, Roberts DD, Wink DA, Yeh GC. Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation. J Biol Chem 2009; 284:22099-107.

MacDonald KS, Fowke KR, Kimani J et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000; 181:1581-9.

MacDonald ME, Barnes G, Srinidhi J et al. Gametic but not somatic instability of CAG repeat leght in Huntigton’s disease. J Med Genet 1993; 30:982-6.

MacDonald ME, Novelletto A, Lin C et al. The Huntington’s disease candidate regions exhibits many different haplotypes. Nat Genet 1992; 1:99-103.

MacDonald ME, Vonsattel JP, Shrinidhi J et al. Evidence for the GluR6 gene associated with younger onset age of Huntington’s disease. Neurology 1999; 53:1330-2.

Macé K, Aguilar F, Wang JS et al. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis 1997; 18:1291-7.

Macé K, Bowman ED, Vautravers P, Shields PG, Harris CC, Pfeifer AM. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur J Cancer 1998; 34:914-20.

Macgregor S, Lind PA, Bucholz KK et al. Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis. Hum Mol Genet 2009; 18:580-93.

Maciel ME, Oliveira FK, Propst GB, da Graça Bicalho M, Cavalli IJ, Ribeiro EM. Population analysis of xenobiotic metabolizing genes in South Brazilian Euro and Afro-descendants. Genet Mol Biol 2009; 32:723-8.

MacInnis MJ, Koehle MS, Rupert JL. Evidence for a genetic basis for altitude illness: 2010 update. High Alt Med Biol 2010; 11:349-68.

Maciolek CM, Ma B, Menzel K et al. Novel cytochrome P450-mediated ring opening of the 1,3,4-oxadiazole in setileuton, a 5-lipoxygenase inhibitor. Drug Metab Dispos 2011; 39:763-70.

Mackenzie PI, Bock KW, Burchell B et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 2005; 15:677-85.

Mackevics V, Heid IM, Wagner SA et al. The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Europ J Hum Genet 2006; 14:349-56.

Mackey JR, Yao SY, Smith KM et al. Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. J Natl Cancer Inst 1999; 91:1876-81.

Macknin JB, Higuchi M, Lee VM, Trojanowski JQ, Doty RL. Olfactory dysfunction occurs in transgenic mice overexpressing human tau protein. Brain Res 2004; 1000:174-8.

MacLean C, Moenning U, Reichel A, Fricker G. Regional absorption of fexofenadine in rat intestine. Eur J Pharm Sci 2010; 41:670-4.

Macmullen CM, Zhou Q, Snider KE et al. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the {beta}-Cell sulfonylurea receptor SUR1. Diabetes 2011; 60:1797-804.

Macpherson L, Matthews J. Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells. Cancer Lett 2010; 299:119-29.

MacQueen G, Born L, Steiner M. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Rev 2001; 7:1-24.

Machinist JM, Mayer MD, Shet MS, Ferrero JL, Rodrigues AD. Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193. Drug Metab Dispos 1995; 23:1163-74.

Machulda MM, Jones DT, Vemuri P et al. Effect of APOE {varepsilon}4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol 2011; 68:1131-6.

Madabushi R, Frank B, Drewelow B, Derendorf H, Butterweck V. Hyperforin in St. John’s wort drug interactions. Eur J Clin Pharmacol 2006; 62:225-33.

Madadi P, Ciszkowski C, Gaedigk A et al. Genetic transmission of cytochrome P450 2D6 (CYP2D6) ultrarapid metabolism: implications for breastfeeding women taking codeine. Curr Drug Saf 2011; 6:36-9.

Madadi P, Hildebrandt D, Gong IY et al. Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions. Pediatrics 2010; 126:986-9.

Madadi P, Koren G. Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use. Pharmacogenomics 2008; 9:1267-84.

Madadi P, Ross CJ, Hayden MR et al. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharmacol Ther 2009; 85:31-5.

Madadi P, Shirazi F, Walter FG, Koren G. Establishing causality of CNS depression in breastfed infants following maternal codeine use. Paediatr Drugs 2008; 10:399-404.

Madan A, Fisher A, Jin L, Chapman D, Bozigian HP. In vitro metabolism of indiplon and an assessment of its drug interaction potential. Xenobiotica 2007; 37:736-52.

Madan A, Graham RA, Carroll KM et al. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos 2003; 31:421-31.

Madan A, Parkinson A, Faiman MD. Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram. Drug Metab Dispos 1995; 23:1153-62.

Madan A, Parkinson A, Faiman MD. Identification of the human P-450 enzymes responsible for the sulfoxidation and thiono-oxidation of diethyldithiocarbamate methyl ester: role of P-450 enzymes in disulfiram bioactivation. Alcohol Clin Exp Res 1998; 22:1212-9.

Madani S, Barilla D, Cramer J, Wang Y, Paul C. Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers. J Clin Pharmacol 2002; 42:1211-8.

Maddocks JL, Al-Safi SA. Lack of inhibition of purine nucleoside phosphorylase and adenosine deaminase in patients treated with azathioprine. Br J Clin Pharmacol 1985; 19:108-11.

Madec S, Cerec V, Plee-Gautier E et al. CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload. Drug Metab Dispos 2011; 39:1987-96.

Madeira M, Levine M, Chang TK, Mirfazaelian A, Bellward GD. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6. Drug Metab Dispos 2004; 32:460-7.

Madgula VL, Ali Z, Smillie T, Khan IA, Walker LA, Khan SI. Alkaloids and saponins as cytochrome P450 inhibitors from blue cohosh (Caulophyllum thalictroides) in an in vitro assay. Planta Med 2009; 75:329-32.

Madgula VL, Avula B, Pawar RS et al. In vitro metabolic stability and intestinal transport of P57AS3 (P57) from Hoodia gordonii and its interaction with drug metabolizing enzymes. Planta Med 2008; 74:1269-75.

Madgula VL, Avula B, Pawar RS et al. Characterization of in vitro pharmacokinetic properties of hoodigogenin A from Hoodia gordonii. Planta Med 2010; 76:62-9.

Madhur MS, Funt SA, Li L et al. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in Apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2011; 31:1565-72.

Madsen H, Rasmussen BB, Brøsen K. Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4. Clin Pharmacol Ther 1997; 61:319-24.

Madsen K, Neumann WJ, Holst K et al. Cerebral serotonin 4 receptors and amyloid-β in early Alzheimer’s disease. J Alzheimers Dis 2011; 26:457-66.

Mae T, Hosoe K, Fujii K et al. In vitro metabolism of a rifamycin derivative by animal and human liver microsomes, whole blood and expressed human CYP3A isoform. Xenobiotica 1996; 26:793-802.

Mae T, Inaba T, Konishi E, Hosoe K, Hidaka T. Identification of enzymes responsible for rifalazil metabolism in human liver microsomes. Xenobiotica 2000; 30:565-74.

Maeda A, Ando H, Asai T et al. Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine. Clin Pharmacol Ther 2011; 89:229-33.

Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996; 221:286-9.

Maeda T, Irokawa M, Arakawa H et al. Uptake transporter organic anion transporting polypeptide 1B3 contributes to the growth of estrogen-dependent breast cancer. J Steroid Biochem Mol Biol 2010; 122:180-5.

Maeda Y, Hizawa N, Jinushi E et al. Polymorphisms in the muscarinic receptor 1 gene confer susceptibility to asthma in Japanese subjects. Am J Respir Crit Care Med 2006; 174:1119-24.

Maekawa K, Fukushima-Uesaka H, Tohkin M et al. Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese. Pharmacogenet Genomics 2006; 16:497-514.

Maekawa K, Yoshimura T, Saito Y et al. Functional characterization of CYP3A4. 16: catalytic activities toward midazolam and carbamazepine. Xenobiotica 2009; 39:140-7.

Maekawa T, Takahashi N, Tabeta K et al. Chronic oral infection with porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One 2011. doi:10. 1371/journal. pone. 0020240.

Maeno K, Nakajima A, Conseil G, Rothnie A, Deeley RG, Cole SP. Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of transmembrane helix (TM) 6 and TM17 mutants of multidrug resistance protein 1 (ABCC1). Drug Metab Dispos 2009; 37:1411-20.

Mäenpää J, Hall SD, Ring BJ, Strom SC, Wrighton SA. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone. Pharmacogenetics 1998; 8:137-55.

Mäenpää J, Pelkonen O, Cresteil T, Rane A. The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. J Steroid Biochem Mol Biol 1993; 44:61-7.

Maezawa K, Matsunaga T, Takezawa T, Kanai M, Ohira S, Ohmori S. Cytochrome P450 3As gene expression and testosterone 6beta-hydroxylase activity in human fetal membranes and placenta at full term. Biol Pharm Bull 2010; 33:249-54.

Maezawa Y, Yamauchi M, Toda G, Suzuki H, Sakurai S. Alcohol-metabolizing enzyme polymorphisms and alcoholism in Japan. Alcohol Clin Exp Res 1995; 19:951-4.

Mafficini A, Ortombina M, Sermet-Gaudelius I et al. Impact of polymorphism of multidrug resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. J Cyst Fibros 2011; 10:228-33.

Mafrica F, Fodale V. Thyroid function, Alzheimer’s disease and postoperative cognitive dysfunction: a tale of dangerous liaisons? J Alzheimers Dis 2008; 14:95-105.

Magdelaine A, Verdy E, Coulet F et al. Deep vein thrombosis during enoxaparin prophylactic treatment in a young pregnant woman homozygous for factor V Leiden and heterozygous for the G127→a mutation in the thrombomodulin gene. Blood Coagul Fibrinolysis 2000; 11:761-5.

Magge SN, Shyng SL, MacMullen C et al. Familial leucine-sensitive hypoglycemia of infancy due to a dominant mutation of the beta-cell sulfonylurea receptor. J Clin Endocrinol Metab 2004; 89:4450-6.

Maggini V, Buda G, Martino A et al. MDR1 diplotypes as prognostic markers in multiple myeloma. Pharmacogenet Genomics 2008; 18:383-9.

Maggo SD, Kennedy MA, Clark DW. Clinical implications of pharmacogenetic variation on the effects of statins. Drug Saf 2011; 34:1-19.

Magliulo L, Dahl ML, Lombardi G et al. Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment? Eur J Clin Pharmacol 2011; 67:47-54.

Magne L, Blanc E, Legrand B et al. ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytes. J Hepatol 2011; 54:729-37.

Magnusson MO, Dahl ML, Cederberg J, Karlsson MO, Sandström R. Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin. Clin Pharmacol Ther 2008; 84:52-62.

Magnusson Y, Levin MC, Eggertsen R et al. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy. Clin Pharmacol Ther 2005; 78:221-31.

Magoori K, Kang M-J, Ito MR et al. Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. J Biol Chem 2003; 278:11331-6.

Magré J, Delépine M, van Maldergem L et al. Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes 2003; 52:1573-8.

Magri C, Gardella R, Valsecchi P et al. Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients. Am J Med Genet B Neuropsychiatr Genet 2008; 147:745-53.

Maguire P, Margolin S, Skoglund J et al. Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer. Breast Cancer Res Treat 2005; 94:145-52.

Mah V, Marquez D, Alavi M et al. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Lung Cancer 2011; 74:318-25.

Mahajan MK, Uttamsingh V, Daniels JS, Gan LS, LeDuc BW, Williams DA. In vitro metabolism of oxymetazoline: evidence for bioactivation to a reactive metabolite. Drug Metab Dispos 2011; 39:693-702.

Mahajan MK, Uttamsingh V, Gan LS, Leduc B, Williams DA. Identification and characterization of oxymetazoline glucuronidation in human liver microsomes: evidence for the involvement of UGT1A9. J Pharm Sci 2011; 100:784-93.

Mahal SP, Asante EA, Antoniou M, Collinge J. Isolation and functional characterisation of the promoter region of the human prion protein gene. Gene 2001; 268:105-14.

Maharjan R, Nagar PS, Nampoothiri L. Effect of Aloe barbadensis Mill. formulation on letrozole induced polycystic ovarian syndrome rat model. J Ayurveda Integr Med 2010; 1:273-9.

Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst 2003; 20:153-214.

Mahatthanatrakul W, Nontaput T, Ridtitid W, Wongnawa M, Sunbhanich M. Rifampin, a cytochrome P450 3A inducer, decreases plasma concentrations of antipsychotic risperidone in healthy volunteers. J Clin Pharm Ther 2007; 32:161-7.

Mahatthanatrakul W, Sriwiriyajan S, Ridtitid W et al. Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers. J Clin Pharm Ther 2011. doi:10. 1111/j. 1365-2710. 2011. 01271. x.

Mahendroo MS, Cala KM, Hess DL, Russell DW. Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes. Endocrinology 2001; 142:4652-62.

Mahéo K, Morel F, Langouët S et al. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res 1997; 57:3649-52.

Maher ER, Eng C. The pressure rises: update on the genetics of phaeochromocytoma. Hum Molec Genet 2002; 11:2347-54.

Mahesh Kumar KN, Ramu P, Rajan S, Shewade DG, Balachander J, Adithan C. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population. J Cardiovasc Pharmacol 2008; 52:459-66.

Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL. Polymorphic hydroxylation of Debrisoquine in man. Lancet 1977; 2:584-6.

Mahieux F, Couderc R, Bailleul S, Mouligner A. Apolipoprotein E epsilon-4 allele frequency in vascular dementia and Alzheimer’s disease. Stroke 1994; 25:1703-4.

Mahmoud AE, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997; 40:798-800.

Mahringer A, Karamustafa S, Klotz D et al. Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. Cancer Genomics Proteomics 2010; 7:191-205.

Mahungu T, Smith C, Turner F et al. Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population. HIV Med 2009; 10:310-7.

Mahungu TW, Nair D, Smith CJ et al. The relationships of ABCB1 3435C>T and CYP2B6 516G>T with high-density lipoprotein cholesterol in HIV-infected patients receiving efavirenz. Clin Pharmacol Ther 2009; 86:204-11.

Maia RC, Vasconcelos FC, de Sá Bacelar T et al. LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells. Invest New Drugs 2011; 29:1143-55.

Maiellaro-Rafferty K, Weiss D, Joseph G, Wan W, Gleason RL Jr, Taylor WR. Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation. Am J Physiol Heart Circ Physiol 2011; 301:355-62.

Maier A, Zimmermann C, Beglinger C, Drewe J, Gutmann H. Effects of budesonide on P-glycoprotein expression in intestinal cell lines. Br J Pharmacol 2007; 150:361-8.

Maier LA, McGrath DS, Sato H et al. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol 2003; 171:6910-8.

Maier P, Spier I, Laufs S et al. Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K). Gene Ther 2010; 17:389-99.

Maier-Salamon A, Trauner G, Hiltscher R et al. Hepatic metabolism and biliary excretion of valerenic acid in isolated perfused rat livers: role of Mrp2 (Abcc2). J Pharm Sci 2009; 98:3839-49.

Maillard V, Uzbekova S, Guignot F et al. Effect of adiponectin on bovine granulosa cell steroidogenesis, oocyte maturation and embryo development. Reprod Biol Endocrinol 2010; 8:23.

Maimoun L, Philibert P, Cammas B et al. Phenotypical, biological, and molecular heterogeneity of 5{alpha}-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab 2011; 96:296-307.

Mairinger S, Erker T, Müller M, Langer O. PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo. Curr Drug Metab 2011. doi:10. 2174/1389211214348592002.

Mairinger S, Langer O, Kuntner C et al. Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate. Nucl Med Biol 2010; 37:637-44.

Maitland-van der Zee AH, Lynch A, Boerwinkle E et al. Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study. Pharmacogenet Genomics 2008; 18:651-6.

Maitland-van der Zee AH, Turner ST, Schwartz GL, Chapman AB, Klungel OH, Boerwinkle E. A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide. Pharmacogenet Genomics 2005; 15:287-93.

Majdalawieh A, Ro HS. PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1. Nucl Recept Signal 2010. doi:10. 1621/nrs. 08004.

Majnik J, Patocs A, Balogh K et al. Overrepresentation of the N363S variant of the glucocorticoid receptor gene in patients with bilateral adrenal incidentalomas. J Clin Endocrinol Metab 2006; 91:2796-9.

Major JM, Yu K, Wheeler W et al. Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum Mol Genet 2011; 20:3876-83.

Majumdar AK, McCrea JB, Panebianco DL et al. Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe. Clin Pharmacol Ther 2003; 74:150-6.

Majumdar AK, Yan KX, Selverian DV et al. Effect of aprepitant on the pharmacokinetics of intravenous midazolam. J Clin Pharmacol 2007; 47:744-50.

Majumder PP, Staats HF, Sarkar-Roy N et al. Genetic determinants of immune-response to a polysaccharide vaccine for typhoid. Hugo J 2009; 3:17-30.

Makaji E, Trambitas CS, Shen P, Holloway AC, Crankshaw DJ. Effects of cytochrome P450 inhibitors on the biotransformation of fluorogenic substrates by adult male rat liver microsomes and cDNA-expressed rat cytochrome P450 isoforms. Toxicol Sci 2010; 113:293-304.

Makhanova N, Lee G, Takahashi N et al. Kidney function in mice lacking aldosterone. Am J Physiol Renal Physiol 2006; 290:61-9.

Makino T, Mizuno F, Mizukami H. Does a kampo medicine containing schisandra fruit affect pharmacokinetics of nifedipine like grapefruit juice? Biol Pharm Bull 2006; 29:2065-9.

Makita N, Behr E, Shimizu W et al. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 2008; 118:2219-29.

Makoff AJ, Graham JM, Arranz MJ et al. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson’s disease. Pharmacogenetics 2000; 10:43-8.

Makridakis NM, Reichardt JK. Molecular epidemiology of androgen-metabolic loci in prostate cancer: predisposition and progression. J Urol 2004; 171:25-8.

Makridakis N, Reichardt JK. Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride. J Mol Endocrinol 2005; 34:617-23.

Malaise M, Steinbach D, Corbacioglu S. Clinical implications of c-Kit mutations in acute myelogenous leukemia. Curr Hematol Malig Rep 2009; 4:77-82.

Malaplate-Armand C, Ferrari L, Masson C, Siest G, Batt AM. Astroglial CYP1B1 up-regulation in inflammatory/oxidative toxic conditions: IL-1beta effect and protection by N-acetylcysteine. Toxicol Lett 2003; 138:243-51.

Malaty LI, Kuper JJ. Drug interactions of HIV protease inhibitors. Drug Saf 1999; 20:147-69.

Malberg JE, Monteggia LM. VGF, a new player in antidepressant action? Sci Signal 2008; 1:19.

Małek LA, Przyłuski J, Spiewak M et al. Cytochrome P450 2C19 polymorphism, suboptimal reperfusion and all-cause mortality in patients with acute myocardial infarction. Cardiology 2010; 117:81-7.

Malek SN, Dordai DI, Reim J, Dintzis H, Desiderio S. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. Proc Natl Acad Sci USA 1998; 95:7351-6.

Maleki M, Sayyah M, Kamgarpour F et al. Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients. Iran Biomed J 2010; 14:89-96.

Malhotra AK, Goldman D, Ozaki N et al. Clozapine response and the 5HT2C Cys23Ser polymorphism. Neuroreport 1996; 7:2100-2.

Malhotra AK, Virkkunen M, Rooney W, Eggert M, Linnoila M, Goldman D. The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Mol Psychiatry 1996; 1:388-91.

Malhotra B, Darsey E, Crownover P, Fang J, Glue P. Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers. Br J Clin Pharmacol 2011; 72:226-34.

Malhotra B, Guan Z, Wood N, Gandelman K. Pharmacokinetic profile of fesoterodine. Int J Clin Pharmacol Ther 2008; 46:556-63.

Malhotra B, Sachse R, Wood N. Evaluation of drug-drug interactions with fesoterodine. Eur J Clin Pharmacol 2009; 65:551-60.

Malhotra BK, Wood N, Sachse R. Influence of age, gender, and race on pharmacokinetics, pharmacodynamics, and safety of fesoterodine. Int J Clin Pharmacol Ther 2009; 47:570-8.

Malhotra D, Darvishi K, Sood S et al. IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy. Hum Genet 2005; 118:295-300.

Malhotra S, Bailey DG, Paine MF, Watkins PB. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther 2001; 69:14-23.

Maliaka YK, Chudina AP, Belev NF, Alday P, Bochkov NP, Buerstedde JM. CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations. Hum Genet 1996; 97:251-5.

Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer 2010; 62:734-42.

Malik MA, Zargar SA, Mittal B. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir Valley. DNA Cell Biol 2011; 30:1-7.

Malik S, Abel L, Tooker H et al. Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc Natl Acad Sci USA 2005; 102:12183-8.

Malinowski JM. Atorvastatin: a hydroxymethylglutaryl-coenzyme A reductase inhibitor. Am J Health Syst Pharm 1998; 55:2253-67.

Malireddy SR, Pinto AG, Chalasani NP, Gorski JC, Hall SD. Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report. Transplant Proc 2008; 40:1789-91.

Malmström RE, Ostergren J, Jørgensen L, Hjemdahl P; CASTOR investigators. Influence of statin treatment on platelet inhibition by clopidogrel – a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment. J Intern Med 2009; 266:457-66.

Maltese P, Canestrari E, Ruzzo A et al. VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int J Colorectal Dis 2009; 24:165-70.

Malumbres M, Sotillo R, Santamaría D et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 2004; 118:493-504.

Malur A, Baker AD, McCoy AJ et al. Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice. Am J Physiol Lung Cell Mol Physiol 2011; 300:73-80.

Mallery DL, Tanganelli B, Colella S et al. Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome. Am J Hum Genet 1998; 62:77-85.

Mallolas J, Sarasa M, Nomdedeu M et al. Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patients. HIV Med 2007; 8:131-4.

Mamah CE, Lesnick TG, Lincoln SJ et al. Interaction of alpha-synuclein and tau genotypes in Parkinson’s disease. Ann Neurol 2005; 57:439-43.

Mamdani F, Alda M, Grof P, Young LT, Rouleau G, Turecki G. Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet 2008; 147:500-4.

Mamiya K, Ieiri I, Miyahara S et al. Association of polymorphisms in the cytochrome P450 (CYP) 2C19 and 2C18 genes in Japanese epileptic patients. Pharmacogenetics 1998; 8:87-90.

Mamiya K, Ieiri I, Shimamoto J et al. The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics. Epilepsia 1998; 39:1317-23.

Man M, Farmen M, Dumaual C et al. Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans. J Clin Pharmacol 2010; 50:929-40.

Manceau S, Giraud C, Declèves X et al. Lack of P-glycoprotein induction by rifampicin and phenobarbital in human lymphocytes. Int J Pharm 2010; 395:98-103.

Mancuso M, Filosto M, Bellan M et al. POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness. Neurology 2004; 62:316-8.

Mancuso M, Galli R, Pizzanelli C, Filosto M, Siciliano G, Murri L. Antimyoclonic effect of levetiracetam in MERRF syndrome. J Neurol Sci 2006; 243:97-9.

Mancuso P, Peters-Golden M, Goel D et al. Disruption of leptin receptor-STAT3 signaling enhances leukotriene production and pulmonary host defense against pneumococcal pneumonia. J Immunol 2011; 186:1081-90.

Manda VK, Mittapalli RK, Bohn KA, Adkins CE, Lockman PR. Nicotine and cotinine increases the brain penetration of saquinavir in rat. J Neurochem 2010; 115:1495-507.

Mandal PK, Pettegrew JW. Abeta peptide interactions with isoflurane, propofol, thiopental and combined thiopental with halothane: a NMR study. Biochim Biophys Acta 2008; 1778:2633-9.

Mandal RK, Gangwar R, Mandhani A, Mittal RD. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India. DNA Cell Biol 2010; 29:183-90.

Mandic R, Rodgarkia-Dara CJ, Krohn V, Wiegand S, Grénman R, Werner JA. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor. Anticancer Res 2009; 29:1181-7.

Mandlekar SV, Rose AV, Cornelius G et al. Development of an in vivo rat screen model to predict pharmacokinetic interactions of CYP3A4 substrates. Xenobiotica 2007; 37:923-42.

Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for MCP-1 in alcoholic liver injury: Regulation of pro-inflammatory cytokines and hepatic steatosis. Hepatology 2011. doi:10. 1002/hep. 24599.

Manev H, Chen H, Dzitoyeva S, Manev R. Cyclooxygenases and 5-lipoxygenase in Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:315-9.

Manev H, Uz T, Sugaya K, Qu T. Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J 2000; 14:1464-9.

Manevski N, Kurkela M, Höglund C et al. Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. Drug Metab Dispos 2010; 38:386-95.

Manfo FP, Moundipa PF, Déchaud H et al. Effect of agropesticides use on male reproductive function: A study on farmers in Djutitsa (Cameroon). Environ Toxicol 2010. doi:10. 1002/tox. 20656.

Manfredi S, Calvi D, del Fiandra M, Botto N, Biagini A, Andreassi MG. Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus. Pharmacogenomics 2009; 10:29-34.

Manga N, Duffy JC, Rowe PH, Cronin MT. Structure-based methods for the prediction of the dominant P450 enzyme in human drug biotransformation: consideration of CYP3A4, CYP2C9, CYP2D6. SAR QSAR Environ Res 2005; 16:43-61.

Mangano NG, Cutuli VM, Caruso A, de Bernardis E, Amico-Roxas M. Grapefruit juice effects on the bioavailability of cyclosporin-A in rats. Eur Rev Med Pharmacol Sci 2001; 5:1-6.

Mangold E, Pagenstecher C, Leister M et al. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet. 2004l; 41:567-72.

Mangold JB, Gu H, Rodriguez LC, Bonner J, Dickson J, Rordorf C. Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects. Drug Metab Dispos 2004; 32:566-71.

Mani O, Körner M, Ontsouka CE et al. Identification of ABCA1 and ABCG1 in milk fat globules and mammary cells-Implications for milk cholesterol secretion. J Dairy Sci 2011; 94:1265-76.

Mani O, Körner M, Sorensen MT et al. Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin. Am J Physiol Regul Integr Comp Physiol 2010; 299:642-54.

Mani S, Huang H, Sundarababu S et al. Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agents. Clin Cancer Res 2005; 11:6359-69.

Mani S, Wang C, Wu K, Francis R, Pestell R. Cyclin-dependent kinase inhibitors: novel anticancer agents. Expert Opin Investig Drugs 2000; 9:1849-70.

Manichaikul A, Wang Q, Shi YL, Zhang Z, Leitinger N, Shi W. Characterization of Ath29, a major mouse atherosclerosis susceptibility locus, and identification of Rcn2 as a novel regulator of cytokine expression. Am J Physiol Heart Circ Physiol 2011; 301:1056-61.

Manimaran A, Sarkar SN, Sankar P. Influence of repeated preexposure to arsenic on acetaminophen-induced oxidative stress in liver of male rats. Food Chem Toxicol 2010; 48:605-10.

Mankowski DC. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6. Drug Metab Dispos 1999; 27:1024-8.

Mankowski DC, Lawton MP, Ekins S. Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates. Xenobiotica 2000; 30:745-54.

Mann A, Miksys S, Lee A, Mash DC, Tyndale RF. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology 2008; 55:1147-55.

Mann A, Tyndale RF. Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells. Eur J Neurosci 2010; 31:1185-93.

Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood 2003; 101:20-30.

Manna P, Bhattacharyya S, Das J, Ghosh J, Sil PC. Phytomedicinal role of Pithecellobium dulce against CCl(4)-mediated hepatic oxidative impairments and necrotic cell death. Evid Based Complement Alternat Med 2011. doi:10. 1093/ecam/neq065.

Mannel M. Drug interactions with St John’s wort: mechanisms and clinical implications. Drug Saf 2004; 27:773-97.

Mannens GS, Snel CA, Hendrickx J et al. The metabolism and excretion of galantamine in rats, dogs, and humans. Drug Metab Dispos 2002; 30:553-63.

Mannheimer B, Bahr CV, Pettersson H, Eliasson E. Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy. Ther Drug Monit 2008; 30:565-9.

Manning BM, Quane KA, Ording H et al. Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation. Am J Hum Genet 1998; 62:599-609.

Mannucci E, Pala L, Ciani S et al. Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia 2005; 48:1168-72.

Mannucci PM, Asselta R, Duga S et al. The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease. J Thromb Haemost 2010; 8:2116-21.

Mano Y, Usui T, Kamimura H. In vitro inhibitory effects of non-steroidal antiinflammatory drugs on UDP-glucuronosyltransferase 1A1-catalysed estradiol 3beta-glucuronidation in human liver microsomes. Biopharm Drug Dispos 2005; 26:35-9.

Mano Y, Usui T, Kamimura H. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes. Drug Metab Dispos 2007; 35:602-6.

Mano Y, Usui T, Kamimura H. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver. Drug Metab Dispos 2007; 35:1182-7.

Mano Y, Usui T, Kamimura H. Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes. Eur J Clin Pharmacol 2007; 63:211-6.

Mano Y, Usui T, Kamimura H. Species differences in inhibition potential of nonsteroidal anti-inflammatory drugs against estradiol 3beta-glucuronidation between rats, dogs, and humans. J Pharm Sci 2008; 97:2805-10.

Manoguerra AS, Erdman AR, Woolf AD et al. Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 2008; 46:661-76.

Manor I, Corbex M, Eisenberg J et al. Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). Am J Med Genet B Neuropsychiatr Genet 2004; 127:73-7.

Manor I, Tyano S, Mel E et al. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 2002; 7:626-32.

Mansoori N, Tripathi M, Alam R et al. IL-6-174 G/C and ApoE gene polymorphisms in Alzheimer’s and vascular dementia patients attending the cognitive disorder clinic of the All India Institute of Medical Sciences, New Delhi. Dement Geriatr Cogn Disord 2010; 30:461-8.

Mansouri MR, Schuster J, Badhai J et al. Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure. Hum Mol Genet 2008; 17:3776-83.

Mansur AJ, Fontes RS, Canzi RA et al. Beta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure. BMC Cardiovasc Disord 2009; 9:50.

Mantegazza M, Gambardella A, Rusconi R et al. Identification of an Nav1. 1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proc Natl Acad Sci USA 2005; 102:18177-82

Mantel-Teeuwisse AK, Klungel OH, Schalekamp T, Verschuren WM, Porsius AJ, de Boer A. Suboptimal choices and dosing of statins at start of therapy. Br J Clin Pharmacol 2005; 60:83-9.

Manthey D, Gamerdinger M, Behl C. The selective beta1-adrenoceptor antagonist nebivolol is a potential oestrogen receptor agonist with neuroprotective abilities. Br J Pharmacol 2010; 159:1264-73.

Manthey HD, Thomas AC, Shiels IA et al. Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice. FASEB J 2011; 25:2447-55.

Manthey JA, Buslig BS. Distribution of furanocoumarins in grapefruit juice fractions. J Agric Food Chem 2005; 53:5158-63.

Mantione KJ, Cadet P, Zhu W et al. Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: autocrine/paracrine feedback inhibition. Addict Biol 2008; 13:118-23.

Manuelian T, Hellwage J, Meri S et al. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 2003; 111:1181-90.

Manunta P, Citterio L, Lanzani C, Ferrandi M. Adducin polymorphisms and the treatment of hypertension. Pharmacogenomics 2007; 8:465-72.

Manunta P, Lavery G, Lanzani C et al. Physiological interaction between alpha-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation. Hypertension 2008; 52:366-72.

Manyike PT, Kharasch ED, Kalhorn TF, Slattery JT. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 2000; 67:275-82.

Mao B, Gozalbes R, Barbosa F et al. QSAR modeling of in vitro inhibition of cytochrome P450 3A4. J Chem Inf Model 2006; 46:2125-34.

Mao J, Chirala SS, Wakil SJ. Human acetyl-CoA carboxylase 1 gene: presence of three promoters and heterogeneity at the 5-prime-untranslated mRNA region. Proc Nat Acad Sci USA 2003; 100:7515-20.

Mao J, DeMayo FJ, Li H et al. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Nat Acad Sci USA 2006; 103:8552-7.

Mao JJ, Su HI, Feng R et al. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Res 2011; 13:8.

Mao MJ, Hu JP, Chen FR, Zhang YY, Liu P. Effects of Chinese herbal medicine Guanxinkang on lipid metabolism and serum C-reactive protein, amyloid A protein and fibrinogen in apolipoprotein E-knockout mice with atherosclerosis. Zhong Xi Yi Jie He Xue Bao 2011; 9:306-12.

Mao QQ, Sun X, Qiu DN, Fu XD, Liu Y, Wang WJ. Effects of Fufang Jiangzhi No. 3 on cholesterol-bile acid metabolism in rabbits with hypercholesterolemia. Zhong Xi Yi Jie He Xue Bao 2010; 8:453-7.

Mao R, Fan Y, Zuo L et al. Association study between methylenetetrahydrofolate reductase gene polymorphisms and Graves’ disease. Cell Biochem Funct 2010; 28:585-90.

Mao W, Rupasinghe S, Zangerl AR, Schuler MA, Berenbaum MR. Remarkable substrate-specificity of CYP6AB3 in Depressaria pastinacella, a highly specialized caterpillar. Insect Mol Biol 2006; 15:169-79.

Mao XJ, Zhang XM, Zhang HL et al. TNF-alpha receptor 1 deficiency reduces antigen-presenting capacity of Schwann cells and ameliorates experimental autoimmune neuritis in mice. Neurosci Lett 2010; 470:19-23.

Mao YM, Liu ZQ, Chen BL et al. Effect of 393T>C polymorphism of GNAS1 gene on dobutamine response in Chinese healthy subjects. J Clin Pharmacol 2009; 49:929-36.

Mao ZL, Alak A, Wheeler JJ, Keirns J. Disposition and mass balance of [14C]vernakalant after single intravenous and oral doses in healthy volunteers. Drug Metab Lett 2011; 5:114-25.

Mao ZL, Townsend RW, Gao C, Wheeler JJ, Kastrissios H, Keirns J. Population pharmacokinetics of vernakalant hydrochloride injection (RSD1235) in patients with atrial fibrillation or atrial flutter. J Clin Pharmacol 2011. doi:10. 1177/0091270011408425.

Marahatta SB, Punyarit P, Bhudisawasdi V, Paupairoj A, Wongkham S, Petmitr S. Polymorphism of glutathione S-transferase omega gene and risk of cancer. Cancer Lett 2006; 236:276-81.

Marambaud P, Alves da Costa C, Ancolio K, Checler F. Alzheimer’s disease-linked mutation of presenilin-2 (N141I-PS2) drastically lowers APPa secretion: control by the proteasome. Biochem Biophys Res Commun 1999; 252:134-8.

Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides. J Biol Chem 2005; 280:37377-82.

Marandi T, Dahl ML, Rägo L, Kiivet R, Sjöqvist F. Debrisoquine and S-mephenytoin hydroxylation polymorphisms in a Russian population living in Estonia. Eur J Clin Pharmacol 1997; 53:257-60.

Marathe P, Tang Y, Sleczka B et al. Preclinical pharmacokinetics and in vitro metabolism of BMS-690514, a potent inhibitor of EGFR and VEGFR2. J Pharm Sci 2010; 99:3579-93.

Maráz A, Furák J, Pálföldi R et al. Roles of BCL-2 and MDR1 expression in the efficacy of paclitaxel-based lung cancer chemoradiation. Anticancer Res 2011; 31:1431-6.

Marciante KD, Bis JC, Rieder MJ et al. Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients. Am J Epidemiol 2007; 166:19-27.

Marciante KD, Durda JP, Heckbert SR et al. Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenet Genomics 2011; 21:280-8.

Marciante KD, Totah RA, Heckbert SR et al. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke. Pharmacogenet Genomics 2008; 18:535-43.

Marcil M, Yu L, Krimbou L et al. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. Arterioscler Thromb Vasc Biol 1999; 19:159-69.

Marcin LR, Higgins MA, Zusi FC et al. Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1. Bioorg Med Chem Lett 2011; 21:537-41.

Marcucci KA, Pearce RE, Crespi C, Steimel DT, Leeder JS, Gaedigk A. Characterization of cytochrome P450 2D6. 1 (CYP2D6. 1), CYP2D6. 2, and CYP2D6. 17 activities toward model CYP2D6 substrates dextromethorphan, bufuralol, and debrisoquine. Drug Metab Dispos 2002; 30:595-601.

Marchbanks RM, Ryan M, Day IN, Owen M, McGuffin P, Whatley SA. A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res 2003; 65:33-8.

Marchetti A, Felicioni L, Pelosi G et al. Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. Hum Mutat 2008; 29:609-16.

Marchetti A, Milella M, Felicioni L et al. Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones. Neoplasia 2009; 11:1084-92.

Marchetti G, Ferrati M, Patracchini P, Redaelli R, Bernardi F. A missense mutation (178Cys→Tyr) and two neutral dimorphisms (115His and 333Ser) in the human coagulation factor VII gene. Hum Mol Genet 1993; 2:1055-6.

Marchetti G, Patracchini P, Gemmati D et al. Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7). Hum Genet 1992; 89:497-502.

Marchetti S, de Vries NA, Buckle T et al. Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice. Mol Cancer Ther 2008; 7:2280-7.

Marchetti S, Mazzanti R, Beijnen JH, Schellens JH. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist 2007; 12:927-41.

Marchioni E, Perucca E, Soragna D et al. Choreiform syndrome associated with fluoxetine treatment in a patient with deficient CYP2D6 activity. Neurology 1996; 46:853.

Marchitti SA, Brocker C, Stagos D, Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008; 4:697-720.

Marder K, Maestre G, Cote L et al. The apolipoprotein E4 allele in Parkinson’s diseasewith and without dementia. Neurology 1994; 44:1330-1.

Maréchal JD, Kemp CA, Roberts GC, Paine MJ, Wolf CR, Sutcliffe MJ. Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions. Br J Pharmacol 2008; 153 Suppl 1:82-9.

Maréchal JD, Sutcliffe MJ. Insights into drug metabolism from modelling studies of cytochrome P450-drug interactions. Curr Top Med Chem 2006; 6:1619-26.

Marechal JD, Yu J, Brown S et al. In silico and in vitro screening for inhibition of cytochrome P450 CYP3A4 by comedications commonly used by patients with cancer. Drug Metab Dispos 2006; 34:534-8.

Maree AO, Curtin RJ, Chubb A et al. Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost 2005; 3:2340-5.

Marez D, Legrand M, Sabbagh N et al. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics 1997; 7:193-202.

Marez D, Legrand M, Sabbagh N, Lo-Guidice JM, Boone P, Broly F. An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine. Hum Genet 1996; 97:668-70.

Marez D, Sabbagh N, Legrand M, Lo-Guidice JM, Boone P, Broly F. A novel CYP2D6 allele with an abolished splice recognition site associated with the poor metabolizer phenotype. Pharmacogenetics 1995; 5:305-11.

Marez-Allorge D, Ellis SW, Lo Guidice JM, Tucker GT, Broly F. A rare G2061 insertion affecting the open reading frame of CYP2D6 and responsible for the poor metabolizer phenotype. Pharmacogenetics 1999; 9:393-6.

Margaglione M, Colaizzo D, D’Andrea G et al. Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost 2000; 84:775-8.

Margolis JM, O’Donnell JP, Mankowski DC, Ekins S, Obach RS. (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes. Drug Metab Dispos 2000; 28:1187-91.

Marí M, Cederbaum AI. Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress. Hepatology 2001; 33:652-61.

Mariani G, Bernardi F. Factor VII Deficiency. Semin Thromb Hemost 2009; 35:400-6.

Mariani SM. ApoE and Alzheimer’s disease – 10 years later. MedGenMed 2004; 6:1-5.

Marichalar-Mendia X, Acha-Sagredo A, Rodriguez-Tojo MJ et al. Alcohol-dehydrogenase (ADH1B) Arg48His Polymorphism in Basque Country patients with oral and laryngeal cancer: preliminary study. Anticancer Res 2011; 31:677-80.

Marie JP, Legrand O. MDR1/P-GP expression as a prognostic factor in acute leukemias. Adv Exp Med Biol 1999; 457:1-9.

Marie S, Heron B, Bitoun P, Timmerman T, van den Berghe G, Vincent MF. AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC. Am J Hum Genet 2004; 74:1276-81.

MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 2010; 119:463-74.

Marill J, Cresteil T, Lanotte M, Chabot GG. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 2000; 58:1341-8.

Marill J, Idres N, Capron CC, Nguyen E, Chabot GG. Retinoic acid metabolism and mechanism of action: a review. Curr Drug Metab 2003; 4:1-10.

Marinaki AM, Ansari A, Duley JA et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 2004; 14:181-7.

Marinec PS, Lancia JK, Gestwicki JE. Bifunctional molecules evade cytochrome P(450) metabolism by forming protective complexes with FK506-binding protein. Mol Biosyst 2008; 4:571-8.

Marinković N, Pašalić D, Ferenčak G, Gršković B, Stavljenić Rukavina A. Dioxins and human toxicity. Arh Hig Rada Toksikol 2010; 61:445-53.

Marino MR, Vachharajani NN. Drug interactions with irbesartan. Clin Pharmacokinet 2001; 40:605-14.

Marinou I, Walters K, Winfield J, Bax DE, Wilson AG. A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibility. Ann Rheum Dis 2010; 69:1191-4.

Marjamaa A, Newton-Cheh C, Porthan K et al. Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med 2009; 265:448-58.

Markatos CN, Grouzi E, Politou M et al. VKORC1 and CYP2C9 allelic variants influence acenocoumarol dose requirements in Greek patients. Pharmacogenomics 2008; 9:1631-8.

Markello TC, Pak LK, St Hilaire C et al. Vascular pathology of medial arterial calcifications in NT5E deficiency: Implications for the role of adenosine in pseudoxanthoma elasticum. Mol Genet Metab 2011; 103:44-50.

Markopoulos C, Tzoracoleftherakis E, Polychronis A et al. Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Breast Cancer Res 2010; 12:24.

Markov V, Krug A, Krach S et al. Genetic variation in schizophrenia-risk-gene dysbindin 1 modulates brain activation in anterior cingulate cortex and right temporal gyrus during language production in healthy individuals. Neuroimage 2009; 47:2016-22.

Markov V, Krug A, Krach S et al. Impact of schizophrenia-risk gene dysbindin 1 on brain activation in bilateral middle frontal gyrus during a working memory task in healthy individuals. Hum Brain Mapp 2010; 31:266-75.

Markovic D, Tang X, Guruju M et al. Association of angiotensinogen gene polymorphisms with essential hypertension in African-Americans and Caucasians. Hum Hered 2005; 60:89-96.

Markowitz JS, Devane CL, Chavin KD, Taylor RM, Ruan Y, Donovan JL. Effects of garlic (Allium sativum L. ) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin Pharmacol Ther 2003; 74:170-7.

Markowitz JS, Donovan JL, Devane CL et al. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin Pharmacol Ther 2003; 74:536-42.

Markowitz JS, Donovan JL, DeVane CL, Sipkes L, Chavin KD. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol 2003; 23:576-81.

Marlowe JL, Puga A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 2005; 96:1174-84.

Marohnic CC, Panda SP, McCammon K, Rueff J, Masters BS, Kranendonk M. Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect. Drug Metab Dispos 2010; 38:332-40.

Marousi S, Ellul J, Antonacopoulou A, Gogos C, Papathanasopoulos P, Karakantza M. Functional polymorphisms of interleukin 4 and interleukin 10 may predict evolution and functional outcome of an ischaemic stroke. Eur J Neurol 2011; 18:637-43.

Marquart TJ, Allen RM, Ory DS, Baldán A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 2010; 107:12228-32.

Marques DS, Sandrini JZ, Boyle RT, Marins LF, Trindade GS. Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines. Leuk Res 2010; 34:757-62.

Marques LP, Cavaco I, Pinheiro JP, Ribeiro V, Ferreira GN. Electrochemical DNA sensor for detection of single nucleotide polymorphisms. Clin Chem Lab Med 2003; 41:475-81.

Marques MP, Coelho EB, Dos Santos NA, Geleilete TJ, Lanchote VL. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus. Eur J Clin Pharmacol 2002; 58:607-14.

Marques-Soares C, Dijols S, Macherey AC et al. Sulfaphenazole derivatives as tools for comparing cytochrome P450 2C5 and human cytochromes P450 2Cs: identification of a new high affinity substrate common to those enzymes. Biochemistry 2003; 42:6363-9.

Márquez A, Orozco G, Martínez A et al. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. Am J Gastroenterol 2009; 104:1968-75.

Marquez B, van Bambeke F. ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions. Curr Drug Targets 2011; 12:600-20.

Marquez EC, Traylor-Knowles N, Novillo-Villajos A, Callard IP. Cloning of estrogen receptor alpha and aromatase cDNAs and gene expression in turtles (Chrysemys picta and Pseudemys scripta) exposed to different environments. Comp Biochem Physiol C Toxicol Pharmacol 2011; 154:213-25.

Marr RA, Spencer BJ. NEP-like endopeptidases and Alzheimer’s disease [corrected]. Curr Alzheimer Res 2010; 7:223-9.

Marraffa JM, Lang L, Ong G, Lehmann DF. Profound metoprolol-induced bradycardia precipitated by acetaminophen-propoxyphene. Clin Pharmacol Ther 2006; 79:282-6.

Marre M, Jeunemaitre X, Gallois Y et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 1997; 99:1585-95.

Marrzoq LF, Sharif FA, Abed AA. Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip. J Cardiovasc Dis Res 2011; 2:29-35.

Marschall HU, Wagner M, Zollner G et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005; 129:476-85.

Marsh EE, Shaw ND, Klingman KM et al. Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women. J Clin Endocrinol Metab 2011; 96:3199-206.

Marsh S. Pharmacogenomics of taxane/platinum therapy in ovarian cancer. Int J Gynecol Cancer 2009; 19 Suppl 2:30-4.

Marsh S, Hoskins JM. Irinotecan pharmacogenomics. Pharmacogenomics 2010; 11:1003-10.

Marsh S, McLeod H, Dolan E et al. Platinum pathway. Pharmacogenet Genomics 2009; 19:563-4.

Marsh S, McLeod HL. Pharmacogenetics and oncology treatment for breast cancer. Expert Opin Pharmacother 2007; 8:119-27.

Marsh S, Paul J, King CR, Gifford G, McLeod HL, Brown R. Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. J Clin Oncol 2007; 25:4528-35.

Marsh S, Somlo G, Li X et al. Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer. Pharmacogenomics J 2007; 7:362-5.

Martelli C, Coronnello M, Dei S et al. Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors. J Med Chem 2010; 53:1755-62.

Martelli C, Dei S, Lambert C et al. Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy. Bioorg Med Chem Lett 2011; 21:106-9.

Martens-Lobenhoffer J, Reiche I, Tröger U, Mönkemüller K, Malfertheiner P, Bode-Böger SM. Enantioselective quantification of omeprazole and its main metabolites in human serum by chiral HPLC-atmospheric pressure photoionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 857:301-7.

Marti A, Corbalán MS, Martínez-Gonzalez MA, Martinez JA. TRP64ARG polymorphism of the beta 3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes Obes Metab 2002; 4:428-30.

Marti F, Garcia GG, Lapinski PE, MacGregor JN, King PD. Essential role of the T cell-specific adapter protein in the activation of LCK in peripheral T cells. J Exp Med 2006; 203:281-7.

Martignetti JA, Aqeel AA, Sewairi WA et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 2001; 28:261-5.

Martin AM, Krueger R, Almeida CA, Nolan D, Phillips E, Mallal S. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenet Genomics 2006; 16:353-7.

Martin AM, Nolan D, Gaudieri S et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc Natl Acad Sci USA 2004; 101:4180-5.

Martin AM, Nolan D, James I et al. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts. AIDS 2005; 19:97-9.

Martin DE, Zussman BD, Everitt DE, Benincosa LJ, Etheredge RC, Jorkasky DK. Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men. J Clin Psychopharmacol 1997; 17:451-9.

Martin ER, Scott WK, Nance MA et al. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA 2001; 286:2245-50.

Martin H, Sarsat JP, Lerche-Langrand C et al. Morphological and biochemical integrity of human liver slices in long-term culture: effects of oxygen tension. Cell Biol Toxicol 2002; 18:73-85.

Martin J, Krum H. Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant? Drug Saf 2003; 26:13-21.

Martin JH, Begg EJ, Kennedy MA, Roberts R, Barclay ML. Is cytochrome P450 2C9 genotype associated with NSAID gastric ulceration? Br J Clin Pharmacol 2001; 51:627-30.

Martin L, Douet V, VanWart CM, Heller MB, Le Saux O. A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression. Am J Pathol 2011; 178:774-83.

Martin MM, Buckenberger JA, Jiang J et al. The human angiotensin II type 1 receptor + 1166A/C polymorphism attenuates microRNA-155 binding. J Biol Chem 2007; 282:24262-9.

Martin MP, Borecki IB, Zhang Z et al. HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. Immunogenetics 2010; 62:761-5.

Martin MP, Dean M, Smith MW et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998; 282:1907-11.

Martin P, Riley R, Back DJ, Owen A. Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells. Br J Pharmacol 2008; 153:805-19.

Martin P, Riley R, Thompson P, Williams D, Back D, Owen A. Effect of prototypical inducers on ligand activated nuclear receptor regulated drug disposition genes in rodent hepatic and intestinal cells. Acta Pharmacol Sin 2010; 31:51-65.

Martin RJ, McKnight AJ, Patterson CC, Sadlier DM, Maxwell AP; Warren 3/UK GoKinD Study Group. A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy. Nephrol Dial Transplant 2010; 25:497-503.

Martin V, Xu J, Pabbisetty SK et al. Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters. Oncogene 2009; 28:2358-63.

Martin YN, Salavaggione OE, Eckloff BW, Wieben ED, Schaid DJ, Weinshilboum RM. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenet Genomics 2006; 16:265-77.

Martineau I, Tchernof A, Bélanger A. Amino acid residue ILE211 is essential for the enzymatic activity of human UDP-glucuronosyltransferase 1A10 (UGT1A10). Drug Metab Dispos 2004; 32:455-9.

Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338:1793-7.

Martinelli I, Taioli E, Bucciarelli P, Akhavan S, Mannucci PM. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol 1999; 19:700-3.

Martinelli N, Girelli D, Lunghi B et al. Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile. Blood 2010; 116:5688-97.

Martinerie L, Viengchareun S, Meduri G, Kim HS, Luther JM, Lombès M. Aldosterone postnatally, but not at birth, is required for optimal induction of renal mineralocorticoid receptor expression and sodium reabsorption. Endocrinology 2011; 152:2483-91.

Martínez C, Albet C, Agúndez JA et al. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists. Clin Pharmacol Ther 1999; 65:369-76.

Martínez C, Blanco G, García-Martín E, Agúndez JA. Clinical pharmacogenomics for CYP2C8 and CYP2C9: general concepts and application to the use of NSAIDs. Farm Hosp 2006; 30:240-8.

Martínez C, Blanco G, Ladero JM et al. Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use. Br J Pharmacol 2004; 141:205-8.

Martínez C, Galván S, García-Martín E, Ramos MI, Gutiérrez-Martín Y, Agúndez JA. Variability in ethanol biodisposition in whites is modulated by polymorphisms in the ADH1B and ADH1C genes. Hepatology 2010; 51:491-500.

Martínez C, García-Martín E, Blanco G, Gamito FJ, Ladero JM, Agúndez JA. The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects. Br J Clin Pharmacol 2005; 59:62-9.

Martínez C, García-Martín E, Pizarro RM, García-Gamito FJ, Agúndez JA. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy. Br J Cancer 2002; 87:681-6.

Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100:3184-8.

Martínez MF, Martín XE, Alcelay LG et al. The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers. BMC Neurosci 2009; 10:125.

Martinez Molina D, Wetterholm A, Kohl A et al. Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Nature 2007; 448:613-16.

Martinez P, Siegl-Cachedenier I, Flores JM, Blasco MA. MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. Aging Cell 2009; 8:2-17.

Martinez-Arguelles DB, Guichard T, Culty M, Zirkin BR, Papadopoulos V. In utero exposure to the antiandrogen di-(2-ethylhexyl) phthalate decreases adrenal aldosterone production in the adult rat. Biol Reprod 2011; 85:51-61.

Martínez-Cruz AB, Santos M, García-Escudero R et al. Spontaneous tumor formation in Trp53-deficient epidermis mediated by chromosomal instability and inflammation. Anticancer Res 2009; 29:3035-42.

Martínez-Jiménez CP, Castell JV, Gómez-Lechón MJ, Jover R. Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4alpha requires coactivators peroxisomal proliferator activated receptor-gamma coactivator 1alpha and steroid receptor coactivator 1. Mol Pharmacol 2006; 70:1681-92.

Martínez-Jiménez CP, Gómez-Lechón MJ, Castell JV, Jover R. Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein). Mol Pharmacol 2005; 67:2088-101.

Martínez-Jiménez CP, Jover R, Donato MT, Castell JV, Gómez-Lechón MJ. Transcriptional regulation and expression of CYP3A4 in hepatocytes. Curr Drug Metab 2007; 8:185-94.

Martinkova E, Dontenwill M, Frei E, Stiborova M. Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells. Neuro Endocrinol Lett 2009; 30 Suppl 1:60-6.

Martins A, Vasas A, Schelz Z et al. Constituents of Carpobrotus edulis inhibit P-glycoprotein of MDR1-transfected mouse lymphoma cells. Anticancer Res 2010; 30:829-35.

Martín-Santos R, Torrens M, Poudevida S et al. 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study. Addict Biol 2010; 15:15-22.

Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16:100-3.

Martirosyan A, Clendening JW, Goard CA, Penn LZ. Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance. BMC Cancer 2010; 10:103.

Martorana A, Esposito Z, Koch G. Beyond the cholinergic hypothesis: do current drugs work in Alzheimer’s disease? CNS Neurosci Ther 2010; 16:235-45.

Martorell L, Virgos C, Valero J et al. Schizophrenic women with the ApoE e4 allele have a worse prognosis than those without it. Mol Psychiatry 2001; 6:307-10.

Marucci G, Finaurini S, Buccioni M et al. In vitro metabolism studies of new adenosine A 2A receptor antagonists. Drug Metab Lett 2008; 2:301-7.

Marull M, Rochat B. Fragmentation study of imatinib and characterization of new imatinib metabolites by liquid chromatography-triple-quadrupole and linear ion trap mass spectrometers. J Mass Spectrom 2006; 41:390-404.

Marumoto S, Oda Y, Miyazawa M. Antigenotoxic activity of naturally occurring furanocoumarins. Environ Mol Mutagen 2011; 52:646-57.

Maruo Y, Serdaroglu E, Iwai M et al. A novel missense mutation of the bilirubin UDP-glucuronosyltransferase gene in a Turkish patient with Crigler-Najjar syndrome type 1. J Pediatr Gastroenterol Nutr 2003; 37:627-30.

Maruta J, Hashimoto H, Yamashita H, Yamashita H, Noguchi S. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma. Arch Surg 2004; 139:83-8.

Maruyama K, Yoshida M, Nishio H et al. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 2001; 16:350-5.

Maruyama M, Matsunaga T, Harada E, Ohmori S. Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells. Biol Pharm Bull 2007; 30:2091-7.

Marx AH, Tharun L, Muth J et al. HER-2 amplification is highly homogenous in gastric cancer. Hum Pathol 2009; 40:769-77.

Marzec M, Kasprzycka M, Lai R et al. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood 2006; 108:1744-50.

Marzocchetti A, Schwarz J, DI Giambenedetto S et al. The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected Caucasians starting antiretroviral therapy. AIDS Res Hum Retroviruses 2011. doi:10. 1089/aid. 2010. 0172.

Marzolini C, Paus E, Buclin T, Kim RB. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 2004; 75:13-33.

Mas S, Gassò P, Álvarez S, Parellada E, Bernardo M, Lafuente A. Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes. Pharmacogenomics J 2010. doi:10. 1038/tpj. 2010. 91.

Mascheretti S, Hampe J, Kühbacher T et al. Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn’s disease treated with infliximab. Pharmacogenomics J 2002; 2:127-36.

Masek V, Anzenbacherova E, Etrych T, Strohalm J, Ulbrich K, Anzenbacher P. Interaction of HPMA copolymer-doxorubicin conjugates with human liver microsomal cytochromes P450. Comparison with free doxorubicin. Drug Metab Dispos 2011; 39:1704-10.

Masek V, Anzenbacherová E, Machová M, Brabec V, Anzenbacher P. Interaction of antitumor platinum complexes with human liver microsomal cytochromes P450. Anticancer Drugs 2009; 20:305-11.

Masellis M, Basile VS, Meltzer HY et al. Lack of association between the T→C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr Res 2001; 47:49-58.

Mash DC, Kovera CA, Pablo J et al. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Ann N Y Acad Sci 2000; 914:394-401.

Mashima T, Sato S, Okabe S et al. Acyl-CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide. Cancer Sci 2009; 100:1556-62.

Mashima T, Sato S, Sugimoto Y, Tsuruo T, Seimiya H. Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions. Oncogene 2009; 28:9-19.

Mashima Y. DNA diagnosis in the age of individual made-to-order medications. Nippon Ganka Gakkai Zasshi 2004; 108:863-86.

Masimirembwa C, Hasler J, Bertilssons L, Johansson I, Ekberg O, Ingelman-Sundberg M. Phenotype and genotype analysis of debrisoquine hydroxylase (CYP2D6) in a black Zimbabwean population. Reduced enzyme activity and evaluation of metabolic correlation of CYP2D6 probe drugs. Eur J Clin Pharmacol 1996; 51:117-22.

Masimirembwa C, Persson I, Bertilsson L, Hasler J, Ingelman-Sundberg M. A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity. Br J Clin Pharmacol 1996; 42:713-9.

Masimirembwa CM, Johansson I, Hasler JA, Ingelman-Sundberg M. Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population. Pharmacogenetics 1993; 3:275-80.

Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 1995; 136:107-22.

Mason BJ, Blackburn KH. Possible serotonin syndrome associated with tramadol and sertraline coadministration. Ann Pharmacother 1997; 31:175-7.

Mason BL, Pariante CM, Jamel S, Thomas SA. Central nervous system (CNS) delivery of glucocorticoids is fine-tuned by saturable transporters at the blood-CNS barriers and nonbarrier regions. Endocrinology 2010; 151:5294-305.

Mason BL, Thomas SA, Lightman SL, Pariante CM. Desipramine treatment has minimal effects on the brain accumulation of glucocorticoids in P-gp-deficient and wild-type mice. Psychoneuroendocrinology 2011; 36:1351-60.

Mason CW, Hassan HE, Kim KP et al. Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl-and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse. J Pharmacol Exp Ther 2010; 333:854-64.

Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 1999; 274:12670-4.

Masood N, Kayani MA, Malik FA, Mahjabeen I, Baig RM, Faryal R. Genetic variation in carcinogen metabolizing genes associated with oral cancer in Pakistani population. Asian Pac J Cancer Prev 2011; 12:491-5.

Masood N, Malik FA, Kayani MA. Expression of xenobiotic metabolizing genes in head and neck cancer tissues. Asian Pac J Cancer Prev 2011; 12:377-82.

Mass MJ, Tennant A, Roop BC et al. Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 2001; 14:355-61.

Massari A, Urbatzka R, Cevasco A et al. Aromatase mRNA expression in the brain of adult Xenopus laevis exposed to Lambro river water and endocrine disrupting compounds. Gen Comp Endocrinol 2010; 168:262-8.

Massaro AM, Lenz KL. Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting. Ann Pharmacother 2005; 39:77-85.

Massart F, Marcucci G, Brandi ML. Pharmacogenetics of bone treatments: the VDR and ERalpha gene story. Pharmacogenomics 2008; 9:733-46.

Masse K, Bhamra S, Eason R, Dale N, Jones EA. Purine-mediated signalling triggers eye development. Nature 2007; 449:1058-62.

Massey LK, Mah AL, Ford DL et al. Overexpression of ubiquilin decrease ubiquitination and degeneration of presenilin proteins. J Alzheimer Dis 2004; 6:79-92.

Masson CJ, Plat J, Mensink RP et al. Fatty acid- and cholesterol transporter protein expression along the human intestinal tract. PLoS One 2010. doi:10. 1371/journal. pone. 0010380

Mast N, Reem R, Bederman I et al. Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. Invest Ophthalmol Vis Sci 2011; 52:594-603.

Mast N, Shafaati M, Zaman W et al. Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters. Biochim Biophys Acta 2010; 1801:674-81.

Mastalerz L, Setkowicz M, Sanak M, Rybarczyk H, Szczeklik A. Familial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variant. Br J Dermatol 2006; 154:256-60.

Masters CL, Gajdusek DC, Gibbs CJ. The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer’s disease. Brain 1981; 104:535-58.

Mastrianni JA, Ros RP. The prion disease. Semin Neurol 2000; 20:337-52.

Masubuchi Y. Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review. Drug Metab Pharmacokinet 2006; 21:347-56.

Masubuchi Y, Fujita S, Chiba M, Kagimoto N, Umeda S, Suzuki T. Impairment of debrisoquine 4-hydroxylase and related monooxygenase activities in the rat following treatment with propranolol. Biochem Pharmacol 1991; 41:861-5.

Masubuchi Y, Hosokawa S, Horie T et al. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. Drug Metab Dispos 1994; 22:909-15.

Masubuchi Y, Nakano T, Ose A, Horie T. Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver. Arch Toxicol 2001; 75:538-43.

Masubuchi Y, Ose A, Horie T. Diclofenac-induced inactivation of CYP3A4 and its stimulation by quinidine. Drug Metab Dispos 2002; 30:1143-8.

Masud S, Ye S; SAS Group. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 2003; 40:773-80.

Masuda H, Otsuka F, Matsumoto Y et al. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation. Mol Cell Endocrinol 2011; 343:7-17.

Masuda M, Tanaka S, Nakajima K et al. Clinical implications of the type 1/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients. Eur J Pharmacol 2010; 627:325-31.

Masuda N, Goto J, Muruyama N, Watanabe M, Kondo I, Kanazawa I. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington’s disease. J Med Genet 1995; 32:701-5.

Masuda S, Goto M, Kiuchi T et al. Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation. Liver Transpl 2003; 9:1108-13.

Masuda S, Goto M, Okuda M et al. Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients. Transplant Proc 2005; 37:1728-9.

Masuda S, Inui K. An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 2006; 112:184-98.

Masuda S, Uemoto S, Goto M, Fujimoto Y, Tanaka K, Inui K. Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients. Clin Pharmacol Ther 2004; 75:352-61.

Masuda S, Uemoto S, Hashida T, Inomata Y, Tanaka K, Inui K. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient. Clin Pharmacol Ther 2000; 68:98-103.

Masui T, Hashimoto R, Kusumi I et al. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:204-8.

Masui T, Kusumi I, Takahashi Y, Koyama T. Effects of itraconazole and tandospirone on the pharmacokinetics of perospirone. Ther Drug Monit 2006; 28:73-5.

Masui T, Kusumi I, Takahashi Y, Koyama T. Effect of carbamazepine on the single oral dose pharmacokinetics of perospirone and its active metabolite. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:1330-3.

Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005; 111:3429-34.

Masuo K, Straznicky NE, Lambert GW et al. Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population. Hypertens Res 2008; 31:1093-100.

Masuyama H, Hiramatsu Y, Kodama J, Kudo T. Expression and potential roles of pregnane X receptor in endometrial cancer. J Clin Endocrinol Metab 2003; 88:4446-54.

Masuyama H, Nakatsukasa H, Takamoto N, Hiramatsu Y. Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells. Mol Pharmacol 2007; 72:1045-53.

Masuyama H, Suwaki N, Tateishi Y, Nakatsukasa H, Segawa T, Hiramatsu Y. The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Mol Endocrinol 2005; 19:1170-80.

Masuyama R, Stockmans I, Torrekens S et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 2006; 116:3150-9.

Matal J, Matuskova Z, Tunkova A, Anzenbacherova E, Anzenbacher P. Porcine CYP2A19, CYP2E1 and CYP1A2 forms are responsible for skatole biotransformation in the reconstituted system. Neuro Endocrinol Lett 2009; 30 Suppl 1:36-40.

Matarin M, Brown WM, Hardy JA et al. Association of integrin alpha2 gene variants with ischemic stroke. J Cereb Blood Flow Metab 2008; 28:81-9.

Mateo I, Vázquez-Higuera JL, Sánchez-Juan P et al. Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer’s disease risk. Acta Neurol Scand 2009; 120:130-3.

Mateos L, Ismail MA, Gil-Bea FJ et al. Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism. J Biol Chem 2011; 286:25574-85.

Materna V, Lage H. Homozygous mutation Arg(768)Trp in the ABC-transporter encoding gene MRP2/cMOAT/ABCC2 causes Dubin-Johnson syndrome in a Caucasian patient. J Hum Genet 2003; 48:484-6.

Matherly LH, Goldman DI. Membrane transport of folates. Vitam Horm 2003; 66:403-56.

Mathew NT, Hettiarachchi J, Alderman J. Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review. Headache 2003; 43:962-74.

Mathews JM, Etheridge AS, Valentine JL et al. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro. Drug Metab Dispos 2005; 33:1555-63.

Mathias RA, Grant AV, Rafaels N et al. A genome-wide association study on African-ancestry populations for asthma. J Allergy Clin Immunol 2010; 125:336-46.

Mathijssen RH, de Jong FA, van Schaik RH et al. Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes. J Natl Cancer Inst 2004; 96:1585-92.

Mathijssen RH, Gurney H. Irinogenetics: how many stars are there in the sky? J Clin Oncol 2009; 27:2578-9.

Mathijssen RH, Marsh S, Karlsson MO et al. Irinotecan pathway genotype analysis to predict pharmacokinetics. Clin Cancer Res 2003; 9:3246-53.

Mathijssen RH, van Alphen RJ, Verweij J et al. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res 2001; 7:2182-94.

Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Effects of St. John’s wort on irinotecan metabolism. J Natl Cancer Inst 2002; 94:1247-9.

Matikainen T, Perez GI, Jurisicova A et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001; 28:355-60.

Matimba A, Del-Favero J, van Broeckhoven C, Masimirembwa C. Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects. Hum Genomics 2009; 3:169-90.

Matin N, Kurani A, Kennedy CA, Liu QY. Dextromethorphan-induced near-fatal suicide attempt in a slow metabolizer at cytochrome P450 2D6. Am J Geriatr Pharmacother 2007; 5:162-5.

Matsson P, Pedersen JM, Norinder U, Bergström CA, Artursson P. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm Res 2009; 26:1816-31.

Matsubara T, Noracharttiyapot W, Toriyabe T, Yoshinari K, Nagata K, Yamazoe Y. Assessment of human pregnane X receptor involvement in pesticide-mediated activation of CYP3A4 gene. Drug Metab Dispos 2007; 35:728-33.

Matsubara T, Yoshinari K, Aoyama K et al. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo. Drug Metab Dispos 2008; 36:2058-63.

Matsubara Y, Kanazawa T, Kojima Y et al. Pharmacokinetics and disposition of silodosin (KMD-3213). Yakugaku Zasshi 2006; 126:237-45.

Matsubara Y, Murata M, Watanabe K et al. Coronary artery disease and a functional polymorphism of hTERT. Biochem Biophys Res Commun 2006; 348:669-72.

Matsuda A, Kosugi S. A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. J Clin Endocrinol Metab 1997; 82:3966-71.

Matsuda H, Kinoshita K, Sumida A et al. Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line. Biochim Biophys Acta 2002; 1593:93-8.

Matsuda JB, Barbosa FR, Morel LJ et al. Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? Rev Bras Reumatol 2010; 50:141-9.

Matsuda M, Sugo T, Sakata Y et al. A thrombotic state due to an abnormal protein C. N Engl J Med 1988; 319:1265-8.

Matsuda Y, Takeuchi H, Yokohira M et al. Enhancing effects of a high fat diet on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced lung tumorigenesis in female A/J mice. Mol Med Report 2009; 2:701-6.

Matsui A, Azuma J, Witcher JW et al. Pharmacokinetics, safety, and tolerability of atomoxetine and effect of CYP2D6*10/*10 genotype in healthy Japanese men. J Clin Pharmacol 2011. doi:10. 1177/0091270011398657.

Matsui I, Hamano T, Tomida K et al. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats. Nephrol Dial Transplant 2009; 24:2354-61.

Matsui M, Araki Y, Karasawa H, Matsubara N, Taketo MM, Seldin MF. Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes. Genes Genet Syst 1999; 74:15-21.

Matsuki K, Tamasawa N, Yamashita M et al. Metformin restores impaired HDL-mediated cholesterol efflux due to glycation. Atherosclerosis 2009; 206:434-8.

Matsumoto K, Nemoto E, Hasegawa T, Akimoto M, Sugibayashi K. In vitro characterization of the cytochrome P450 isoforms involved in the metabolism of 6-Methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone. Biol Pharm Bull 2011; 34:734-9.

Matsumoto K, Watanabe Y, Ohya MA, Yokoyama S. Young persimmon fruits prevent the rise in plasma lipids in a diet-induced murine obesity model. Biol Pharm Bull 2006; 29:2532-5.

Matsumoto K, Watanabe Y, Yokoyama S. Okara, soybean residue, prevents obesity in a diet-induced murine obesity model. Biosci Biotechnol Biochem 2007; 71:720-7.

Matsumoto M, Takahashi H, Maruyama K et al. Genotypes of alcohol-metabolizing enzymes and the risk for alcoholic chronic pancreatitis in Japanese alcoholics. Alcohol Clin Exp Res 1996; 20(9 Suppl):289-92.

Matsumoto S, Hirama T, Matsubara T, Nagata K, Yamazoe Y. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole. Drug Metab Dispos 2002; 30:1240-5.

Matsumoto S, Nishimura M, Sakamoto T et al. Modulation of the onset age in primary dystonia by APOE genotype. Neurology 2003; 60:2003-5.

Matsumoto S, Yamazoe Y. Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine. Br J Clin Pharmacol 2001; 51:133-42.

Matsumura K, Saito T, Takahashi Y et al. Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol Pharmacol 2004; 65:326-34.

Matsumura T, Kinoshita H, Ishii N et al. Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-{gamma} in macrophages. Arterioscler Thromb Vasc Biol 2011; 31:1268-75.

Matsunaga A, Arishima H, Niimura H et al. Strong linkage disequilibrium and association of -1131T>C and c. 553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Circ J 2007; 71:746-52.

Matsunaga E. Hereditary retinoblastoma: host resistance and second primary tumors. J Nat Cancer Inst 1980; 65:47-51.

Matsunaga E, Zanger UM, Hardwick JP, Gelboin HV, Meyer UA, Gonzalez FJ. The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry 1989; 28:7349-55.

Matsunaga M, Yamazaki H, Kiyotani K et al. Two novel CYP2D6*10 haplotypes as possible causes of a poor metabolic phenotype in Japanese. Drug Metab Dispos 2009; 37:699-701.

Matsunaga T, Kishi N, Higuchi S, Watanabe K, Ohshima T, Yamamoto I. CYP3A4 is a major isoform responsible for oxidation of 7-hydroxy-Delta(8)-tetrahydrocannabinol to 7-oxo-delta(8)-tetrahydrocannabinol in human liver microsomes. Drug Metab Dispos 2000; 28:1291-6.

Matsunaga T, Maruyama M, Harada E et al. Expression and induction of CYP3As in human fetal hepatocytes. Biochem Biophys Res Commun 2004; 318:428-34.

Matsunaga T, Nomoto M, Kozak CA, Gonzalez FJ. Structure and in vitro transcription of the rat CYP2A1 and CYP2A2 genes and regional localization of the CYP2A gene subfamily on mouse chromosome 7. Biochemistry 1990; 29:1329-41.

Matsuo H, Takada T, Ichida K et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 2009; 1:5ra11.

Matsuo K, Hiraki A, Hirose K et al. Impact of the alcohol-dehydrogenase (ADH) 1C and ADH1B polymorphisms on drinking behavior in nonalcoholic Japanese. Hum Mutat 2007; 28:506-10.

Matsuo M, Campenot RB, Vance DE, Ueda K, Vance JE. Involvement of low-density lipoprotein receptor-related protein and ABCG1 in stimulation of axonal extension by apoE-containing lipoproteins. Biochim Biophys Acta 2011; 1811:31-8.

Matsuo M. ATP-binding cassette proteins involved in glucose and lipid homeostasis. Biosci Biotechnol Biochem 2010; 74:899-907.

Matsuo Y, Yokoyama R, Yokoyama S. The genes for human alcohol dehydrogenases beta-1 and beta-2 differ by only one nucleotide. Eur J Biochem 1989; 183:317-20.

Matsuoka Y, Furuyashiki T, Bito H et al. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. Proc Nat Acad Sci USA 2003; 100:4132-7.

Matsuoka Y, Furuyashiki T, Yamada K et al. Prostaglandin E receptor E1 controls impulsive behavior under stress. Proc Nat Acad Sci USA 2005; 102:16066-71.

Matsuoka-Kawano K, Yoshinari K, Nagayama S, Yamazoe Y. TSU-16, (Z)-3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone, is a potent activator of aryl hydrocarbon receptor and increases CYP1A1 and CYP1A2 expression in human hepatocytes. Chem Biol Interact 2010; 185:33-41.

Matsushita T, Matsuoka T, Isobe N et al. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens 2009; 73:171-6.

Matsushita Y, Yokoyama T, Yoshiike N et al. The Trp(64)Arg polymorphism of the beta(3)-adrenergic receptor gene is not associated with body weight or body mass index in Japanese: a longitudinal analysis. J Clin Endocrinol Metab 2003; 88:5914-20.

Matsusue A, Hara K, Kageura M et al. An autopsy case of rhabdomyolysis related to vegetamin and genetic analysis of the rhabdomyolysis-associated genes. J Forensic Leg Med 2010; 17:46-9.

Matsusue A, Hara K, Kashiwagi M, Kageura M, Sugimura T, Kubo S. Genetic analysis of the rhabdomyolysis-associated genes in forensic autopsy cases of methamphetamine abusers. Leg Med 2011; 13:7-11.

Matsuyama A, Sakai N, Ishigami M et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 2003; 108:1469-73.

Matsuzaka Y, Kikuti YY, Mizutani A et al. Association study between sick building syndrome and polymorphisms of seven human detoxification genes in the Japanese. Environ Toxicol Pharmacol 2010; 29:190-4.

Mattei MG, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F. Angiotensin-I converting enzyme gene is on chromosome 17. Cytogenet Cell Genet 1989; 51:1041.

Matthes H, Friedel WE, Bock PR, Zänker KS. Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer. Curr Mol Med 2010; 10:430-9.

Mattila KM, Rinne JO, Lehtimäki T, Röyttä M, Ahonen JP, Hurme M. Association of an interleukin 1B gene polymorphism (-511) with Parkinson’s disease in Finnish patients. J Med Genet 2002; 39:400-2.

Mattioli B, Giordani L, Quaranta MG, Viora M. Effect of indinavir used alone or in double or triple combination with AZT and ddC on human immune functions. Life Sci 2004; 74:2291-300.

Mattison LK, Johnson MR, Diasio RB. A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphisms. Pharmacogenetics 2002; 12:133-44.

Mattson MP, Guo Q. The presenilins. Neuroscientist 1999, 5:112-24.

Mattsson N, Zetterberg H, Bianconi S et al. Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study. Neurology 2011; 76:366-72.

Matucci A, Rossolillo P, Baroni M, Siccardi AG, Beretta A, Zipeto D. HLA-C increases HIV-1 infectivity and is associated with gp120. Retrovirology 2008; 5:68.

Matusiak D, Benya RV. CYP27A1 and CYP24 expression as a function of malignant transformation in the colon. J Histochem Cytochem 2007; 55:1257-64.

Matuskova Z, Tunkova A, Anzenbacherova E et al. Effects of probiotic Escherichia coli Nissle 1917 on expression of cytochromes P450 along the gastrointestinal tract of male rats. Neuro Endocrinol Lett 2010; 31 Suppl 2:46-50.

Matuskova Z, Tunkova A, Anzenbacherova E, Zidek Z, Tlaskalova-Hogenova H, Anzenbacher P. Influence of probiotics on rat liver biotransformation enzymes. Neuro Endocrinol Lett 2009; 30 Suppl 1:41-5.

Matysik S, Martin J, Bala M, Scherer M, Schäffler A, Schmitz G. Bile acid signaling after an oral glucose tolerance test. Chem Phys Lipids 2011; 164:525-9.

Mauerer R, Ebert S, Langmann T. High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages. Exp Mol Med 2009; 41:126-32.

Maul R, Siegl D, Kulling SE. Glucuronidation of the red clover isoflavone irilone by liver microsomes from different species and human UDP-glucuronosyltransferases. Drug Metab Dispos 2011; 39:610-6.

Mauldin JP, Nagelin MH, Wojcik AJ et al. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation 2008; 117:2785-92.

Mauray A, Felgines C, Morand C, Mazur A, Scalbert A, Milenkovic D. Bilberry anthocyanin-rich extract alters expression of genes related to atherosclerosis development in aorta of apo E-deficient mice. Nutr Metab Cardiovasc Dis 2010. doi:10. 1016/j. numecd. 2010. 04. 011.

Maurelli S, Chiesa M, Giamello E et al. Direct spectroscopic evidence for binding of anastrozole to the iron heme of human aromatase. Peering into the mechanism of aromatase inhibition. Chem Commun 2011; 47:10737-9.

Maurer HH, Kraemer T, Springer D, Staack RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther Drug Monit 2004; 26:127-31.

Mavaddat N, Dunning AM, Ponder BA, Easton DF, Pharoah PD. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18:255-9.

Mavis CK, Morey Kinney SR, Foster BA, Karpf AR. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors. Prostate 2009; 69:1312-24.

Maxa JL, Melton LB, Ogu CC, Sills MN, Limanni A. Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole. Ann Pharmacother 2002; 36:820-3.

Maxwell DM, Brecht KM, Koplovitz I, Sweeney RE. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds? Arch Toxicol 2006; 80:756-60.

Maxwell SS, Jackson CA, Paternoster L et al. Genetic associations with brain microbleeds: Systematic review and meta-analyses. Neurology 2011; 77:158-67.

May K, Giessmann T, Wegner D et al. Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination. Eur J Clin Pharmacol 2008; 64:1085-92.

May K, Westphal K, Giessmann T et al. Disposition and antimuscarinic effects of the urinary bladder spasmolytics propiverine: influence of dosage forms and circadian-time rhythms. J Clin Pharmacol 2008; 48:570-9.

Mayatepek E, Flock B, Zschocke J. Benzydamine metabolism in vivo is impaired in patients with deficiency of flavin-containing monooxygenase 3. Pharmacogenetics 2004; 14:775-7.

Mayersohn M, Guentert TW. Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide. Clin Pharmacokinet 1995; 29:292-332.

Mayhew BS, Jones DR, Hall SD. An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. Drug Metab Dispos 2000; 28:1031-7.

May-Manke A, Kroemer H, Hempel G et al. Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide. Cancer Chemother Pharmacol 1999; 44:327-34.

Maynard GL, Soni P. Thioridazine interferences with imipramine metabolism and measurement. Ther Drug Monit 1996; 18:729-31.

Mayol RF, Jajoo HK, Klunk LJ, Blair IA. Metabolism of the antipsychotic drug tiospirone in humans. Drug Metab Dispos 1991; 19:394-9.

Mayur YC, Zaheeruddin, Peters GJ, Lemos C, Kathmann I, Prasad VV. Synthesis of 2-fluoro N(10)-substituted acridones and their cytotoxicity studies in sensitive and resistant cancer cell lines and their DNA intercalation studies. Arch Pharm 2009; 342:640-50.

Maznyczka A, Braund P, Mangino M, Samani NJ. Arachidonate 5-lipoxygenase (5-LO) promoter genotype and risk of myocardial infarction: a case-control study. Atherosclerosis 2008; 199:328-32.

Mazoit JX, Dalens BJ. Pharmacokinetics of local anaesthetics in infants and children. Clin Pharmacokinet 2004; 43:17-32.

Mazur A, Lichti CF, Prather PL et al. Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids. Drug Metab Dispos 2009; 37:1496-504.

Mazur CS, Kenneke JF. Cross-species comparison of conazole fungicide metabolites using rat and rainbow trout (Onchorhynchus mykiss) hepatic microsomes and purified human CYP 3A4. Environ Sci Technol 2008; 42:947-54.

Mazziotti G, Canalis E, Giustina A. Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 2010; 123:877-84.

Mazzone A, Strege PR, Tester DJ et al. A mutation in telethonin alters Nav1. 5 function. J Biol Chem 2008; 24:16537-44.

Mazzu AL, Lasseter KC, Shamblen EC, Agarwal V, Lettieri J, Sundaresen P. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin. Clin Pharmacol Ther 2000; 68:391-400.

McAlpine DE, Biernacka JM, Mrazek DA et al. Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine. Ther Drug Monit 2011; 33:14-20.

McAlpine DE, O’Kane DJ, Black JL, Mrazek DA. Cytochrome P450 2D6 genotype variation and venlafaxine dosage. Mayo Clin Proc 2007; 82:1065-8.

McAllister C, Long J, Bowers A et al. Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment. J Neurosci 2010; 30:7326-34.

McArdle EJ, Kunic JD, George AL Jr. Novel SCN1A frameshift mutation with absence of truncated Nav1. 1 protein in severe myoclonic epilepsy of infancy. Am J Med Genet 2008; 146:2421-3.

McAulay KA, Higgins CD, Macsween KF et al. HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 2007; 117:3042-8.

McAuley EZ, Fullerton JM, Blair IP, Donald JA, Mitchell PB, Schofield PR. Association between the serotonin 2A receptor gene and bipolar affective disorder in an Australian cohort. Psychiatr Genet 2009; 19:244-52.

McBride OW, Umeno M, Gelboin HV, Gonzalez FJ. A Taq I polymorphism in the human P450IIE1 gene on chromosome 10 (CYP2E). Nucleic Acids Res 1987; 15:10071.

McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am J Ind Med 2004; 46:95-103.

McCanlies EC, Kreiss K, Andrew M, Weston A. HLA-DPB1 and chronic beryllium disease: a HuGE review. Am J Epidemiol 2003; 157:388-98.

McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999; 53:1308-11.

McCarthy BA, Reddi AS, Coakley KM et al. Administration of human umbilical cord blood cells produces Interleukin-10 (IL-10) in IL-10 deficient mice without immunosuppression. Curr Stem Cell Res Ther 2010; 5:13-6.

McCarthy DM, Pedersen SL, Lobos EA, Todd RD, Wall TL. ADH1B*3 and Response to Alcohol in African-Americans. Alcohol Clin Exp Res 2010; 34:1274-81.

McCarthy HO, Yakkundi A, McErlane V et al. Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N. Cancer Gene Ther 2003; 10:40-8.

McCarthy TC, Li X, Sinal CJ. Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J Biol Chem 2005; 280:23232-42.

McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W. A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol 1998; 152:276-81.

McCleskey TM, Buchner V, Field RW, Scott BL. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review. Rev Environ Health 2009; 24:75-115.

McClue SJ, Blake D, Clarke R et al. In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). Int J Cancer 2002; 102:463-8.

McClue SJ, Stuart I. Metabolism of the trisubstituted purine cyclin-dependent kinase inhibitor seliciclib (R-roscovitine) in vitro and in vivo. Drug Metab Dispos 2008; 36:561-70.

McConn DJ 2nd, Lin YS, Allen K, Kunze KL, Thummel KE. Differences in the inhibition of cytochromes P450 3A4 and 3A5 by metabolite-inhibitor complex-forming drugs. Drug Metab Dispos 2004; 32:1083-91.

McCracken JT, Aman MG, McDougle CJ et al. Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. J Child Adolesc Psychopharmacol 2010; 20:1-5.

McCune JS, Hawke RL, LeCluyse EL et al. In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone. Clin Pharmacol Ther 2000; 68:356-66.

McCune JS, Lindley C, Decker JL et al. Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan. J Clin Pharmacol 2001; 41:723-31.

McCune JS, Risler LJ, Phillips BR, Thummel KE, Blough D, Shen DD. Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation. Drug Metab Dispos 2005; 33:1074-81.

McCusker SM, Curran MD, Dynan KB et al. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer’s disease and vascular dementia: a case-control study. Lancet 2001; 357:436-9.

McDermott MF, Aksentijevich I, Galon J et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97:133-44.

McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE. CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol 2009; 75:1337-46.

McDonald RB, Walker KM, Warman DB et al. Characterization of survival and phenotype throughout the life span in UCP2/UCP3 genetically altered mice. Exp Gerontol 2008; 43:1061-8.

McElroy S, Sachse C, Brockmoller J et al. CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting. AAPS PharmSci 2000; 2:33.

McEnroe JD, Fleishaker JC. Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine. Clin Pharmacokinet 2005; 44:237-46.

McErlane V, Yakkundi A, McCarthy HO et al. A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4N. J Gene Med 2005; 7:851-9.

McGeachie M, Ramoni RL, Mychaleckyj JC et al. Integrative predictive model of coronary artery calcification in atherosclerosis. Circulation 2009; 120:2448-54.

McGeer PL, McGeer EG. NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 2007; 28:639-47.

McGeer PL, Rogers J, McGeer EG. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J Alzheimers Dis 2006; 9(3 Suppl):271-6.

McGinnity DF, Berry AJ, Kenny JR, Grime K, Riley RJ. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes. Drug Metab Dispos 2006; 34:1291-300.

McGinnity DF, Griffin SJ, Moody GC et al. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli. Drug Metab Dispos 1999; 27:1017-23.

McGinnity DF, Parker AJ, Soars M, Riley RJ. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s. Drug Metab Dispos 2000; 28:1327-34.

McGinnity DF, Zhang G, Kenny JR et al. Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells. Drug Metab Dispos 2009; 37:1259-68.

McGough J, McCracken J, Swanson J et al. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006; 45:1314-22.

McGough JJ, McCracken JT, Loo SK et al. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2009; 48:1155-64.

McGuinness L, Magoulas C, Sesay AK et al. Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice. Endocrinology 2003; 144:720-31.

McKay GJ, Silvestri G, Chakravarthy U et al. Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol 2011; 173:1357-64.

McKillop D, Back DJ, McCormick AD, Evans JA, Tjia J. Preclinical and in vitro assessment of the potential of D0870, an antifungal agent, for producing clinical drug interactions. Xenobiotica 1999; 29:395-408.

McKillop D, McCormick AD, Millar A, Miles GS, Phillips PJ, Hutchison M. Cytochrome P450-dependent metabolism of gefitinib. Xenobiotica 2005; 35:39-50.

McKillop D, Wild MJ, Butters CJ, Simcock C. Effects of propofol on human hepatic microsomal cytochrome P450 activities. Xenobiotica 1998; 28:845-53.

McKindley DS, Boulet J, Sachdeva K, Wang P, Chichester C. Endotoxic shock alters the pharmacokinetics of lidocaine and monoethylglycinexylidide. Shock 2002; 17:199-204.

McKinnon RA, Burgess WM, Hall PM, Roberts-Thomson SJ, Gonzalez FJ, McManus ME. Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut 1995; 36:259-67.

McKinnon RA, McManus ME. Function and localization of cytochromes P450 involved in the metabolic activation of food-derived heterocyclic amines. Princess Takamatsu Symp 1995; 23:145-53.

McKinnon RA, McManus ME. Localization of cytochromes P450 in human tissues: implications for chemical toxicity. Pathology 1996; 28:148-55.

McKnight AJ, Patterson CC, Sandholm N et al. Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a meta-analysis. Am J Nephrol 2010; 32:476-81.

McLaren N, Reed DM, Musch DC et al. Evaluation of the beta2-adrenergic receptor gene as a candidate glaucoma gene in 2 ancestral populations. Arch Ophthalmol 2007; 125:105-11.

McLaughlin BA, Spencer C, Eberwine J. CAG trinucleotide RNA repeats interacts with RNA-binding proteins. Am J Hum Genet 1996; 59:561-9.

McLaughlin LA, Dickmann LJ, Wolf CR, Henderson CJ. Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening. Drug Metab Dispos 2008; 36:1322-31.

McLellan RA, Drobitch RK, Monshouwer M, Renton KW. Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human. Drug Metab Dispos 1996; 24:1134-8.

McLeod HL, Collie-Duguid ESR, Vreken P et al. Nomenclature for human DPYD alleles. Pharmacogenetics 1998; 8:455-9.

McLeod JF. Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent. Clin Pharmacokinet 2004; 43:97-120.

McMahon FJ, Buervenich S, Charney D et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 2006; 78:804-14.

McNair WP, Ku L, Taylor MRG et al. Familial Cardiomyopathy Registry Research Group: SCNA5 mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004; 110:2163-7.

McNamara DM. Genomic variation and neurohormonal intervention in heart failure. Heart Fail Clin 2010; 6:35-43.

McNamara DM, MacGowan GA, London B. Clinical importance of beta-adrenoceptor polymorphisms in cardiovascular disease. Am J Pharmacogenomics 2002; 2:73-8.

McNeish J, Aiello RJ, Guyot D et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Nat Acad Sci USA 2009; 7:4245-50.

McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC, Bastida J. Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids. Bioorg Med Chem Lett 2009; 19:3233-7.

McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC. Potent and selective inhibition of human cytochrome P450 3A4 by seco-pancratistatin structural analogs. Bioorg Med Chem Lett 2010; 20:2335-9.

McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC. Structure-activity studies on seco-pancratistatin analogs: potent inhibitors of human cytochrome P450 3A4. Bioorg Med Chem Lett 2009; 19:5607-12.

McNulty J, Thorat A, Vurgun N et al. Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor. J Nat Prod 2011; 74:106-8.

McPate MJ, Duncan RS, Witchel HJ, Hancox JC. Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome. J Mol Cell Cardiol 2006; 41:563-6.

McRobie DJ, Glover DD, Tracy TS. Effects of gestational and overt diabetes on human placental cytochromes P450 and glutathione S-transferase. Drug Metab Dispos 1998; 26:367-71.

Mead S, Mahal SP, Beck J et al. Sporadic—but not variant—Creutzfeldt-Jacob disease is associated with polymorphisms upstream of PRNP exon 1. Am J Hum Genet 2001; 69:1225-35.

Mead S, Stumpf MPH, Whitfield J et al. Balancing selection at the prion protein gene consistent with prehistoric Kurulike epidemics. Science 2003; 300:640-3.

Mead S, Whitfield J, Poulter M et al. A novel protective prion protein variant that colocalizes with kuru exposure. New Eng. J. Med 2009; 361:2056-65.

Meadowcroft AM, Williamson KM, Patterson JH, Hinderliter AL, Pieper JA. The effects of fluvastatin, a CYP2C9 inhibitor, on losartan pharmacokinetics in healthy volunteers. J Clin Pharmacol 1999; 39:418-24.

Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001; 11:727-33.

Mealey KL, Jabbes M, Spencer E, Akey JM. Differential expression of CYP3A12 and CYP3A26 mRNAs in canine liver and intestine. Xenobiotica 2008; 38:1305-12.

Mealey KL, Waiting D, Raunig DL, Schmidt KR, Nelson FR. Oral bioavailability of P-glycoprotein substrate drugs do not differ between ABCB1-1Δ and ABCB1 wild type dogs. J Vet Pharmacol Ther 2010; 33:453-60.

Méary A, Brousse G, Jamain S et al. Pharmacogenetic study of atypical antipsychotic drug response: involvement of the norepinephrine transporter gene. Am J Med Genet B Neuropsychiatr Genet 2008; 147:491-4.

Meckley LM, Wittkowsky AK, Rieder MJ, Rettie AE, Veenstra DL. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients. Thromb Haemost 2008; 100:229-39.

Medina MW, Gao F, Ruan W, Rotter JI, Krauss RM. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. Circulation 2008; 118:355-62.

Medina PP, Carretero J, Ballestar E et al. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells. Hum Mol Genet 2005; 14:973-82.

Medina-Díaz IM, Arteaga-Illán G, de León MB et al. Pregnane X receptor-dependent induction of the CYP3A4 gene by o,p’-1,1,1,-trichloro-2,2-bis (p-chlorophenyl)ethane. Drug Metab Dispos 2007; 35:95-102.

Medina-Díaz IM, Elizondo G. Transcriptional induction of CYP3A4 by o,p’-DDT in HepG2 cells. Toxicol Lett 2005; 157:41-7.

Medina-Díaz IM, Estrada-Muñiz E, Reyes-Hernández OD, Ramírez P, Vega L, Elizondo G. Arsenite and its metabolites, MMA(III) and DMA(III), modify CYP3A4, PXR and RXR alpha expression in the small intestine of CYP3A4 transgenic mice. Toxicol Appl Pharmacol 2009; 239:162-8.

Medori R, Montagna P, Tritschler HJ et al. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 1992; 42:669-70.

Medori R, Tritschler H-J. Prion protein gene analysis in three kindred with mutations of prion protein gene at codon 178. Neurology 1992; 42:669-70.

Medori R, Tritschler H-J, LeBlanc A et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. New Eng J Med 1992; 326:444-9.

Meena K, Misra A, Vikram N, Ali S, Pandey RM, Luthra K. Cholesterol ester transfer protein and apolipoprotein E gene polymorphisms in hyperlipidemic Asian Indians in North India. Mol Cell Biochem 2011; 352:189-96.

Meenakshisundaram R, Gragnoli C. CDK4 IVS4-nt40G→A and T2D-associated obesity in Italians. J Cell Physiol 2009; 221:273-5.

Mees B, Récalde A, Loinard C et al. Endothelial nitric oxide synthase overexpression restores the efficiency of bone marrow mononuclear cell-based therapy. Am J Pathol 2011; 178:55-60.

Mega JL, Close SL, Wiviott SD et al. Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009; 119:2553-60.

Mega JL, Close SL, Wiviott SD et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Lancet 2010; 376:1312-9.

Mega JL, Simon T, Collet JP et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA 2010; 304:1821-30.

Megaraj V, Iida T, Jungsuwadee P, Hofmann AF, Vore M. Hepatobiliary disposition of 3alpha,6alpha,7alpha,12alpha-tetrahydroxy-cholanoyl taurine: a substrate for multiple canalicular transporters. Drug Metab Dispos 2010; 38:1723-30.

Mehlotra RK, Cheruvu VK, Blood Zikursh MJ et al. Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic success. J Infect Dis 2011; 204:291-8.

Mehrabian M, Allayee H, Stockton J et al. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat Genet 2005; 37:1224-33.

Mehri S, Mahjoub S, Farhati A et al. Angiotensinogen gene polymorphism in acute myocardial infarction patients. J Renin Angiotensin Aldosterone Syst 2011; 12:42-7.

Mehrotra S, Vanmolkot KR, Frants RR, van den Maagdenberg AM, Ferrari MD, MaassenVanDenBrink A. The phe-124-Cys and A-161T variants of the human 5-HT1B receptor gene are not major determinants of the clinical response to sumatriptan. Headache 2007; 47:711-6.

Mehta AM, Jordanova ES, Corver WE et al. Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma. Genes Chromosomes Cancer 2009; 48:410-8.

Mehta AM, Jordanova ES, Kenter GG, Ferrone S, Fleuren GJ. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 2008; 57:197-206.

Mehta AM, Jordanova ES, van Wezel T et al. Genetic variation of antigen processing machinery components and association with cervical carcinoma. Genes Chromosomes Cancer 2007; 46:577-86.

Mei L, Zhang L, Dai R. An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats. J Enzyme Inhib Med Chem 2009; 24:753-62.

Mei Q, Tang C, Assang C et al. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism. J Pharmacol Exp Ther 1999; 291:749-59.

Mei Q, Tang C, Lin Y, Rushmore TH, Shou M. Inhibition kinetics of monoclonal antibodies against cytochromes P450. Drug Metab Dispos 2002; 30:701-8.

Meibohm B, Beierle I, Derendorf H. How important are gender differences in pharmacokinetics? Clin Pharmacokinet 2002; 41:329-42.

Meier Y, Zodan T, Lang C et al. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. World J Gastroenterol 2008; 14:38-45.

Meiers I, Shanks JH, Bostwick DG. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007. Pathology 2007; 39:299-304.

Mein CA, Caulfield MJ, Dobson RJ, Munroe PB. Genetics of essential hypertension. Hum Mol Genet 2004; 13:169-75.

Meineke C, Tzvetkov MV, Bokelmann K et al. Functional characterization of a -100_-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene. Pharmacogenet Genomics 2008; 18:219-30.

Meinsma R, Fernandez-Salguero P, van Kuilenburg ABP, van Gennip AH, Gonzalez FJ. Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uracilurea (sic). DNA Cell Biol 1995; 14:1-6.

Meir K, Kitsberg D, Alkalay I et al. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J Biol Chem 2002; 277:34036-41.

Meirhaeghe A, Fajas L, Helbecque N et al. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 1998; 7:435-40.

Mekhtiev AR, Fedchenko VI, Tkachev IaV, Timofeev VP, Misharin AIu. Regulation of cholesterol biosynthesis and metabolism in Hep G2 cells by delta8(14)-15-ketoergostane derivatives. Biomed Khim 2010; 56:576-86.

Melcangi RC, Panzica G, Garcia-Segura LM. Neuroactive steroids: focus on human brain. Neuroscience 2011; 191:1-5.

Melchini A, Catania S, Stancanelli R, Tommasini S, Costa C. Interaction of a functionalized complex of the flavonoid hesperetin with the AhR pathway and CYP1A1 expression: involvement in its protective effects against benzo[a]pyrene-induced oxidative stress in human skin. Cell Biol Toxicol 2011; 27:371-9.

Meletiadis J, Chanock S, Walsh TJ. Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents. Pharmacogenomics 2008; 9:561-84.

Melillo JA, Song L, Bhagat G et al. Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J Immunol 2010; 184:2638-45.

Melis MG, Secchi G, Brizzi P, Severino C, Maioli M, Tonolo G. The Trp64Arg beta3-adrenergic receptor amino acid variant confers increased sensitivity to the pressor effects of noradrenaline in Sardinian subjects. Clin Sci 2002; 103:397-402.

Melke J, Westberg L, Nilsson S et al. A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch Gen Psychiatry 2003; 60:1017-23.

Melkersson K, Hulting AL. Serotonin receptor 2A gene polymorphisms and schizophrenia: association with family history, diagnostic subtype and height in patients. Neuro Endocrinol Lett 2009; 30:343-51.

Melkersson KI, Gunes A, Dahl ML. Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patients. Hum Psychopharmacol 2010; 25:347-52.

Melkersson KI, Scordo MG, Gunes A, Dahl ML. Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and on insulin and lipid elevations and insulin resistance in clozapine-treated patients. J Clin Psychiatry 2007; 68:697-704.

Meloni I, Muscettola M, Raynaud M et al. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat Genet 2002; 30:436-40.

Meloni I, Vitelli F, Pucci L et al. Alport syndrome and mental retardation: clinical and genetic dissection of the contiguous gene deletion syndrome in Xq22. 3 (ATS-MR). J Med Genet 2002; 39:359-65.

Mellen PB, Herrington DM. Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens 2005; 23:1311-25.

Mellick GD. CYP450, genetics and Parkinson’s disease: gene x environment interactions hold the key. J Neural Transm Suppl 2006; 159-65.

Mello-Grand M, Singh V, Ghimenti C et al. Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer. Breast Cancer Res Treat 2010; 121:399-411.

Mellor HR, Callaghan R. Accumulation and distribution of doxorubicin in tumour spheroids: the influence of acidity and expression of P-glycoprotein. Cancer Chemother Pharmacol 2011. doi:10. 1007/s00280-011-1598-8.

Mellström B, Säwe J, Bertilsson L, Sjöqvist F. Amitriptyline metabolism: association with debrisoquin hydroxylation in nonsmokers. Clin Pharmacol Ther 1986; 39:369-71.

Memisoglu A, Hu FB, Hankinson SE et al. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 2003; 12:2923-9.

Memon AA, Sorensen BS, Melgard P, Fokdal L, Thykjaer T, Nexo E. Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients. Br J Cancer 2004; 91:2034-41.

Memon AA, Sorensen BS, Meldgaard P, Fokdal L, Thykjaer T, Nexo E. The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients. Br J Cancer 2006; 94:1703-9.

Mencarelli A, Cipriani S, Renga B et al. The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. PLoS One 2010. doi:10. 1371/journal. pone. 0013238.

Mendes CT, Mury FB, de Sá Moreira E et al. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease. Eur Arch Psychiatry Clin Neurosci 2009; 259:16-22.

Méndez-González J, Süren-Castillo S, Calpe-Berdiel L et al. Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice. Br J Nutr 2010; 103:153-60.

Mendonca BB, Leite MV, de Castro M et al. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 2002; 87:1805-9.

Mendonça MI, dos Reis RP, Freitas AI et al. Gene-gene interaction affects coronary artery disease risk. Rev Port Cardiol 2009; 28:397-415.

Mendoza JL, Urcelay E, Lana R et al. MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn’s disease. Inflamm Bowel Dis 2007; 13:585-90.

Mendoza R, Wan YJ, Poland RE et al. CYP2D6 polymorphism in a Mexican American population. Clin Pharmacol Ther 2001; 70:552-60.

Mendoza-Carrera F, Ramírez-López G, Ayala-Martínez NA, García-Zapién AG, Flores-Martínez SE, Sánchez-Corona J. Influence of CRP, IL6, and TNFA gene polymorphisms on circulating levels of C-reactive protein in Mexican adolescents. Arch Med Res 2010; 41:472-7.

Meneses-Lorente G, Pattison C, Guyomard C et al. Utility of long-term cultured human hepatocytes as an in vitro model for cytochrome p450 induction. Drug Metab Dispos 2007; 35:215-20.

Meng FT, Ni RJ, Zhang Z, Zhao J, Liu YJ, Zhou JN. Inhibition of oestrogen biosynthesis induces mild anxiety in C57BL/6J ovariectomized female mice. Neurosci Bull 2011; 27:241-50.

Meng H, Guo G, Ren J, Zhou H, Ge Y, Guo Y. Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Epilepsy Behav 2011; 21:27-30.

Meng H, Liong M, Xia T et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010; 4:4539-50.

Meng H, Vera I, Che N et al. Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc Natl Acad Sci USA 2007; 104:4530-5.

Meng Q, Liu Q, Wang C et al. Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters. Drug Metab Pharmacokinet 2010; 25:320-7.

Meng Y, Baldwin CT, Bowirrat A et al. Association of polymorphisms in the angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community. Am J Hum Genet 2006; 78:871-7.

Mengual L, Oriola J, Ascaso C, Ballescà JL, Oliva R. An increased CAG repeat length in the androgen receptor gene in azoospermic ICSI candidates. J Androl 2003; 24:279-84.

Menheniott TR, Woodfine K, Schulz R et al. Genomic imprinting of Dopa decarboxylase in heart and reciprocal allelic expression with neighboring Grb10. Mol Cell Biol 2008; 28:386-96.

Mennigen JA, Lado WE, Zamora JM et al. Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish, Carassius auratus. Aquat Toxicol 2010; 100:354-64.

Mensah-Osman EJ, Thomas DG, Tabb MM et al. Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer 2007; 109:957-65.

Menu P, Gressier F, Verstuyft C, Hardy P, Becquemont L, Corruble E. Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study. Neuropsychobiology 2010; 62:193-7.

Menu P, Pellegrin M, Aubert JF et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis 2011; 2:137.

Menzaghi C, Ercolino T, Di Paola R et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51:2306-12.

Menzaghi C, Salvemini L, Paroni G et al. Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study. J Intern Med 2010; 267:287-94.

Mercado M, González B, Sandoval C et al. Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly. J Clin Endocrinol Metab 2008; 93:3411-5.

Mercado-Lubo R, McCormick BA. The interaction of gut microbes with host ABC transporters. Gut Microbes 2010; 1:301-6.

Mercer SL, Coop A. Opioid analgesics and P-glycoprotein efflux transporters: A potential systems-level contribution to analgesic tolerance. Curr Top Med Chem 2011; 11:1157-64.

Mercier C, Ciccolini J. Profiling dihydropyrimidine dehydrogenase deficiency in patients with cancer undergoing 5-fluorouracil/capecitabine therapy. Clin Colorectal Cancer 2006; 6:288-96.

Meredith JE Jr, Thompson LA, Toyn JH et al. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice. J Pharmacol Exp Ther 2008; 326:502-13.

Mericq V, Iñíguez G, Martínez A et al. Ala54Thr polymorphism of the fatty acid-binding protein 2 gene (intestinal-type FABP) is associated with changes in insulin sensitivity in SGA pubertal girls. J Pediatr Endocrinol Metab 2008; 21:117-25.

Mérillat AM, Charles RP, Porret A et al. Conditional gene targeting of the ENaC subunit genes Scnn1b and Scnn1g. Am J Physiol Renal Physiol 2009; 296:249-56.

Merino G, Álvarez AI, Prieto JG, Kim RB. The anthelminthic agent albendazole does not interact with p-glycoprotein. Drug Metab Dispos 2002; 30:365-9.

Merino G, Jonker JW, Wagenaar E et al. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metab Dispos 2005; 33:614-8.

Merino G, Pérez M, Real R, Egido E, Prieto JG, Álvarez AI. In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice. Pharm Res 2010; 27:2098-105.

Merk J, Rolff J, Dorn C, Leschber G, Fichtner I. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy? Eur J Cardiothorac Surg 2011; 40:29-33.

Merlotti D, Gennari L, Stolakis K, Nuti R. Aromatase activity and bone loss in men. J Osteoporos 2011. doi:10. 4061/2011/230671.

Merner ND, Dion PA, Rouleau GA. Recent advances in the genetics of distal hereditary motor neuropathy give insight to a disease mechanism involving copper homeostasis that may extend to other motor neuron disorders. Clin Genet 2011; 79:23-34.

Merriman TR, Dalbeth N. The genetic basis of hyperuricaemia and gout. Joint Bone Spine 2011; 8:35-40.

Merry C, Barry MG, Mulcahy F et al. Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS 1997; 11:29-33.

Mésangeau C, Pérès B, Descamps-François C et al. Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands. Bioorg Med Chem 2010; 18:3426-36.

Mesdjian E, Sérée E, Charvet B et al. Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies. Life Sci 1999; 64:827-35.

Meshinchi S, Woods WG, Stirewalt DL et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 2001; 97:89-94.

Meskar A, Plee-Gautier E, Amet Y, Berthou F, Lucas D. Alcohol-xenobiotic interactions. Role of cytochrome P450 2E1. Pathol Biol 2001; 49:696-702.

Messaoud O, Ben Rekaya M, Cherif W et al. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients. Int J Dermatol 2010; 49:544-8.

Messina A, Nencioni S, Gervasi PG, Gotlinger KH, Schwartzman ML, Longo V. Molecular cloning and enzymatic characterization of sheep CYP2J. Xenobiotica 2010; 40:109-18.

Messina A, Siniscalco A, Puccinelli E, Gervasi PG, Longo V. Cloning and tissues expression of the pig CYP1B1 and CYP2J34. Res Vet Sci 2011. doi:10. 1016/j. rvsc. 2011. 04. 012.

Messina D, Annesi G, Serra P et al. Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson’s disease. Neurology 2002; 58:828-9.

Metry KJ, Neale JR, Doll MA et al. Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx). Mutat Res 2010; 684:66-73.

Mettimano M, Specchia ML, La Torre G et al. Blood pressure regulation by CCR genes. Clin Exp Hypertens 2006; 28:611-8.

Meulenbelt I, Bos SD, Kloppenburg M et al. Interleukin-1 gene cluster variants with innate cytokine production profiles and osteoarthritis in subjects from the Genetics, Osteoarthritis and Progression Study. Arthritis Rheum 2010; 62:1119-26.

Meulenbelt I, Min JL, Bos S et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet 2008; 17:1867-75.

Meunier V, Bourrié M, Julian B et al. Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up. Xenobiotica 2000; 30:589-607.

Meuwese MC, Broekhuizen LN, Kuikhoven M et al. Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient mice. PLoS One 2010. doi:10. 1371/journal. pone. 0014262.

Mey V, Giovannetti E, de Braud F et al. In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients. Br J Cancer 2006; 95:289-97.

Meyer A, Merkel S, Brückl W et al. Cdc2 as prognostic marker in stage UICC II colon carcinomas. Eur J Cancer 2009; 45:1466-73.

Meyer CG, Gallin M, Erttmann KD et al. HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc Natl Acad Sci USA 1994; 91:7515-9.

Meyer MC, Baldessarini RJ, Goff DC, Centorrino F. Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Saf 1996; 15:333-46.

Meyer MR, Peters FT, Maurer HH. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxyethylamphetamine and its single enantiomers. Drug Metab Dispos 2009; 37:1152-6.

Meyer MR, Peters FT, Maurer HH. Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers. Biochem Pharmacol 2009; 77:1725-34.

Meyer MR, Peters FT, Maurer HH. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Toxicol Lett 2009; 190:54-60.

Meyer MR, Tschanz JT, Norton MC et al. APOE genotype predicts when –not whether- one is predisposed to develop Alzheimer disease. Nat Genet 1998; 19:321-2.

Meyer S, Ipek M, Keth A et al. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor. Growth Horm IGF Res 2007; 17:307-14.

Meyer SE, Hasenstein JR, Baktula A et al. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival. Am J Pathol 2010; 177:1503-13.

Meyer T, Robles-Carrillo L, Robson T et al. Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice. J Thromb Haemost 2009; 7:171-81.

Meyer UA. Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs. Eur J Gastroenterol Hepatol 1996; 8 Suppl 1:21-5.

Meyer UA. Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions. Yale J Biol Med 1996; 69:203-9.

Meyer zu Schwabedissen HE, Ware JA, Finkelstein D et al. Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis. Hepatology 2011; 54:644-54.

Meyer-Lindenberg A, Buckholtz JW, Kolachana B et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA 2006; 103:6269-74.

Meyers NL, Hickling RI. Pharmacology and metabolism of renzapride: a novel therapeutic agent for the potential treatment of irritable bowel syndrome. Drugs R D 2008; 9:37-63.

Meyre D, Delplanque J, Chèvre JC et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009; 41:157-9.

Meza M, Gandolfi AJ, Klimecki WT. Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction? Toxicol Appl Pharmacol 2007; 222:381-7.

Meznikova M, Erdmann N, Allsopp R, Harrington LA. Telomerase reverse transcriptase-dependent telomere equilibration mitigates tissue dysfunction in mTert heterozygotes. Dis Model Mech 2009; 2:620-6.

Mi YJ, Liang YJ, Huang HB et al. Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters. Cancer Res 2010; 70:7981-91.

Mialet Perez J, Rathz DA, Petrashevskaya NN et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 2003; 9:1300-5.

Miao J, Choi SE, Seok SM et al. Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes. Mol Endocrinol 2011; 25:1159-69.

Miao J, Fang S, Lee J, Comstock C, Knudsen KE, Kemper JK. Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis. Mol Cell Biol 2009; 29:6170-81.

Miao J, Jin Y, Marunde RL et al. Association of genotypes of the CYP3A cluster with midazolam disposition in vivo. Pharmacogenomics J 2009; 9:319-26.

Miao J, Wang Z, Provencher H et al. HOXB13 promotes ovarian cancer progression. Proc Natl Acad Sci USA 2007; 104:17093-8.

Miao L, Yang J, Huang C, Shen Z. Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients. Eur J Clin Pharmacol 2007; 63:1135-41.

Miao Y, Chen J, Zhang Q, Sun A. Deletion of tau attenuates heat shock-induced injury in cultured cortical neurons. J Neurosci Res 2010; 88:102-10.

Miao Z, Kamel A, Prakash C. Characterization of a novel metabolite intermediate of ziprasidone in hepatic cytosolic fractions of rat, dog, and human by ESI-MS/MS, hydrogen/deuterium exchange, and chemical derivatization. Drug Metab Dispos 2005; 33:879-83.

Miceli JJ, Anziano RJ, Robarge L, Hansen RA, Laurent A. The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers. Br J Clin Pharmacol 2000; 49 Suppl 1:65-70.

Miceli JJ, Smith M, Robarge L, Morse T, Laurent A. The effects of ketoconazole on ziprasidone pharmacokinetics-a placebo-controlled crossover study in healthy volunteers. Br J Clin Pharmacol 2000; 49 Suppl 1:71-6.

Miceli-Richard C, Comets E, Verstuyft C et al. A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis. Ann Rheum Dis 2008; 67:478-84.

Micka J, Milatovich A, Menon A et al. Human Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. Pharmacogenetics 1997; 7:95-101.

Micuda S, Mundlova L, Anzenbacherova E et al. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions. Eur J Clin Pharmacol 2004; 60:583-9.

Micuda S, Sispera L, Hodac M et al. Diurnal variation of 6beta-hydroxycortisol in cardiac patients. Physiol Res 2007; 56:307-13.

Michalets EL, Smith LK, van Tassel ED. Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction. Ann Pharmacother 1998; 32:761-5.

Michalets EL, Williams CR. Drug interactions with cisapride: clinical implications. Clin Pharmacokinet 2000; 39:49-75.

Michalk A, Stricker S, Becker J et al. Acetylcholine receptor pathway mutations explain various fetal akinesia deformation sequence disorders. Am J Hum Genet 2008; 82:464-76.

Michalsen A, Frey UH, Merse S, Siffert W, Dobos GJ. Hunger and mood during extended fasting are dependent on the GNB3 C825T polymorphism. Ann Nutr Metab 2009; 54:184-8.

Michaud J, Naud J, Ouimet D et al. Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol 2010; 21:1488-97.

Michaud M, Barakat S, Magnard S, Rigal D, Baggetto LG. Leucine-rich protein 130 contributes to apoptosis resistance of human hepatocarcinoma cells. Int J Oncol 2011; 38:169-78.

Michaud V, Frappier M, Dumas MC, Turgeon J. Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism. PLoS One 2010. doi:10. 1371/journal. pone. 0015666.

Michaud V, Mouksassi MS, Labbé L et al. Inhibitory effects of propafenone on the pharmacokinetics of caffeine in humans. Ther Drug Monit 2006; 28:779-83.

Michaud V, Simard C, Turgeon J. Characterization of CYP3A isozymes involved in the metabolism of domperidone: Role of cytochrome b(5) and inhibition by ketoconazole. Drug Metab Lett 2010; 4:95-103.

Michaud V, Turgeon J. Assessment of competitive and mechanism-based inhibition by clarithromycin: Use of domperidone as a CYP3A probe-drug substrate and various enzymatic sources including a new cell-based assay with Freshly isolated human hepatocytes. Drug Metab Lett 2010; 4:69-76.

Michelon H, König J, Durrbach A et al. SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients. Pharmacogenomics 2010; 11:1703-13.

Michihara A, Anraku M, Abe A et al. Comparison of receptors and enzymes regulating cholesterol levels in liver between SHR/NDmcr-cp rats and normotensive Wistar Kyoto rats at ten weeks of age. Biol Pharm Bull 2011; 34:1116-9.

Mie Y, Suzuki M, Komatsu Y. Electrochemically driven drug metabolism by membranes containing human cytochrome P450. J Am Chem Soc 2009; 131:6646-7.

Mielke MM, Bandaru VV, Haughey NJ, Rabins PV, Lyketsos CG, Carlson MC. Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging 2010; 31:17-24.

Mielke MM, Leoutsakos JM, Tschanz JT et al. Interaction between vascular factors and the APOE E4 allele in predicting rate of progression in Alzheimer’s disease. J Alzheimers Dis 2011; 26:127-34.

Mielke S. Individualized pharmacotherapy with paclitaxel. Curr Opin Oncol 2007; 19:586-9.

Mierau J, Schneider FJ, Ensinger HA, Chio CL, Lajiness ME, Huff RM. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. Eur J Pharmacol 1995; 290:29-36.

Migaud M, Daveau A, Malpaux B. MTNR1A melatonin receptors in the ovine premammillary hypothalamus: day-night variation in the expression of the transcripts. Biol Reprod 2005; 72:393-8.

Migita O, Noguchi E, Jian Z et al. ADRB2 polymorphisms and asthma susceptibility: transmission disequilibrium test and meta-analysis. Int Arch Allergy Immunol 2004; 134:150-7.

Migliardi G, D’Arrigo C, Santoro V et al. Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders. Clin Neuropharmacol 2007; 30:107-13.

Mihara K, Otani K, Ishida M et al. Increases in plasma concentration of m chlorophenylpiperazine, but not trazodone, with low-dose haloperidol. Ther Drug Monit 1997; 19:43-5.

Mihara K, Otani K, Suzuki A et al. Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine. Psychopharmacology 1997; 133:95-8.

Mihara K, Suzuki A, Kondo T et al. Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia. Ther Drug Monit 2000; 22:245-9.

Mihara K, Svensson US, Tybring G, Hai TN, Bertilsson L, Ashton M. Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19. Fundam Clin Pharmacol 1999; 13:671-5.

Mikami LR, Wieseler S, Souza RL, Schopfer LM, Lockridge O, Chautard-Freire-Maia EA. Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase. Pharmacogenet Genomics 2007; 17:681-5.

Mikami LR, Wieseler S, Souza RL et al. Five new naturally occurring mutations of the BCHE gene and frequencies of 12 butyrylcholinesterase alleles in a Brazilian population. Pharmacogenet Genomics 2008; 18:213-8.

Mikhail N, Iskander E, Cope D. Rhabdomyolysis in an HIV-infected patient on anti-retroviral therapy precipitated by high-dose pravastatin. Curr Drug Saf 2009; 4:121-2.

Miki A, Ohtani H, Sawada Y. Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model. J Clin Pharm Ther 2010. doi:10. 1111/j. 1365-2710. 2010. 01229. x.

Miki Y, Suzuki T, Tazawa C, Blumberg B, Sasano H. Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol Cell Endocrinol 2005; 231:75-85.

Miksits M, Maier-Salamon A, Vo TP et al. Glucuronidation of piceatannol by human liver microsomes: major role of UGT1A1, UGT1A8 and UGT1A10. J Pharm Pharmacol 2010; 62:47-54.

Miksits M, Wlcek K, Svoboda M et al. Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism. Cancer Lett 2010; 289:237-45.

Miksys S, Lerman C, Shields PG, Mash DC, Tyndale RF. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology 2003; 45:122-32.

Miksys S, Rao Y, Hoffmann E, Mash DC, Tyndale RF. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J Neurochem 2002; 82:1376-87.

Miksys S, Tyndale RF. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev 2004; 36:313-33.

Miksys S, Tyndale RF. Nicotine induces brain CYP enzymes: relevance to Parkinson’s disease. J Neural Transm Suppl 2006; 177-80.

Miksys SL, Cheung C, Gonzalez FJ, Tyndale RF. Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model. Drug Metab Dispos 2005; 33:1495-502.

Miksys SL, Tyndale RF. Drug-metabolizing cytochrome P450s in the brain. J Psychiatry Neurosci 2002; 27:406-15.

Mikus G, Bochner F, Eichelbaum M, Horak P, Somogyi AA, Spector S. Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphism. J Pharmacol Exp Ther 1994; 268:546-51.

Mikus G, Scholz IM, Weiss J. Pharmacogenomics of the triazole antifungal agent voriconazole. Pharmacogenomics 2011; 12:861-72.

Mikus G, Schöwel V, Drzewinska M et al. Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir. Clin Pharmacol Ther 2006; 80:126-35.

Milane A, Fernandez C, Dupuis L et al. P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis. Neurosci Lett 2010; 472:166-70.

Milani CJ, Kobori H, Mullins JJ, Mitchell KD. Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Med Sci 2010; 340:389-94.

Milanowski B, Lulek J, Lehmler HJ, Kania-Korwel I. Assessment of the disposition of chiral polychlorinated biphenyls in female mdr 1a/b knockout versus wild-type mice using multivariate analyses. Environ Int 2010; 36:884-92.

Milazzo L, Mazzali C, Bestetti G et al. Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. Curr HIV Res 2011; 9:186-93.

Milic NL, Ngo SN, Marchant CL, Height TA, McKinnon RA. Pulmonary cytochrome P450 enzymes belonging to the CYP4B subfamily from an Australian marsupial, the tammar wallaby (Macropus eugenii). Comp Biochem Physiol C Toxicol Pharmacol 2011; 153:60-6.

Milman U, Blum S, Shapira C et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol 2008; 28:341-7.

Miltiadous G, Xenophontos S, Bairaktari E, Ganotakis M, Cariolou M, Elisaf M. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia. Pharmacogenet Genomics 2005; 15:219-25.

Millan MJ, Brocco M, Gobert A, Dekeyne A. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology 2005; 177:448-58.

Millar DS, Allgrove J, Rodeck C, Kakkar VV, Cooper DN. A homozygous deletion/insertion mutation in the protein C (PROC) gene causing neonatal Purpura fulminans: prenatal diagnosis in an at-risk pregnancy. Blood Coagul Fibrinolysis 1994; 5:647-9.

Millar DS, Grundy CB, Bignell P et al. A novel nonsense mutation in the protein C (PROC) gene (Trp-29→term) causing recurrent venous thrombosis. Hum Genet 1993; 91:196.

Millat G, Marçais C, Rafi MA et al. Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype. Am J Hum Genet 1999; 65:1321-9.

Millat G, Marçais C, Tomasetto C et al. Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am J Hum Genet 2001; 68:1373-85.

Miller DB, Spence JD. Clinical pharmacokinetics of fibric acid derivatives (fibrates). Clin Pharmacokinet 1998; 34:155-62.

Miller GP, Jones DR, Sullivan SZ et al. Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans. Chem Res Toxicol 2009; 22:1239-45.

Miller GP, Lichti CF, Zielinska AK et al. Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin. Drug Metab Dispos 2008; 36:2211-8.

Miller JA, Thai K, Scholey JW. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 1999; 56:2173-80.

Miller KK, Cai J, Ripp SL, Pierce WM Jr, Rushmore TH, Prough RA. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450. Drug Metab Dispos 2004; 32:305-13.

Miller MA, Conley Y, Scanlon JM et al. APOE genetic associations with seizure development after severe traumatic brain injury. Brain Inj 2010; 24:1468-77.

Miller TW, Balko JM, Ghazoui Z et al. A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance. Clin Cancer Res 2011; 17:2024-34.

Miller VP, Stresser DM, Blanchard AP, Turner S, Crespi CL. Fluorometric high-throughput screening for inhibitors of cytochrome P450. Ann N Y Acad Sci 2000; 919:26-32.

Miller WL, Agrawal V, Sandee D et al. Consequences of POR mutations and polymorphisms. Mol Cell Endocrinol 2011; 336:174-9.

Millet P, Moulin M, Stieger B, Daali Y, Pastor CM. How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver. J Pharmacol Exp Ther 2011; 336:624-32.

Milligan PA, Marshall SF, Karlsson MO. A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction. Br J Clin Pharmacol 2002; 53 Suppl 1:45-52.

Milligan SA, Burke P, Coleman DT et al. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin Cancer Res 2009; 15:4885-94.

Millikan R, Eaton A, Worley K et al. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat 2003; 79:355-64.

Millington DJ, Villanueva C, Obirek J, Kaufman J, Smith C. Safety pharmacology, acute toxicity and pharmacokinetics of SCP-123 and acetaminophen. Basic Clin Pharmacol Toxicol 2010; 107:701.

Millonig G, Wang Y, Homann N et al. Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions. Int J Cancer 2011; 128:533-40.

Mills BM, Zaya MJ, Walters RR et al. Current cytochrome P450 phenotyping methods applied to metabolic drug-drug interaction prediction in dogs. Drug Metab Dispos 2010; 38:396-404.

Mills JB, Rose KA, Sadagopan N, Sahi J, de Morais SM. Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line. J Pharmacol Exp Ther 2004; 309:303-9.

Mills SG, DeMartino JA. Chemokine receptor-directed agents as novel anti-HIV-1 therapies. Curr Top Med Chem 2004; 4:1017-33.

Millstein J, Conti DV. Gilliland FD, Gauderman WJ. A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet 2006; 78:15-27.

Mimura N, Kobayashi K, Nakamura Y, Shimada N, Hosokawa M, Chiba K. Metabolism of medroxyprogesterone acetate (MPA) via CYP enzymes in vitro and effect of MPA on bleeding time in female rats in dependence on CYP activity in vivo. Life Sci 2003; 73:3201-12.

Min DI, Ellingrod VL. Association of the CYP3A4*1B 5’-flanking region polymorphism with cyclosporine pharmacokinetics in healthy subjects. Ther Drug Monit 2003; 25:305-9.

Min DI, Ku YM, Vichiendilokkul A, Fleckenstein LL. A urine metabolic ratio of dextromethorphan and 3-methoxymorphinan as a probe for CYP3A activity and prediction of cyclosporine clearance in healthy volunteers. Pharmacotherapy 1999; 19:753-9.

Min KH, Xia Y, Kim EK et al. A novel class of highly potent multidrug resistance reversal agents: disubstituted adamantyl derivatives. Bioorg Med Chem Lett 2009; 19:5376-9.

Min SI, Kim SY, Ahn SH et al. CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. Transplantation 2010; 90:1394-400.

Minami S, Ito K, Honma M et al. Posttranslational regulation of Abcc2 expression by SUMOylation system. Am J Physiol Gastrointest Liver Physiol 2009; 296:406-13.

Minamiyama Y, Takemura S, Akiyama T et al. Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels. FEBS Lett 1999; 452:165-9.

Minamiyama Y, Takemura S, Imaoka S, Funae Y, Okada S. Cytochrome P450 is responsible for nitric oxide generation from NO-aspirin and other organic nitrates. Drug Metab Pharmacokinet 2007; 22:15-9.

Minato K, Suzuki R, Asagarasu A, Matsui T, Sato M. Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes. Drug Metab Dispos 2008; 36:831-40.

Minematsu T, Hashimoto T, Usui T, Kamimura H. Characterization of renal tubular apical efflux of zonampanel, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist, in humans. Xenobiotica 2008; 38:1191-202.

Minematsu T, Lee J, Zha J et al. Time-dependent inhibitory effects of (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28-dioxa-4-azatricyclo[22. 3. 1. 0(4. 9)]octacos-18-ene-2,3,10,16-tetrone (FK1706), a novel nonimmunosuppressive immunophilin ligand, on CYP3A4/5 activity in humans in vivo and in vitro. Drug Metab Dispos 2010; 38:249-59.

Miners JO. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid. Clin Pharmacokinet 1989; 17:327-44.

Miners JO, Day RO. Relationships between the adverse effects of drugs and genetic polymorphism in genes encoding drug metabolizing enzymes. Br J Clin Pharmacol 2007; 63:380-1.

Miners JO, Rees DL, Valente L, Veronese ME, Birkett DJ. Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism. J Pharmacol Exp Ther 1995; 272:1076-81.

Miners JS, Kehoe P, Love S. Neprilysin protects against cerebral amyloid angiopathy and Aβ-induced degeneration of cerebrovascular smooth muscle cells. Brain Pathol 2011; 21:594-605.

Minn AJ, Gupta GP, Siegel PM et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436:518-24.

Minoda Y, Kharasch ED. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Anesthesiology 2001; 95:509-14.

Minov C. Risk of QTc prolongation due to combination of ziprasidone and quetiapine. Psychiatr Prax 2004; 31 Suppl 1:142-4.

Minushkina LO, Zateĭshchikova AA, Zateĭshchikov DA et al. Genetic aspects of individual sensitivity to betaxolol in patients with arterial hypertension. Kardiologiia 2008; 48:20-6.

Minuzzo M, Ceribelli M, Pitarque-Martì M et al. Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promoters. Mol Pharmacol 2005; 68:1496-503.

Miquet JG, González L, Matos MN et al. Transgenic mice overexpressing GH exhibit hepatic upregulation of GH-signaling mediators involved in cell proliferation. J Endocrinol 2008; 198:317-30.

Mira MT, Alcaïs A, Nguyen VT et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004; 427:636-40.

Miranda DM, Wajchenberg BL, Calsolari MR et al. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome. Clin Endocrinol 2009; 71:512-7.

Miranda SR, Lee JK, Brouwer KL, Wen Z, Smith PC, Hawke RL. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2). Drug Metab Dispos 2008; 36:2219-26.

Miranda SR, Meyer SA. Cytotoxicity of chloroacetanilide herbicide alachlor in HepG2 cells independent of CYP3A4 and CYP3A7. Food Chem Toxicol 2007; 45:871-7.

Miravalle L, Tokuda T, Chiarle R et al. Substitutions at codon 22 of Alzheimer’s A-beta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J Biol Chem 2000; 275:27110-6.

Mirghani RA, Ericsson O, Tybring G, Gustafsson LL, Bertilsson L. Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man. Eur J Clin Pharmacol 2003; 59:23-8.

Mirghani RA, Hellgren U, Bertilsson L, Gustafsson LL, Ericsson O. Metabolism and elimination of quinine in healthy volunteers. Eur J Clin Pharmacol 2003; 59:423-7.

Mirghani RA, Hellgren U, Westerberg PA, Ericsson O, Bertilsson L, Gustafsson LL. The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo. Clin Pharmacol Ther 1999; 66:454-60.

Mirghani RA, Sayi J, Aklillu E et al. CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population. Pharmacogenet Genomics 2006; 16:637-45.

Mirghani RA, Yasar U, Zheng T et al. Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro; 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway. Drug Metab Dispos 2002; 30:1368-71.

Mirkov S, Komoroski BJ, Ramírez J et al. Effects of green tea compounds on irinotecan metabolism. Drug Metab Dispos 2007; 35:228-33.

Mirzatoni A, Spence RD, Naranjo KC, Saldanha CJ, Schlinger BA. Injury-induced regulation of steroidogenic gene expression in the cerebellum. J Neurotrauma 2010; 27:1875-82.

Misbahuddin A, Placzek MR, Chaudhuri KR, Wood NW, Bhatia KP, Warner TT. A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm. Neurology 2002; 58:124-6.

Misener VL, Luca P, Azeke O et al. Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Mol Psychiatry 2004; 9:500-9.

Mishra BK, Wu T, Belfer I et al. Do motor control genes contribute to interindividual variability in decreased movement in patients with pain? Mol Pain 2007; 3:20.

Mishra DK, Chen Z, Wu Y, Sarkissyan M, Koeffler HP, Vadgama JV. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mol Cancer Ther 2010; 9:33-45.

Mismetti P, Laporte S. Rivaroxaban: clinical pharmacology. Ann Fr Anesth Reanim 2008; 27 Suppl 3:16-21.

Missler M, Zhang W, Rohlmann A et al. Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 2003, 423:939-48.

Mistry PK, Sirrs S, Chan A et al. Pulmonary hypertension in type 1 Gaucher’s disease: genetic and epigenetic determinants of phenotype and response to therapy. Mol Genet Metab 2002; 77:91-8.

Mital S, Chung WK, Colan SD et al. Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation 2011; 123:2353-62.

Mitani A, Ishigami M, Watase K, Minakata T, Yamamura T. A novel apolipoprotein E mutation, apoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy. J Atheroscler Thromb 2011; 18:531-5.

Mitchel RE, Hasu M, Bugden M et al. Low-dose radiation exposure and atherosclerosis in ApoE(-/-) mice. Radiat Res 2011; 175:665-76.

Mitchell A, Rushentsova U, Siffert W, Philipp T, Wenzel RR. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism. Clin Pharmacol Ther 2006; 79:274-81.

Mitchell AL, Bale AE, Gonzalez F, McBride OW. Mapping of cytochrome p450 IIA, IIB, and IIF subfamilies on chromosome 19 by linkage analysis. Cytogenet Cell Genet 1989; 51:1045.

Mitchell BD, Cole SA, Comuzzie AG et al. A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor. Diabetes 1999; 48:1863-7.

Mitchell C, Gregersen N, Krause A. Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population. Pharmacogenomics 2011; 12:953-63.

Mitchell C, Mignon A, Guidotti JE et al. Therapeutic liver repopulation in a mouse model of hypercholesterolemia. Hum Molec Genet 2000; 9:1597-602.

Mitchell MD, Elrick MM, Walgren JL, Mueller RA, Morris DL, Thompson DC. Peptide-based in vitro assay for the detection of reactive metabolites. Chem Res Toxicol 2008; 21:859-68.

Mitchell PB. Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Drug Saf 1997; 17:390-406.

Miteva L, Stanilov N, Deliysky T, Mintchev N, Stanilova S. Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer. Cancer Invest 2009; 27:924-31.

Mitin T, von Moltke LL, Court MH, Greenblatt DJ. Levothyroxine up-regulates P-glycoprotein independent of the pregnane X receptor. Drug Metab Dispos 2004; 32:779-82.

Mitomo H, Kato R, Ito A et al. A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport. Biochem J 2003; 373:767-74.

Mitra AK, Thummel KE, Kalhorn TF, Kharasch ED, Unadkat JD, Slattery JT. Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo. Clin Pharmacol Ther 1995; 58:556-66.

Mitra P, Audus K, Williams G, Yazdanian M, Galinis D. A comprehensive study demonstrating that p-glycoprotein function is directly affected by changes in pH: Implications for intestinal pH and effects on drug absorption. J Pharm Sci 2011. doi:10. 1002/jps. 22596.

Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Nat Acad Sci USA 2006; 103:16394-9.

Mitre N, Lteif A. Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor. J Pediatr Endocrinol Metab 2009; 22:1163-7.

Mitsuhashi J, Hosoyama H, Tsukahara S et al. In vivo expansion of MDR1-transduced cells accompanied by a post-transplantation chemotherapy regimen with mitomycin C and methotrexate. J Gene Med 2010; 12:596-603.

Mitsui T, Nomura S, Itakura A, Mizutani S. Role of aminopeptidases in the blood pressure regulation. Biol Pharm Bull 2004; 27:768-71.

Mitsunaga Y, Kubota T, Ishiguro A et al. Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population. Mutat Res 2002; 505:83-5.

Miura M. Enantioselective disposition of lansoprazole and rabeprazole in human plasma. Yakugaku Zasshi 2006; 126:395-402.

Miura M, Inoue K, Kagaya H, Saito M, Habuchi T, Satoh S. Inter-individual difference determinant of prednisolone pharmacokinetics for Japanese renal transplant recipients in the maintenance stage. Xenobiotica 2009; 39:939-45.

Miura M, Inoue K, Satoh S et al. Influence of cytochrome P450 (CYP) 3A5 polymorphisms on the pharmacokinetics of lansoprazole enantiomers in CYP2C19 extensive metaboliser renal transplant recipients. Clin Drug Investig 2007; 27:251-8.

Miura M, Kagaya H, Satoh S et al. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Ther Drug Monit 2008; 30:559-64.

Miura M, Kagaya H, Tada H et al. Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole. Xenobiotica 2006; 36:95-102.

Miura M, Motoyama S, Hinai Y et al. Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration. Xenobiotica 2010; 40:630-6.

Miura M, Niioka T, Kagaya H et al. Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation. J Clin Pharm Ther 2011; 36:208-16.

Miura M, Niioka T, Kato S et al. Monitoring of mycophenolic acid predose concentrations in the maintenance phase more than one year after renal transplantation. Ther Drug Monit 2011; 33:295-302.

Miura M, Ohkubo T. In vitro metabolism of quazepam in human liver and intestine and assessment of drug interactions. Xenobiotica 2004; 34:1001-11.

Miura M, Ohkubo T. Identification of human cytochrome P450 enzymes involved in the major metabolic pathway of fluvoxamine. Xenobiotica 2007; 37:169-79.

Miura M, Otani K, Ohkubo T. Identification of human cytochrome P450 enzymes involved in the formation of 4-hydroxyestazolam from estazolam. Xenobiotica 2005; 35:455-65.

Miura M, Satoh S, Inoue K et al. Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Eur J Clin Pharmacol 2007; 63:1161-9.

Miura M, Satoh S, Inoue K et al. Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation. Ther Drug Monit 2008; 30:46-51.

Miura M, Satoh S, Inoue K, Saito M, Habuchi T, Suzuki T. Telmisartan pharmacokinetics in Japanese renal transplant recipients. Clin Chim Acta 2009; 399:83-7.

Miura M, Satoh S, Tada H et al. Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus. Int J Clin Pharmacol Ther 2006; 44:605-13.

Miura M, Satoh S, Tada H, Habuchi T, Suzuki T. Stereoselective metabolism of rabeprazole-thioether to rabeprazole by human liver microsomes. Eur J Clin Pharmacol 2006; 62:113-7.

Miura M, Tada H, Yasui-Furukori N et al. Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes. Chirality 2005; 17:338-44.

Miura M, Takahashi N, Kanno S et al. Drug interaction of (S)-warfarin, and not (R)-warfarin, with itraconazole in a hematopoietic stem cell transplant recipient. Clin Chim Acta 2011; 412:2002-6.

Miura M, Uno T, Tateishi T, Suzuki T. Pharmacokinetics of fexofenadine enantiomers in healthy subjects. Chirality 2007; 19:223-7.

Miura M, Uno T. Clinical pharmacokinetics of fexofenadine enantiomers. Expert Opin Drug Metab Toxicol 2010; 6:69-74.

Miwatashi S, Arikawa Y, Kotani E et al. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent. J Med Chem 2005; 48:5966-79.

Miyachi K, Miyakawa H, Oda M, Horigome T, Fritzler MJ. Primary biliary cirrhosis and autoantibodies. Nihon Rinsho Meneki Gakkai Kaishi 2008; 31:47-55.

Miyagata Y, Nakai K, Sugiyama Y. Clinical significance of combined CYP2C9 and VKORC1 genotypes in Japanese patients requiring warfarin. Int Heart J 2011; 52:44-9.

Miyahara N, Ohnishi H, Miyahara S et al. Leukotriene B4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol 2009; 40:672-82.

Miyajima A, Furihata T, Chiba K. Functional analysis of GC Box and its CpG methylation in the regulation of CYP1A2 gene expression. Drug Metab Pharmacokinet 2009; 24:269-76.

Miyajima S, Nemoto K, Sekimoto M et al. Induction of hepatic cytochrome P450 isoforms by nicardipine at therapeutic doses in spontaneously hypertensive rats. J Toxicol Sci 2007; 32:79-90.

Miyakawa H, Kitazawa E, Kikuchi K et al. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C. Autoimmunity 2000; 33:23-32.

Miyake K, Nakashima H, Akahoshi M et al. Genetically determined interferon-gamma production influences the histological phenotype of lupus nephritis. Rheumatology 2002; 41:518-24.

Miyaki K, Htun NC, Song Y, Ikeda S, Muramatsu M, Shimbo T. The combined impact of 12 common variants on hypertension in Japanese men, considering GWAS results. J Hum Hypertens 2011. doi:10. 1038/jhh. 2011. 50.

Miyaki K, Sutani S, Kikuchi H et al. Increased risk of obesity resulting from the interaction between high energy intake and the Trp64Arg polymorphism of the beta3-adrenergic receptor gene in healthy Japanese men. J Epidemiol 2005; 15:203-10.

Miyamoto K, Iwase M, Nyui M et al. Histamine type 1 receptor deficiency reduces airway inflammation in a murine asthma model. Int Arch Allergy Immunol 2006; 140:215-22.

Miyamoto K, Kowalska A, Hasegawa M et al. Familial frontotemporal dementia and parkinsonism with a novel mutation at an intron 10+11-splice site in the tau gene. Ann Neurol 2001; 50:117-20.

Miyamoto M, Umetsu Y, Dosaka-Akita H et al. CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem Biophys Res Commun 1999; 261:658-60.

Miyamoto T, Koh E, Sakugawa N et al. Two single nucleotide polymorphisms in PRDM9 (MEISETZ) gene may be a genetic risk factor for Japanese patients with azoospermia by meiotic arrest. J Assist Reprod Genet 2008; 25:553-7.

Miyata A, Yokoyama C, Ihara H et al. Characterization of the human gene (TBXAS1) encoding thromboxane synthase. Eur J Biochem 1994; 224:273-9.

Miyata M, Matsuda Y, Nomoto M et al. Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption. Drug Metab Dispos 2009; 37:338-44.

Miyata M, Takamatsu Y, Kuribayashi H, Yamazoe Y. Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression. J Pharmacol Exp Ther 2009; 331:1079-85.

Miyata M, Yasuda K, Burioka N et al. The influence of granisetron on the pharmacokinetics and pharmacodynamics of docetaxel in Asian lung cancer patients. Cancer J 2006; 12:69-72.

Miyata N, Taniguchi K, Seki T et al. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol 2001; 133:325-9.

Miyata T, Morita T, Inomoto T, Kawauchi S, Shirakami A, Iwanaga S. Prothrombin Tokushima, a replacement of arginine-418 by tryptophan that impairs the fibrinogen clotting activity of derived thrombin Tokushima. Biochemistry 1987; 26:1117-22.

Miyata T, Sato Y, Ishikawa J et al. Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis. Thromb Res 2009; 124:14-8.

Miyazaki M, Maekawa C, Iwanaga K, Morimoto K, Kakemi M. Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat. Biol Pharm Bull 2000; 23:1363-9.

Miyazaki M, Nakamura K, Fujita Y, Guengerich FP, Horiuchi R, Yamamoto K. Defective activity of recombinant cytochromes P450 3A4. 2 and 3A4. 16 in oxidation of midazolam, nifedipine, and testosterone. Drug Metab Dispos 2008; 36:2287-91.

Miyazaki M, Sugawara E, Yoshimura T, Yamazaki H, Kamataki T. Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108. Mutat Res 2005; 581:165-71.

Miyazawa M, Marumoto S, Takahashi T, Nakahashi H, Haigou R, Nakanishi K. Metabolism of (+)- and (-)-menthols by CYP2A6 in human liver microsomes. J Oleo Sci 2011; 60:127-32.

Miyazawa M, Shindo M, Shimada T. Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos 2002; 30:602-7.

Miyazawa M, Shindo M, Shimada T. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metab Dispos 2001; 29:200-5.

Miyazawa M, Shindo M, Shimada T. Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes. Xenobiotica 2001; 31:713-23.

Miyoshi K, Takaishi M, Nakajima K et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol 2011; 131:108-17.

Miyoshi Y, Ando A, Takamura Y, Taguchi T, Tamaki Y, Noguchi S. Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues. Int J Cancer 2002; 97:129-32.

Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S. Breast cancer risk associated with polymorphism in CYP19 in Japanese women. Int J Cancer 2000; 89:325-8.

Miyoshi Y, Taguchi T, Kim SJ, Tamaki Y, Noguchi S. Prediction of response to docetaxel by immunohistochemical analysis of CYP3A4 expression in human breast cancers. Breast Cancer 2005; 12:11-5.

Mizerovska J, Dracinska H, Arlt VM, Schmeiser HH, Frei E, Stiborova M. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 – similarity between human and rat enzymes. Neuro Endocrinol Lett 2009; 30 Suppl 1:52-9.

Mizerovská J, Dračínská H, Frei E, Schmeiser HH, Arlt VM, Stiborová M. Induction of biotransformation enzymes by the carcinogenic air-pollutant 3-nitrobenzanthrone in liver, kidney and lung, after intra-tracheal instillation in rats. Mutat Res 2011; 720:34-41.

Mizuma T. Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10. Int J Pharm 2009; 378:140-1.

Mizuno D, Hiroi T, Ng P, Kishimoto W, Imaoka S, Funae Y. Regulation of CYP2D expression in rat brain by toluene. Osaka City Med J 2003; 49:49-56.

Mizuno K, Katoh M, Okumura H et al. Metabolic activation of benzodiazepines by CYP3A4. Drug Metab Dispos 2009; 37:345-51.

Mizuno T, Terada T, Kamba T et al. ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma. Ann Oncol 2010; 21:1382-3.

Mizuno Y, Tani N, Komuro S, Kanamaru H, Nakatsuka I. In vitro metabolism of perospirone in rat, monkey and human liver microsomes. Eur J Drug Metab Pharmacokinet 2003; 28:59-65.

Mizushima H, Takanaka K, Abe K, Fukazawa I, Ishizuka H. Stereoselective pharmacokinetics of oxybutynin and N-desethyloxybutynin in vitro and in vivo. Xenobiotica 2007; 37:59-73.

Mizuta N, Akiyoshi J, Sato A et al. Serotonin receptor 3A (HTR3A) gene is associated with personality traits, but not panic disorder. Psychiatr Genet 2008; 18:44.

Mizutani S, Ishii M, Hattori A et al. New insights into the importance of aminopeptidase A in hypertension. Heart Fail Rev 2008; 13:273-84.

Mizutani T. PM frequencies of major CYPs in Asians and Caucasians. Drug Metab Rev 2003; 35:99-106.

Mizutani T. Toxicity of xanthene food dyes by inhibition of human drug-metabolizing enzymes in a noncompetitive manner. J Environ Public Health 2009. doi:10. 1155/2009/953952.

Mlejnek P, Dolezel P, Faber E, Kosztyu P. Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells. Ann Hematol 2011; 90:837-42.

Mlejnek P, Dolezel P, Kosztyu P. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N(6)-(3-iodobenzyl)-adenosine-5’-N-methyluronamide in human leukemia cells. J Cell Physiol 2011. doi:10. 1002/jcp. 22775.

Mlejnek P, Dolezel P. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5’-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism. Acta Physiol 2010; 199:171-9.

Mnif W, Pascussi JM, Pillon A et al. Estrogens and antiestrogens activate hPXR. Toxicol Lett 2007; 170:19-29.

Mo J, Xia Y, Ning Z, Wade TJ, Mumford JL. Elevated ERCC1 gene expression in blood cells associated with exposure to arsenic from drinking water in Inner Mongolia. Anticancer Res 2009; 29:3253-9.

Mo R, Jin X, Li N et al. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 2011; 32:4609-20.

Mo R, Xiao Y, Sun M, Zhang C, Ping Q. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption. Int J Pharm 2011; 409:38-45.

Mo SL, Liu WF, Chen Y et al. Ligand- and protein-based modeling studies of the inhibitors of human cytochrome P450 2D6 and a virtual screening for potential inhibitors from the Chinese herbal medicine, Scutellaria Baicalensis (Huangqin, Baikal Skullcap). Comb Chem High Throughput Screen 2012; 15:36-80.

Mo SL, Liu YH, Duan W, Wei MQ, Kanwar JR, Zhou SF. Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6. Curr Drug Metab 2009; 10:730-53.

Mo SL, Zhou ZW, Yang LP, Wei MQ, Zhou SF. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I. Curr Drug Metab 2009; 10:1075-126.

Mo SL, Zhou ZW, Yang LP, Wei MQ, Zhou SF. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II. Curr Drug Metab 2009; 10:1127-50.

Mo SM, Oh IJ. Release of adriamycin from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles. J Nanosci Nanotechnol 2011; 11:1795-8.

Mo W, Zhang GG, Yang TL et al. The genetic polymorphisms of beta3-adrenergic receptor (AR) Trp64Arg and beta2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients. Clin Chem Lab Med 2007; 45:493-8.

Mo Z, Gao Y, Cao Y, Gao F, Jian L. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 2009; 69:662-88.

Mobascher A, Rujescu D, Mittelstrass K et al. Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction. Am J Med Genet B Neuropsychiatr Genet 2010; 153:684-90.

Mochizuki N, Matsumoto K, Ohno K et al. Effects of hepatic CYP3A4 activity on disposition of micafungin in liver transplant recipients with markedly small-for-size grafts. Transplant Proc 2006; 38:3649-50.

Modarai M, Silva E, Suter A, Heinrich M, Kortenkamp A. Safety of herbal medicinal products: Echinacea and selected alkylamides do not induce CYP3A4 mRNA expression. Evid Based Complement Alternat Med 2009. doi:10. 1093/ecam/nep174.

Modarai M, Suter A, Kortenkamp A, Heinrich M. The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil’s claw (Harpagophyti radix) preparations. J Pharm Pharmacol 2011; 63:429-38.

Modarai M, Yang M, Suter A, Kortenkamp A, Heinrich M. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on Cytochrome P450 3A4 (CYP3A4). Planta Med 2010; 76:378-85.

Modregger J, DiProspero NA, Charles V, Tangle DA, Plomann M. PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington’s disease brains. Hum Molec Genet 2002; 11:2547-58.

Modrianský M, Ulrichová J, Bachleda P et al. Human hepatocyte-a model for toxicological studies. Functional and biochemical characterization. Gen Physiol Biophys 2000; 19:223-35.

Modugno F, Knoll C, Kanbour-Shakir A, Romkes M. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat 2003; 82:191-7.

Moe M, Lien S, Aasmundstad T et al. Association between SNPs within candidate genes and compounds related to boar taint and reproduction. BMC Genet 2009; 10:32.

Moerman L, Wyffels L, Slaets D, Raedt R, Boon P, de Vos F. Antiepileptic drugs modulate P-glycoproteins in the brain: A mice study with (11)C-desmethylloperamide. Epilepsy Res 2011; 94:18-25.

Moghrabi N, Clarke DJ, Boxer M, Burchell B. Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics 1993; 18:171-3.

Moghrabi N, Clarke DJ, Burchell B, Boxer M. Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis. Am J Hum Genet 1993; 53:722-9.

Mogil JS, Ritchie J, Smith SB et al. Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans. J Med Genet 2005; 42:583-7.

Mogil JS, Wilson SG, Chesler EJ et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci USA 2003; 100:4867-72.

Mogilenko DA, Shavva VS, Dizhe EB, Orlov SV, Perevozchikov AP. PPARγ activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells. Biochem Biophys Res Commun 2010; 402:477-82.

Mohamadi A, Clark LM, Lipkin PH, Mahone EM, Wodka EL, Plotnick LP. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM. Pediatric Diabetes 2010; 11:203-7

Mohamed AA, Rashed L, Amin H, Abu-Farha M, El Fadl SA, Pakhoum S. K469E polymorphism of the intercellular adhesion molecule-1 gene in Egyptians with coronary heart disease. Ann Saudi Med 2010; 30:432-6.

Mohamed AA, Rashed LA, Shaker SM, Ammar RI. Association of tumor necrosis factor-a polymorphisms with susceptibility and clinical outcomes of rheumatic heart disease. Saudi Med J 2010; 31:644-9.

Mohamed ME, Frye RF. Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities. Drug Metab Dispos 2011; 39:1522-8.

Mohamed MF, Tseng T, Frye RF. Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity. Xenobiotica 2010; 40:663-9.

Mohamed S, Schaa K, Cooper ME et al. Genetic contributions to the development of retinopathy of prematurity. Pediatr Res 2009; 65:193-7.

Mohammed HA, Ba LA, Burkholz T et al. Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors. Nat Prod Commun 2011; 6:31-4.

Moheimani F, Moore L, Ferrante JV, Trout N, Hii CS, Ferrante A. Inhibition of atherosclerotic lesion development in the ApoE-/- mouse by a novel β-oxa polyunsaturated fatty acid. J Cardiovasc Pharmacol 2010; 56:431-9.

Möhlig M, Boeing H, Spranger J et al. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab 2004; 89:1885-90.

Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, Yokoi T. Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 2010; 79:1045-52.

Mohrschladt MF, van der Sman-de Beer F, Hofman MK et al. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia. Eur J Hum Genet 2005; 13:877-82.

Mohsenin A, Burdick MD, Molina JG, Keane MP, Blackburn MR. Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease. FASEB J 2007; 21:1026-36.

Moirand R, Jouanolle AM, Brissot P, Le Gall JY, David V, Deugnier Y. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 1999; 116:372-7.

Moisés EC, Duarte Lde B, Cavalli Rde C et al. Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus. Eur J Clin Pharmacol 2008; 64:1189-96.

Moitra K, Scally M, McGee K, Lancaster G, Gold B, Dean M. Molecular evolutionary analysis of ABCB5: the ancestral gene is a full transporter with potentially deleterious single nucleotide polymorphisms. PLoS One 2011. doi:10. 1371/journal. pone. 0016318.

Mojarrabi B, Mackenzie PI. Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon. Biochem Biophys Res Commun 1998; 247:704-9.

Mojarrabi B, Mackenzie PI. The human UDP glucuronosyltransferase, UGT1A10, glucuronidates mycophenolic acid. Biochem Biophys Res Commun 1997; 238:775-8.

Mok TS, Wu YL, Thongprasert S et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361:947-57.

Mokry M, Joppa P, Slaba E et al. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD. Med Sci Monit 2008; 14:392-8.

Molchadski I, Korczyn AD, Cohen OS et al. The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia. Acta Neurol Scand 2011; 123:117-21.

Molden E, Andersson KS. Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients. Pharmacotherapy 2007; 27:603-7.

Molden E, Asberg A. Metabolic interactions with statins. Tidsskr Nor Laegeforen 2001; 121:189-93.

Molden E, Asberg A, Christensen H. CYP2D6 is involved in O-demethylation of diltiazem. An in vitro study with transfected human liver cells. Eur J Clin Pharmacol 2000; 56:575-9.

Molden E, Asberg A, Christensen H. Desacetyl-diltiazem displays severalfold higher affinity to CYP2D6 compared with CYP3A4. Drug Metab Dispos 2002; 30:1-3.

Molden E, Garcia BH, Braathen P, Eggen AE. Co-prescription of cytochrome P450 2D6/3A4 inhibitor-substrate pairs in clinical practice. A retrospective analysis of data from Norwegian primary pharmacies. Eur J Clin Pharmacol 2005; 61:119-25.

Molden E, Johansen PW, Bøe GH et al. Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype. Clin Pharmacol Ther 2002; 72:333-42.

Molden E, Lunde H, Lunder N, Refsum H. Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients. Ther Drug Monit 2006; 28:744-9.

Molden E, Skovlund E, Braathen P. Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors. Drug Saf 2008; 31:587-96.

Molema J, Lammers JW, van Herwaarden CL, Folgering HT. Effects of inhaled beclomethasone dipropionate on beta 2-receptor function in the airways and adrenal responsiveness in bronchial asthma. Eur J Clin Pharmacol 1988; 34:577-83.

Molenaar P, Christ T, Ravens U, Kaumann A. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. Cardiovasc Res 2006; 69:128-39.

Moliaka YK, Grigorenko A, Madera D, Rogaev EI. Impas 1 possesses endoproteolytic activity against multipass membrane protein substrate cleaving the presenilin 1 holoprotein. FEBS Lett 2004; 557:185-92.

Molnar E, Lazary J, Benko A et al. Seasonality and winter-type seasonal depression are associated with the rs731779 polymorphism of the serotonin-2A receptor gene. Eur Neuropsychopharmacol 2010; 20:655-62.

Molnár J, Engi H, Hohmann J et al. Reversal of multidrug resitance by natural substances from plants. Curr Top Med Chem 2010; 10:1757-68.

Molnar S, Mihanović M, Grah M, Kezić S, Filaković P, Degmecić D. Comparative study on gene tags of the neurotransmission system in schizophrenic and suicidal subjects. Coll Antropol 2010; 34:1427-32.

Molnari JC, Hassan HE, Moeller BM, Myers AL. Drug interaction study between bupropion and ticlopidine in male CF-1 mice. Biol Pharm Bull 2011; 34:447-51.

Molowa DT, Chen WS, Cimis GM, Tan CP. Transcriptional regulation of the human cholesterol 7 alpha-hydroxylase gene. Biochemistry 1992; 31:2539-44.

Moltó J, Valle M, Clotet B. Pharmacological interactions with darunavir. Enferm Infecc Microbiol Clin 2008; 26 Suppl 10:43-50.

Molvarec A, Vér A, Fekete A et al. Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia. Hypertens Res 2007; 30:205-11.

Molven A, Grimstvedt MB, Steine SJ et al. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer 2005; 44:10-8.

Molven A, Njølstad PR. Role of molecular genetics in transforming diagnosis of diabetes mellitus. Expert Rev Mol Diagn 2011; 11:313-20.

Mollazadeh S, Matin MM, Iranshahi M, Bahrami AR, Neshati V, Behnam-Rassouli F. The enhancement of vincristine cytotoxicity by combination with feselol. J Asian Nat Prod Res 2010; 12:569-75.

Möller JC, Paul D, Ganser G et al. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clin Exp Rheumatol 2010; 28:912-8.

Møller LB, Tümer Z, Lund C et al. Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome. Am J Hum Genet 2000; 66:1211-20.

Möller M, Flachsbart F, Till A et al. A functional haplotype in the 3’untranslated region of TNFRSF1B is associated with tuberculosis in two African populations. Am J Respir Crit Care Med 2010; 181:388-93.

Möllsten A, Kockum I, Svensson M et al. The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk. J Diabetes Complications 2008; 22:377-83.

Mollsten A, Marklund SL, Wessman M et al. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes 2007; 56:265-9.

Momary KM, Dorsch MP, Bates ER. Genetic causes of clopidogrel nonresponsiveness: which ones really count? Pharmacotherapy 2010; 30:265-74.

Momary KM, Shapiro NL, Viana MA, Nutescu EA, Helgason CM, Cavallari LH. Factors influencing warfarin dose requirements in African-Americans. Pharmacogenomics 2007; 8:1535-44.

Momo K, Homma M, Osaka Y, Inomata S, Tanaka M, Kohda Y. Effects of mexiletine, a CYP1A2 inhibitor, on tizanidine pharmacokinetics and pharmacodynamics. J Clin Pharmacol 2010; 50:331-7.

Momper JD, Venkataramanan R, Nolin TD. Nonrenal drug clearance in CKD: Searching for the path less traveled. Adv Chronic Kidney Dis 2010; 17:384-91.

Monaghan G, Clarke DJ, Povey S, See CG, Boxer M, Burchell B. Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13. Genomics 1994; 23:496-9.

Monajemi H, Zhang L, Li G et al. Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma. J Clin Endocr Metab 2007; 92:1606-12.

Monaldini L, Asselta R, Duga S et al. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects. Thromb Haemost 2007; 97:546-51.

Monari L, Chen SG, Brown P et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Nat Acad Sci USA 1994; 91:2839-42.

Mondorf UF, Russ A, Wiesemann A, Herrero M, Oremek G, Lenz T. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension. Am J Hypertens 1998; 11:174-83.

Mondry A, Loh M, Liu P, Zhu AL, Nagel M. Polymorphisms of the insertion / deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrol 2005; 6:1.

Monera TG, Wolfe AR, Maponga CC, Benet LZ, Guglielmo J. Moringa oleifera leaf extracts inhibit 6beta-hydroxylation of testosterone by CYP3A4. J Infect Dev Ctries 2008; 2:379-83.

Monga R, Ghai S, Datta TK, Singh D. Tissue-specific promoter methylation and histone modification regulate CYP19 gene expression during folliculogenesis and luteinization in buffalo ovary. Gen Comp Endocrinol 2011; 173:205-15.

Monks DA, Rao P, Mo K, Johansen JA, Lewis G, Kemp MQ. Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy. Horm Behav 2008; 53:729-40.

Monks TJ, Butterworth M, Lau SS. The fate of benzene-oxide. Chem Biol Interact 2010; 184:201-6.

Monostory K, Hazai E, Vereczkey L. Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chem Biol Interact 2004; 147:331-40.

Monostory K, Pascussi JM, Szabó P et al. Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent. Drug Metab Dispos 2009; 37:375-85.

Monroe KR, Murphy SP, Kolonel LN, Pike MC. Prospective study of grapefruit intake and risk of breast cancer in postmenopausal women: the Multiethnic Cohort Study. Br J Cancer 2007; 97:440-5.

Monsarrat B, Chatelut E, Royer I et al. Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4. Drug Metab Dispos 1998; 26:229-33.

Monsarrat B, Royer I, Wright M, Cresteil T. Biotransformation of taxoids by human cytochromes P450: structure-activity relationship. Bull Cancer 1997; 84:125-33.

Montagna P. Recent advances in the pharmacogenomics of pain and headache. Neurol Sci 2007; 28:208-12.

Montané E, Barriocanal A, Isern I, Parajon T, Costa J. Multiple drug interactions – induced serotonin syndrome: a case report. J Clin Pharm Ther 2009; 34:485-7.

Montane-Jaime K, Moore S, Shafe S et al. ADH1C*2 allele is associated with alcohol dependence and elevated liver enzymes in Trinidad and Tobago. Alcohol 2006; 39:81-6.

Montasser ME, Shimmin LC, Gu D et al. Blood pressure response to potassium supplementation is associated with genetic variation in endothelin 1 and interactions with E selectin in rural Chinese. J Hypertens 2010; 28:748-55.

Monte MJ, Marin JJ, Antelo A, Vazquez-Tato J. Bile acids: chemistry, physiology, and pathophysiology. World J Gastroenterol 2009; 15:804-16.

Montecucco F, Vuilleumier N, Pagano S et al. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability. Eur Heart J 2011; 32:412-21.

Montefusco L, Filopanti M, Ronchi CL et al. d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype. Clin Endocrinol 2010; 72:661-7.

Monteleone P, Tortorella A, Martiadis V, Serino I, Di Filippo C, Maj M. Association between A218C polymorphism of the tryptophan-hydroxylase-1 gene, harm avoidance and binge eating behavior in bulimia nervosa. Neurosci Lett 2007; 42:42-6.

Montesinos MC, Desai A, Delano D et al. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum 2003; 48:240-7.

Montiel V, Huberlant V, Vincent MF, Bonbled F, Hantson P. Multiple organ failure after an overdose of less than 0. 4 mg/kg of colchicine: role of coingestants and drugs during intensive care management. Clin Toxicol 2010; 48:845-8.

Montoya L, Ambros L, Kreil V et al. A pharmacokinetic comparison of meloxicam and ketoprofen following oral administration to healthy dogs. Vet Res Commun 2004; 28:415-28.

Monzo M, Brunet S, Urbano-Ispizua A et al. Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia. Blood 2006; 107:4871-9.

Monzo M, Moreno I, Navarro A et al. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine. Oncology 2007; 72:364-70.

Moody DE, Chang Y, Huang W, McCance-Katz EF. The in vivo response of novel buprenorphine metabolites, M1 and M3, to antiretroviral inducers and inhibitors of buprenorphine metabolism. Basic Clin Pharmacol Toxicol 2009; 105:211-5.

Moody DE, Walsh SL, Rollins DE, Neff JA, Huang W. Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-alpha-methadol in opioid-naive individuals. Clin Pharmacol Ther 2004; 76:154-66.

Moody GC, Griffin SJ, Mather AN, McGinnity DF, Riley RJ. Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential. Xenobiotica 1999; 29:53-75.

Mookherjee S, Banerjee D, Chakraborty S et al. Association of IL1A and IL1B loci with primary open angle glaucoma. BMC Med Genet 2010; 11:99.

Moon MS, Lee MS, Kim CT, Kim Y. Dietary chitosan enhances hepatic CYP7A1 activity and reduces plasma and liver cholesterol concentrations in diet-induced hypercholesterolemia in rats. Nutr Res Pract 2007; 1:175-9.

Moon Y, Kim SY, Ji HY et al. Characterization of cytochrome P450s mediating ipriflavone metabolism in human liver microsomes. Xenobiotica 2007; 37:246-59.

Moon YJ, Brazeau DA, Morris ME. Dietary phenethyl isothiocyanate alters gene expression in human breast cancer cells. Evid Based Complement Alternat Med 2011. doi:10. 1155/2011/462525.

Moore A, Pinkerton R. Vincristine: Can its therapeutic index be enhanced? Pediatr Blood Cancer 2009; 53:1180-7.

Moore AF, Jablonski KA, McAteer JB et al. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes 2008; 57:2503-10.

Moore CD, Reilly CA, Yost GS. CYP3A4-mediated oxygenation versus dehydrogenation of raloxifene. Biochemistry 2010; 49:4466-75.

Moore KH, Leese PT, McNeal S et al. The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers. Clin Ther 2002; 24:583-94.

Moore KJ, Rayner KJ, Suárez Y, Fernández-Hernando C. microRNAs and cholesterol metabolism. Trends Endocrinol Metab 2010; 21:699-706.

Moore KT, Plotnikov AN, Thyssen A, Vaccaro N, Ariyawansa J, Burton PB. Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban. J Cardiovasc Pharmacol 2011; 58:581-8.

Moore LB, Goodwin B, Jones SA et al. St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000; 97:7500-2.

Moore LE, Hung R, Karami S et al. Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer 2008; 8:1710-5.

Moore PE, Ryckman KK, Williams SM, Patel N, Summar ML, Sheller JR. Genetic variants of GSNOR and ADRB2 influence response to albuterol in African-American children with severe asthma. Pediatr Pulmonol 2009; 44:649-54.

Moore RC, Lee IY, Silverman GL et al. Ataxia in prion protein (PrP)- deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Molec Biol 1999; 292:797-817.

Moore TD, Nawarskas JJ, Anderson JR. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure. Heart Dis 2003; 5:354-63.

Moore ZW, Zhu B, Kuhel DG, Hui DY. Vascular apolipoprotein E expression and recruitment from circulation to modulates smooth muscle cell response to endothelial denudation. Am J Pathol 2004; 164:2109-16.

Moores JN, Roy S, Nicholson DW, Staveley BE. Huntingtin interacting protein 1 can regulate neurogenesis in Drosophila. Eur J Neurosci 2008; 28:599-609.

Moorjani M, Zhang X, Chen Y et al. 2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liability. Bioorg Med Chem Lett 2008; 18:1269-73.

Mooyaart AL, Valk EJ, van Es LA et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 2011; 54:544-53.

Moraes CT, Ciacci F, Bonilla E et al. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot? J Clin Invest 1993; 92:2906-15.

Moraes CT, Ciacci F, Bonilla E, Ionasescu V, Schon EA, DiMauro S. A mitochondrial tRNA anticodon swap associated with a muscle disease. Nat Genet 1993; 4:284-8.

Moraes MO, Pacheco AG, Schonkeren JJ et al. Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy. Genes Immun 2004; 5:592-5.

Moraga F, Troncoso R, Mellado R et al. Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure. Rev Med Chil 2008; 136:1371-80.

Morahan G, Kaur G, Singh M et al. Association of variants in the IL12B gene with leprosy and tuberculosis. Tissue Antigens 2007; 69 Suppl 1:234-6.

Morahan G, McKinnon E, Berry J et al. Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium. Genes Immun 2009; 10 Suppl 1:64-8.

Morahan JM, Yu B, Trent RJ, Pamphlett R. Genetic susceptibility to environmental toxicants in ALS. Am J Med Genet B Neuropsychiatr Genet 2007; 144:885-90.

Morais C, Gobe G, Johnson DW, Healy H. Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma. Apoptosis 2010; 15:412-25.

Morales A, Painter T, Li R et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010; 121:2176-82.

Morales MG, Amigo L, Balboa E et al. Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice. Liver Int 2010; 30:887-97.

Morales-Olivas FJ, Estañ L. Solifenacin pharmacology. Arch Esp Urol 2010; 63:43-52.

Morales-Suarez-Varela MM, Riera-Fortuny C, Mansego ML et al. Association between AT C573T polymorphism and cardiovascular risk factors in myocardial infarction. Cardiovasc Pathol 2011; 20:156-61.

Moran JL, Siegel D, Ross D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci USA 1999; 96:8150-5.

Morandi A, Maffeis C, Lobbens S et al. Early detrimental metabolic outcomes of rs17300539-A allele of ADIPOQ gene despite higher adiponectinemia. Obesity 2010; 18:1469-73.

Morava E, Wevers RA, Cantagrel V et al. A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism. Brain 2010; 133:3210-20.

Morcillo S, Cardona F, Rojo-Martínez G et al. Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). Clin Endocrinol 2008; 68:102-7.

Morcillo S, Rojo-Martínez G, Martín-Núñez GM et al. Trp64Arg polymorphism of the ADRB3 gene predicts hyperuricemia risk in a population from southern Spain. J Rheumatol 2010; 37:417-21.

Mor-Cohen R, Zivelin A, Rosenberg N, Shani M, Muallem S, Seligsohn U. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J Biol Chem 2001; 276:36923-30.

Moreau A, Le Vee M, Jouan E, Parmentier Y, Fardel O. Drug transporter expression in human macrophages. Fundam Clin Pharmacol 2011; 25:743-52.

Moreau A, Maurel P, Vilarem MJ, Pascussi JM. Constitutive androstane receptor-vitamin D receptor crosstalk: consequence on CYP24 gene expression. Biochem Biophys Res Commun 2007; 360:76-82.

Moreau C, Destée A. A new perspective on brain derived neurotrophin factor polymorphism in L-dopa induced dyskinesia. J Neurol Neurosurg Psychiatry 2009; 80:129.

Moreb JS, Baker HV, Chang LJ et al. ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. Mol Cancer 2008; 7:87.

Moree WJ, Li BF, Zamani-Kord S et al. Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia. Bioorg Med Chem Lett 2010; 20:5874-8.

Morel F, Rauch C, Coles B, Le Ferrec E, Guillouzo A. The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter. Pharmacogenetics 2002; 12:277-86.

Morel F, Rauch C, Petit E et al. Gene and protein characterization of the human glutathione S-transferase kappa and evidence for a peroxisomal localization. J Biol Chem 2004; 279:16246-53.

Morel O, Ohlmann P, Jesel L et al. Variable extent of platelet responsiveness to clopidogrel inhibition: “clopidogrel resistance”? Ann Cardiol Angeiol 2005; 54:194-200.

Moreno F, Alzualde A, Camblor PM et al. Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C. 709-1G>A progranulin mutation. Alzheimer Dis Assoc Disord 2011; 25:93-5.

Moretti P, Lieberman AP, Wilde EA et al. Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis. Neurology 2004; 62:1865-8.

Morgan CP, Bale TL. Early prenatal stress epigenetically programs dysmasculinization in second-generation offspring via the paternal lineage. J Neurosci 2011; 31:11748-55.

Morgan J, Jackson JD, Zheng X, Pandey SK, Pandey RK. Substrate affinity of photosensitizers derived from chlorophyll-a: The ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy. Mol Pharm 2010. doi:10. 1021/mp100154j.

Mori A, Maruo Y, Iwai M, Sato H, Takeuchi Y. UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation. Drug Metab Dispos 2005; 33:672-5.

Mori E, Lee K, Yasuda M et al. Accelerated hippocampal atrophy in Alzheimer’s disease with apolipoprotein E E4 allele. Ann Neurol 2002; 51:209-14.

Mori M, Nakagami H, Morishita R et al. N14I mutant presenilin-2 gene enhances cell death and decreases bcl-2 expression. Life Sci 2002; 70:2567-80.

Mori T, Chen YF, Feng JA, Hayashi T, Oparil S, Perry GJ. Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse. Cardiovasc Res 2004; 61:771-9.

Mori T, Devlin RH. Transgene and host growth hormone gene expression in pituitary and nonpituitary tissues of normal and growth hormone transgenic salmon. Mol Cell Endocrinol 1999; 149:129-39.

Mori T, Itoh S, Ohgiya S, Ishizaki K, Kamataki T. Regulation of CYP1A and CYP3A mRNAs by ascorbic acid in guinea pigs. Arch Biochem Biophys 1997; 348:268-77.

Mori T, Town T, Kobayashi M, Tan J, Fujita SC, Asano T. Augmented delayed infarct expansion and reactive astrocytosis after permanent focal ischemia in apolipoprotein E4 knock-in mice. J Cereb Blood Flow Metab 2004; 24:646-56.

Mori Y, Katsumata K, Tsuchida A, Aoki T. Single nucleotide polymorphism analysis in the GSTP1 and ABCC2 genes about neuropathy by the Oxaliplatin. Gan To Kagaku Ryoho 2008; 35:2377-81.

Mori Y, Koide A, Kobayashi Y, Morimura K, Kaneko M, Fukushima S. Effect of ethanol treatment on metabolic activation and detoxification of esophagus carcinogenic N-nitrosamines in rat liver. Mutagenesis 2002; 17:251-6.

Morikawa K, Kondo I, Kanamaru Y, Nagaoka S. A novel regulatory pathway for cholesterol degradation via lactostatin. Biochem Biophys Res Commun 2007; 352:697-702.

Mörike K, Kivistö KT, Schaeffeler E et al. Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial. Clin Pharmacol Ther 2008; 84:104-10.

Morimoto M, Reitz RC, Morin RJ, Nguyen K, Ingelman-Sundberg M, French SW. CYP-2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet. J Nutr 1995; 125:2953-64.

Morinaga T, Hasegawa G, Koyama S, Ishihara Y, Nishikawa T. Acute inflammation and immunoresponses induced by ortho-phthalaldehyde in mice. Arch Toxicol 2010; 84:397-404.

Morioka Y, Nishimura M, Imai T et al. Assessment of induction of cytochrome P450 by NO-1886 (ibrolipim), a lipoprotein lipase-promoting agent, in primary cultures of human hepatocytes and in female rat liver. Drug Metab Pharmacokinet 2006; 21:19-28.

Morioka Y, Otsu M, Naito S, Imai T. Phosphonate O-deethylation of [4-(4-bromo-2-cyano-phenylcarbamoyl) benzyl]-phosphonic acid diethyl ester, a lipoprotein lipase-promoting agent, catalyzed by cytochrome P450 2C8 and 3A4 in human liver microsomes. Drug Metab Dispos 2002; 30:301-6.

Morisaki K, Robey RW, Ozvegy-Laczka C et al. Single nucleotide polymorphisms modify the transporter activity of ABCG2. Cancer Chemother Pharmacol 2005; 56:161-72.

Morishita E, Saito M, Kumabashiri I, Asakura H, Matsuda T, Yamaguchi K. Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337→Thr and Arg-388→His). Blood 1992; 80:2275-80.

Morita A, Nakayama T, Doba N, Hinohara S, Soma M. Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP Level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res 2006; 29:323-31.

Morita H, Kurihara H, Kurihara Y et al. Responses of blood pressure and catecholamine metabolism to high salt loading in endothelin-1 knockout mice. Hypertens Res 1999; 22:11-6.

Morita H, Taguchi J, Kurihara H et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95:2032-6.

Morita J, Kobayashi K, Wanibuchi A et al. A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a Japanese subject with lowered capacity of mephobarbital 4’-hydroxylation. Drug Metab Pharmacokinet 2004; 19:236-8.

Morita K, Maeda Y, Masuda M et al. Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats. Biochem Pharmacol 1998; 55:1405-11.

Morita N, Kusuhara H, Nozaki Y, Endou H, Sugiyama Y. Functional involvement of rat organic anion transporter 2 (Slc22a7) in the hepatic uptake of the nonsteroidal anti-inflammatory drug ketoprofen. Drug Metab Dispos 2005; 33:1151-7.

Morita N, Yasumori T, Nakayama K. Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities. Biochem Pharmacol 2003; 65:1843-52.

Morita S, Shimoda K, Someya T, Yoshimura Y, Kamijima K, Kato N. Steady-state plasma levels of nortriptyline and its hydroxylated metabolites in Japanese patients: impact of CYP2D6 genotype on the hydroxylation of nortriptyline. J Clin Psychopharmacol 2000; 20:141-9.

Moriwaki Y, Yamamoto T, Higashino K. Enzymes involved in purine metabolism a review of histochemical localization and functional implications. Histol Histopathol 1999; 14:1321-40.

Moriyama B, Elinoff J, Danner RL et al. Accelerated metabolism of voriconazole and its partial reversal by cimetidine. Antimicrob Agents Chemother 2009; 53:1712-4.

Morjani H, Madoulet C. Immunosuppressors as multidrug resistance reversal agents. Methods Mol Biol 2010; 596:433-46.

Moro S, Gao ZG, Jacobson KA, Spalluto G. Progress in the pursuit of therapeutic adenosine receptor antagonists. Med Res Rev 2006; 26:131-59.

Mórocz M, Czibula A, Grózer ZB et al. Association study of BMP4, IL6, Leptin, MMP3, and MTNR1B gene promoter polymorphisms and adolescent idiopathic scoliosis. Spine 2011; 36:123-30.

Morris DW, Murphy K, Kenny N et al. Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility. Biol Psychiatry 2008; 63:24-31.

Morris GA, Lowe CE, Cooper JD et al. Polymorphism discovery and association analyses of the interferon genes in type 1 diabetes. BMC Genet 2006; 7:12.

Morris HR, Osaki Y, Holton J et al. Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSD. Neurology 2003; 61:102-4.

Morrison AC, Brancati FL, Folsom AR, Smith L, Boerwinkle E. Beta3-adrenergic receptor Trp64Arg polymorphism does not predict incident CHD or carotid intima-media thickness in a community-based sample of whites: the ARIC study. Atherosclerosis Risk in Communities. Hum Genet 1999; 105:314-9.

Morrison BA, Ucisik-Akkaya E, Flores H, Alaez C, Gorodezky C, Dorak MT. Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk. Autoimmunity 2010; 43:690-7.

Morrison PJ, JohnstonWP, Nevin NC. The epidemiology of Huntington’s disease in Northern Ireland. J Med Genet 1995; 32:524-30.

Morris-Rosenfeld S, Blessing E, Preusch MR et al. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression. Eur J Clin Invest 2011; 41:1164-71.

Morrow JA, Hatters DM, Lu B et al. Apolipoprotein E4 forms a molten globule: a potential basis for its association with disease. J Biol Chem 2002; 277:50380-5.

Morrow MP, Grant A, Mujawar Z et al. Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol Pharmacol 2010; 78:215-25.

Morrow PK, Serna R, Broglio K et al. Effect of CYP2D6 polymorphisms on breast cancer recurrence. Cancer 2011. doi:10. 1002/cncr. 26407.

Morrow T. Implications of pharmacogenomics in the current and future treatment of asthma. J Manag Care Pharm 2007; 13:497-505.

Morse MA, Lu J, Stoner GD, Murphy SE, Peterson LA. Metabolism of N-nitrosobenzylmethylamine by human cytochrome P-450 enzymes. J Toxicol Environ Health A 1999; 58:397-411.

Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J. A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 1993; 2:2081-7.

Mortensen AS, Letcher RJ, Cangialosi MV, Chu S, Arukwe A. Tissue bioaccumulation patterns, xenobiotic biotransformation and steroid hormone levels in Atlantic salmon (Salmo salar) fed a diet containing perfluoroactane sulfonic or perfluorooctane carboxylic acids. Chemosphere 2011; 83:1035-44.

Mortensen EL, Hogh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 2001; 57:89-95.

Mosaffa F, Kalalinia F, Parhiz BH, Behravan J. Tumor necrosis factor alpha induces stronger cytotoxicity in ABCG2-overexpressing resistant breast cancer cells compared with their drug-sensitive parental line. DNA Cell Biol 2011; 30:413-8.

Moshal KS, Zeldin DC, Sithu SD et al. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia. J Cell Physiol 2008; 215:771-81.

Mosher CM, Tai G, Rettie AE. CYP2C9 amino acid residues influencing phenytoin turnover and metabolite regio- and stereochemistry. J Pharmacol Exp Ther 2009; 329:938-44.

Mosig RA, Dowling O, DiFeo A et al. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum Mol Genet 2007; 16:1113-23.

Moss DM, Kwan WS, Liptrott NJ et al. Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir. Antimicrob Agents Chemother 2011; 55:879-87.

Mössner R, Döring N, Scherag A et al. Transmisión disequilibrium analysis of the functional 5-HT3A receptor variant C178T in early-onset obsessive compulsive-disorder. J Psychopharmacol 2007; 21:833-6.

Mössner R, Schuhmacher A, Schulze-Rauschenbach S et al. Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia. Eur Neuropsychopharmacol 2008; 18:768-72.

Mostowska A, Biedziak B, Dunin-Wilczynska I, Komorowska A, Jagodzinski PP. Polymorphisms in CHDH gene and the risk of tooth agenesis. Birth Defects Res A Clin Mol Teratol 2011; 91:169-76.

Mostowska A, Hozyasz KK, Jagodzinski PP. Maternal MTR genotype contributes to the risk of non-syndromic cleft lip and palate in the Polish population. Clin Genet 2006; 69:512-7.

Mosyagin I, Runge U, Schroeder HW et al. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients. Epilepsia 2008; 49:1555-61.

Mota-Velasco JC, Ferreira IA, Cioffi MB et al. Characterisation of the chromosome fusions in Oreochromis karongae. Chromosome Res 2010; 18:575-86.

Motazacker MM, Rost BR, Hucho T et al. A defect in the ionotropic glutamate receptor 6 gene (GRIK2) is associated with autosomal recessive mental retardation. Am J Hum Genet 2007; 81:792-8.

Motomura K, Ishitobi M, Komoike Y et al. Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors. Oncology 2010; 79:55-61.

Moton A, Ma L, Krishna G, Martinho M, Seiberling M, McLeod J. Effects of oral posaconazole on the pharmacokinetics of sirolimus. Curr Med Res Opin 2009; 25:701-7.

Motsinger AA, Donahue BS, Brown NJ, Roden DM, Ritchie MD. Risk factor interactions and genetic effects associated with post-operative atrial fibrillation. Pac Symp Biocomput 2006:584-95.

Motsinger AA, Ritchie MD, Shafer RW et al. Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenet Genomics 2006; 16:837-45.

Motsinger-Reif AA, Antas PR, Oki NO, Levy S, Holland SM, Sterling TR. Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. BMC Med Genet 2010; 11:37.

Mottl AK, Shoham DA, North KE. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med 2008; 10:560-74.

Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev 2006; CD003491.

Motushchuk AE, Komarova TIu, Grudinina NA et al. Genetic variants of CYP1B1 and WDR36 in the patients with primary congenital glaucoma and primary open angle glaucoma from Saint-Petersburg. Genetika 2009; 45:1659-67.

Motwani M, Li X, Schwartz GK. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells. Clin Cancer Res 2000; 6:924-32.

Moubarak AS, Rosenkrans CF Jr, Johnson ZB. Modulation of cytochrome P450 metabolism by ergonovine and dihydroergotamine. Vet Hum Toxicol 2003; 45:6-9.

Mougey EB, Feng H, Castro M, Irvin CG, Lima JJ. Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics 2009; 19:129-38.

Mouillet-Richard S, Ermonval M, Chebassier C et al. Signal transduction through prion protein. Science 2000; 289:1925-8.

Mouillet-Richard S, Teil C, Lenne M et al. Mutation condon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease. J Neurol Sci 1999; 168:141-4.

Moukdar F, Robidoux J, Lyght O, Pi J, Daniel KW, Collins S. Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice. J Lipid Res 2009; 50:59-70.

Mouly S, Lown KS, Kornhauser D et al. Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans. Clin Pharmacol Ther 2002; 72:1-9.

Mouly S, Meune C, Bergmann JF. Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4. Intensive Care Med 2009; 35:417-29.

Mouly S, Rizzo-Padoin N, Simoneau G et al. Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients. Br J Clin Pharmacol 2006; 62:200-9.

Mouly SJ, Matheny C, Paine MF et al. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5. Clin Pharmacol Ther 2005; 78:605-18.

Mouly SJ, Paine MF, Watkins PB. Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavir. J Pharmacol Exp Ther 2004; 308:941-8.

Mounsey KE, Pasay CJ, Arlian LG et al. Increased transcription of Glutathione S-transferases in acaricide exposed scabies mites. Parasit Vectors 2010; 3:43.

Mountfield RJ, Senepin S, Schleimer M, Walter I, Bittner B. Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. Int J Pharm 2000; 211:89-92.

Mourskaia AA, Dong Z, Ng S et al. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone. Oncogene 2009; 28:1005-15.

Moustakas AK, van de Wal Y, Routsias J et al. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int Immunol 2000; 12:1157-66.

Mouzo R, Álvarez XA, Pichel V, Alcaraz M, Cacabelos R. Apolipoprotein E-related blood pressure parameters in senile dementia. Ann Psychiatry 1999; 7:93-7.

Mowat BF, Skinner ER, Watt C et al. Lipoprotein profiles in Alzheimer’s disease: lack of an effect of apolipoprotein E4 phenotype on the distribution of high density lipoprotein subfractions. Alzheimer’s Research 1996; 2:89-94.

Moyer AM, Sun Z, Batzler AJ et al. Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy. Cancer Epidemiol Biomarkers Prev 2010; 19:811-21.

Moyer RA, Wang D, Papp AC et al. Intronic polymorphisms affecting alternative splicing of human dopamine d2 receptor are associated with cocaine abuse. Neuropsychopharmacology 2011; 36:753-62.

Mrazek DA, Biernacka JM, O’Kane DJ et al. CYP2C19 variation and citalopram response. Pharmacogenet Genomics 2011; 21:1-9.

Mrozikiewicz PM, Bogacz A, Czerny B et al. The influence of a standardized soybean extract (Glycine max) on the expression level of cytochrome P450 genes in vivo. Ginekol Pol 2010; 81:516-20.

Mrozikiewicz PM, Bogacz A, Karasiewicz M et al. The effect of standardized Echinacea purpurea extract on rat cytochrome P450 expression level. Phytomedicine 2010; 17:830-3.

Mruk DD, Su L, Cheng CY. Emerging role for drug transporters at the blood-testis barrier. Trends Pharmacol Sci 2011; 32:99-106.

Mück W. Clinical pharmacokinetics of cerivastatin. Clin Pharmacokinet 2000; 39:99-116.

Mück W, Ochmann K, Rohde G, Unger S, Kuhlmann J. Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. Eur J Clin Pharmacol 1998; 53:469-73.

Muchowski PJ, Ning K, D’Souza-Schorey C, Fields S. Requirement of a intact microtubule cytoskeleton for aggression and inclusion body formation by a mutant huntingtin fragment. Proc Nat Acad Sci USA 2002; 99:727-32.

Muftuoglu Y, Mustata G. Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). Bioorg Med Chem Lett 2010; 20:3050-64.

Muftuoglu Y, Mustata G. Aromatase inhibitors and antiepileptic drugs: a computational systems biology analysis. Reprod Biol Endocrinol 2011; 9:92.

Mugat B, Parmentier ML, Bonneaud N, Chan HY, Maschat F. Protective role of Engrailed in a Drosophila model of Huntington’s disease. Hum Mol Genet 2008; 17:3601-16.

Muggerud AA, Rønneberg JA, Wärnberg F et al. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res 2010; 12:3.

Mugundu GM, Hariparsad N, Desai PB. Impact of ritonavir, atazanavir and their combination on the CYP3A4 induction potential of efavirenz in primary human hepatocytes. Drug Metab Lett 2010; 4:45-50.

Mui S, Rebeck GW, McKenna-Yasek D, Hyman BT, Brown RH Jr. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 1995; 38:460-3.

Muijsers RB, Plosker GL, Noble S. Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs Aging 2002; 19:377-92.

Muir VJ, Scott LJ. Denosumab: in cancer treatment-induced bone loss. BioDrugs 2010; 24:379-86.

Muirhead GJ, Faulkner S, Harness JA, Taubel J. The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers. Br J Clin Pharmacol 2002; 53 Suppl 1:37-43.

Muirhead GJ, Wulff MB, Fielding A, Kleinermans D, Buss N. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir. Br J Clin Pharmacol 2000; 50:99-107.

Mujawar Z, Tamehiro N, Grant A, Sviridov D, Bukrinsky M, Fitzgerald ML. Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation. Biochemistry 2010; 49:8338-49.

Mukai K, Imai M, Shimada H, Ishimura Y. Isolation and characterization of rat CYP11B genes involved in late steps of mineralo- and glucocorticoid syntheses. J Biol Chem 1993; 268:9130-7.

Mukanganyama S, Widersten M, Naik YS, Mannervik B, Hasler JA. Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance. Int J Cancer 2002; 97:700-5.

Mukherjee B, Salavaggione OE, Pelleymounter LL et al. Glutathione S-transferase omega 1 and omega 2 pharmacogenomics. Drug Metab Dispos 2006; 34:1237-46.

Mukherjee D, Kline-Rogers E, Fang J, Munir K, Eagle KA. Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome. Heart 2005; 91:23-6.

Mukonzo JK, Röshammar D, Waako P et al. A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans. Br J Clin Pharmacol 2009; 68:690-9.

Mukonzo JK, Waako P, Ogwal-Okeng J, Gustafsson LL, Aklillu E. Genetic variations in ABCB1 and CYP3A5 as well as sex influence quinine disposition among Ugandans. Ther Drug Monit 2010; 32:346-52.

Mukundan L, Odegaard JI, Morel CR et al. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med 2009; 15:1266-72.

Mula M, Monaco F. Carbamazepine-risperidone interactions in patients with epilepsy. Clin Neuropharmacol 2002; 25:97-100.

Mulatero P, Tizzani D, Viola A et al. Prevalence and Characteristics of Familial Hyperaldosteronism: The PATOGEN Study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension 2011; 58:797-803.

Mulder AB, van Lijf HJ, Bon MA et al. Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin. Clin Pharmacol Ther 2001; 70:546-51.

Mulder H, Cohen D, Scheffer H et al. HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study. J Clin Psychopharmacol 2009; 29:16-20.

Mulder H, Franke B, van der-Beek AA et al. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. Pharmacogenomics J 2007; 7:318-24.

Mulder H, Franke B, van der-Beek van der AA et al. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. J Clin Psychopharmacol 2007; 27:338-43.

Mulder H, Herder A, Wilmink FW, Tamminga WJ, Belitser SV, Egberts AC. The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice. Pharmacoepidemiol Drug Saf 2006; 15:107-14.

Mulder H, Nagorny CL, Lyssenko V, Groop L. Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia 2009; 52:1240-9.

Mullan M, Crawford F, Axelman K et al. A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992; 1:345-7.

Mullany LK, Hanse EA, Romano A et al. Cyclin D1 regulates hepatic estrogen and androgen metabolism. Am J Physiol Gastrointest Liver Physiol 2010; 298:884-95.

Mullen Grey AK, Riddick DS. The aryl hydrocarbon receptor pathway and the response to 3-methylcholanthrene are altered in the liver of adrenalectomized rats. Drug Metab Dispos 2011; 39:83-91.

Müller DJ, Kennedy JL. Genetics of antipsychotic treatment emergent weight gain in schizophrenia. Pharmacogenomics 2006; 7:863-87.

Muller M, Yong M, Peng XH, Petre B, Arora S, Ambudkar SV. Evidence for the role of glycosylation in accessibility of the extracellular domains of human MRP1 (ABCC1). Biochemistry 2002; 41:10123-32.

Müller PJ, Dally H, Klappenecker CN et al. Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients. Int J Cancer 2009; 124:1669-74.

Muller YL, Infante AM, Hanson RL et al. Variants in hepatocyte nuclear factor 4alpha are modestly associated with type 2 diabetes in Pima Indians. Diabetes 2005; 54:3035-9.

Müller-Enoch D. Investigations on the role of cytochrome b5 and divalent cations in the maximal nifedipine oxidase activity of human liver. Arzneimittelforschung 1999; 49:470-5.

Müller-Enoch D, Gruler H. Complexation of membrane-bound enzyme systems. Z Naturforsch C 2000; 55:747-52.

Mulley JC, Nelson P, Guerrero S et al. A new molecular mechanism for severe myoclonic epilepsy of infancy: exonic deletions in SCN1A. Neurology 2006; 67:1094-5.

Mulligan CJ, Robin RW, Osier MV et al. Allelic variation at alcohol metabolism genes (ADH1B, ADH1C, ALDH2) and alcohol dependence in an American Indian population. Hum Genet 2003; 113:325-36.

Mulligan LM, Eng C, Healey CS et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 1994; 6:70-4.

Mumford AD, McVey JH, Morse CV et al. Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C. Br J Haematol 2003; 123:496-501.

Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol 2000; 228:151-65.

Mumm JS, Schroeter EH, Saxena MT et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 2000; 5:197-206.

Munić V, Kelnerić Z, Mikac L, Eraković Haber V. Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays. Eur J Pharm Sci 2010; 41:86-95.

Munshi A, Sharma V, Kaul S et al. Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke. Mol Biol Rep 2011. doi:10. 1007/s11033-011-0907-y.

Munshi A, Sharma V, Kaul S et al. Association of the -344C/T aldosterone synthase (CYP11B2) gene variant with hypertension and stroke. J Neurol Sci 2010; 296:34-8.

Munshi A, Sharma V, Kaul S et al. Estrogen receptor α genetic variants and the risk of stroke in a South Indian population from Andhra Pradesh. Clin Chim Acta 2010; 411:1817-21.

Munster PN, Thurn KT, Thomas S et al. A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer. Br J Cancer 2011; 104):1828-35.

Muntané-Relat J, Ourlin JC, Domergue J, Maurel P. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 1995; 22:1143-53.

Muntjewerff JW, Hoogendoorn ML, Kahn RS et al. Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: a Dutch population based case-control study. Am J Med Genet B Neuropsychiatr Genet 2005; 135:69-72.

Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry 2006; 11:143-9.

Muñoz de Benito RM, Arribas López JR. Prospective validation of a pharmacogenetic test: the PREDICT-1 study. Enferm Infecc Microbiol Clin 2008; 26 Suppl 6:40-4.

Muñoz S, Vollrath V, Vallejos MP et al. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile. Pharmacogenetics 1998; 8:343-51.

Muñoz-Descalzo S, Tkocz K, Balayo T, Martinez Arias A. Modulation of the ligand-independent traffic of Notch by Axin and Apc contributes to the activation of Armadillo in Drosophila. Development 2011; 138:1501-6.

Muñoz-Martínez F, Lu P, Cortés-Selva F et al. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance. Cancer Res 2004; 64:7130-8.

Mura A, Gadau S, Lepore G et al. Expression and distribution of P450-aromatase in the ovine hypothalamus at different stages of fetal development. Neuro Endocrinol Lett 2010; 31:690-9.

Murai K, Yamazaki H, Nakagawa K, Kawai R, Kamataki T. Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes. Xenobiotica 2009; 39:795-802.

Murai T, Mori Y, Tatematsu K et al. Differences in susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis. Cancer Sci 2005; 96:637-44.

Murakami T, Paitel E, Kawarabayashi T et al. Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation. Am J Pathol 2006; 169:1365-75.

Murakami T, Yokooji T, Mori N. Study on absorption sites of quinidine and methotrexate in rat intestine. Pharmazie 2010; 65:440-7.

Muralidharan G, Cooper JK, Hawes EM, Korchinski ED, Midha KK. Quinidine inhibits the 7-hydroxylation of chlorpromazine in extensive metabolisers of debrisoquine. Eur J Clin Pharmacol 1996; 50:121-8.

Muramori K, Taguchi S, Taguchi T et al. High aromatase activity and overexpression of epidermal growth factor receptor in fibrolamellar hepatocellular carcinoma in a child. J Pediatr Hematol Oncol 2011; 33:195-7.

Muraoka-Cook RS, Feng SM, Strunk KE, Earp HS 3rd. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. J Mammary Gland Biol Neoplasia 2008; 13:235-46.

Murase T, Okubo M, Takeuchi I. Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia. J Clin Lipidol 2010; 4:99-104.

Murayama N, Imai N, Nakane T, Shimizu M, Yamazaki H. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes. Biochem Pharmacol 2007; 73:2020-6.

Murayama N, Minoshima M, Shimizu M, Guengerich FP, Yamazaki H. Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol. Xenobiotica 2007; 37:717-24.

Murayama N, Nakamura T, Saeki M et al. CYP3A4 gene polymorphisms influence testosterone 6beta-hydroxylation. Drug Metab Pharmacokinet 2002; 17:150-6.

Murdoch ME, Payton A, Abiose A et al. HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna-London-Manchester Collaboration for Research on Onchocerciasis. Hum Immunol 1997; 55:46-52.

Mürdter TE, Schroth W, Bacchus-Gerybadze L et al. Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma. Clin Pharmacol Ther 2011; 89:708-17.

Murn J, Alibert O, Wu N, Tendil S, Gidrol X. Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4. J Exp Med 2008; 205:3091-103.

Murphy GM Jr, Kremer C, Rodrigues HE, Schatzberg AF. Pharmacogenetics of antidepressant medication intolerance. Am J Psychiatry 2003; 160:1830-5.

Murphy M, Antia U, Chang HY et al. Party pills and drug-drug interactions. N Z Med J 2009; 122:3564.

Murphy MJ, Dominiczak MH. Efficacy of statin therapy: possible effect of phenytoin. Postgrad Med J 1999; 75:359-60.

Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008; 4:200-13.

Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 1998; 35:637-40.

Murray BP, Correia MA. Ubiquitin-dependent 26S proteasomal pathway: a role in the degradation of native human liver CYP3A4 expressed in Saccharomyces cerevisiae? Arch Biochem Biophys 2001; 393:106-16.

Murray BP, Zgoda VG, Correia MA. Native CYP2C11: heterologous expression in Saccharomyces cerevisiae reveals a role for vacuolar proteases rather than the proteasome system in the degradation of this endoplasmic reticulum protein. Mol Pharmacol 2002; 61:1146-53.

Murray GI, McFadyen MC, Mitchell RT, Cheung YL, Kerr AC, Melvin WT. Cytochrome P450 CYP3A in human renal cell cancer. Br J Cancer 1999; 79:1836-42.

Murray GI, Patimalla S, Stewart KN, Miller ID, Heys SD. Profiling the expression of cytochrome P450 in breast cancer. Histopathology 2010; 57:202-11.

Murray IA, Flaveny CA, Chiaro CR et al. Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3’,4’-dimethoxy-α-naphthoflavone. Mol Pharmacol 2011; 79:508-19.

Murray M. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab 2006; 7:67-81.

Murray M. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents. J Pharm Pharmacol 2006; 58:871-85.

Murray S, Odupitan AO, Murray BP, Boobis AR, Edwards RJ. Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline. Xenobiotica 2001; 31:135-51.

Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 1991; 254:97-9.

Murrell JR, Spillantini MG, Zolo P et al. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. J Neuropathol Exp Neurol 1999; 58:1207-26.

Murry DJ, Cherrick I, Salama V et al. Influence of phenytoin on the disposition of irinotecan: a case report. J Pediatr Hematol Oncol 2002; 24:130-3.

Murugesan D, Arunachalam T, Ramamurthy V, Subramanian S. Association of polymorphisms in leptin receptor gene with obesity and type 2 diabetes in the local population of Coimbatore. Indian J Hum Genet 2010; 16:72-7.

Muscatello MR, Bruno A, Pandolfo G, Micò U, Settineri S, Zoccali R. Emerging treatments in the management of schizophrenia – focus on sertindole. Drug Des Devel Ther 2010; 4:187-201.

Muschler E, Lal J, Jetter A et al. The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro. Basic Clin Pharmacol Toxicol 2009; 105:374-9.

Mushiroda T, Douya R, Takahara E, Nagata O. The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. Drug Metab Dispos 2000; 28:1231-7.

Mushiroda T, Wattanapokayakit S, Takahashi A et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 2008; 45:654-6.

Mushiroda T, Yokoi T, Itoh K et al. The house musk shrew (Suncus murinus): a unique animal with extremely low level of expression of mRNAs for CYP3A and flavin-containing monooxygenase. Comp Biochem Physiol C Toxicol Pharmacol 2000; 126:225-34.

Musilek K, Dolezal M, Gunn-Moore F, Kuca K. Design, evaluation and structure-Activity relationship studies of the AChE reactivators against organophosphorus pesticides. Med Res Rev 2011; 31:548-75.

Musshoff F, Madea B, Stüber F, Stamer UM. Enantioselective determination of ondansetron and 8-hydroxyondansetron in human plasma from recovered surgery patients by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2010; 34:581-6.

Mustajoki P, Mustajoki S, Rautio A, Arvela P, Pelkonen O. Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy men. Clin Pharmacol Ther 1994; 56:9-13.

Musuamba FT, Mourad M, Haufroid V, Delattre IK, Verbeeck RK, Wallemacq P. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study. Ther Drug Monit 2009; 31:734-42.

Muszkat M, Bialer O, Blotnick S et al. Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults. Clin Ther 2010; 32:347-56.

Mutafova-Yambolieva VN, Hwang SJ, Hao X et al. Beta-nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle. Proc Nat Acad Sci USA 2007; 104:16359-64.

Mutch E, Daly AK, Leathart JB, Blain PG, Williams FM. Do multiple cytochrome P450 isoforms contribute to parathion metabolism in man? Arch Toxicol 2003; 77:313-20.

Mutch E, Williams FM. Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Toxicology 2006; 224:22-32.

Mutlu GM, Adir Y, Jameel M et al. Interdependency of beta-adrenergic receptors and CFTR in regulation of alveolar active Na+ transport. Circ Res 2005; 96:999-1005.

Muto S, Fujita K, Yamazaki Y, Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 2001; 479:197-206.

Mutsuddi M, Morris DW, Waggoner SG, Daly MJ, Scolnick EM, Sklar P. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am J Hum Genet 2006; 79:903-9.

Muzeeb S, Basha SJ, Shashikumar D, Mullangi R, Srinivas NR. Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8. Eur J Drug Metab Pharmacokinet 2006; 31:299-309.

Mwantembe O, Gaillard MC, Barkhuizen M et al. Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals. Immunogenetics 2001; 52:249-54.

Mwenifumbo JC, Al Koudsi N, Ho MK et al. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. Hum Mutat 2008; 29:679-88.

Mwenifumbo JC, Lessov-Schlaggar CN, Zhou Q et al. Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. Clin Pharmacol Ther 2008; 83:115-21.

Mwenifumbo JC, Tyndale RF. Molecular genetics of nicotine metabolism. Handb Exp Pharmacol 2009; 192:235-59.

Mwenifumbo JC, Zhou Q, Benowitz NL, Sellers EM, Tyndale RF. New CYP2A6 gene deletion and conversion variants in a population of Black African descent. Pharmacogenomics 2010; 11:189-98.

Mwinyi J, Cavaco I, Pedersen RS et al. Regulation of CYP2C19 expression by estrogen receptor α: implications for estrogen-dependent inhibition of drug metabolism. Mol Pharmacol 2010; 78:886-94.

Mwinyi J, Cavaco I, Yurdakok B, Mkrtchian S, Ingelman-Sundberg M. The ligands of estrogen receptor alpha regulate cytochrome P4502C9 (CYP2C9) expression. J Pharmacol Exp Ther 2011; 338:302-9.

Mwinyi J, Hofmann Y, Pedersen RS et al. The transcription factor GATA-4 regulates cytochrome P4502C19 gene expression. Life Sci 2010; 86:699-706.

Myers AJ, Kaleem M, Marlowe L et al. The H1c haplotype at the MAPT locus is associated with Alzheimer’s disease. Hum Molec Genet 2005; 14:2399-404.

Myers MJ, Farrell DE, Howard KD, Kawalek JC. Effects of intravenous administration of lipopolysaccharide on cytochrome P450 isoforms and hepatic drug metabolizing enzymes in swine. Am J Vet Res 2010; 71:342-8.

Myers RH, Cupples LA, Schoenfeld M et al. Maternal factor in onset of Huntington’s disease. Am J Hum Genet 1985; 37:511-23.

Myers RH, Goldman D, Bird ED et al. Maternal transmission in Huntigtons’s disease. Lancet 1983; 1:208-10.

Myers RH, Madden JJ, Teague JL, Falek A. Factor related to onset age of Huntigton’s disease. Am J Hum Genet 1982; 34:481-8.

Myers RH, Schaefer Ej, Wilson PWF et al. Apolipoprotein e epsilon-4 association with dementia in a population-based study: the Framingham study. Neurology 1996; 46:673-7.

Myles S, Lea RA, Ohashi J et al. Testing the thrifty gene hypothesis: the Gly482Ser variant in PPARGC1A is associated with BMI in Tongans. BMC Med Genet 2011; 12:10.

Myllynen P, Kummu M, Kangas T et al. ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol 2008; 232:210-7.

Myllynen P, Kummu M, Sieppi E. ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison. Expert Opin Drug Metab Toxicol 2010; 6:1385-98.

Myrand SP, Sekiguchi K, Man MZ et al. Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations. Clin Pharmacol Ther 2008; 84:347-61.